Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3011960	p-bnp	ng/l (ng/l)	28855	86896	0.00%
3011960	p-bnp	— (—)	6014	9405	100.00%	Distribution not available
3011960	p-bnp	ng/l______ (ng/l)	712	1230	0.00%
3011960	p-bnp	ng/L (ng/l)	142	221	0.00%
3011960	p-bnp	NG/L (ng/l)	117	159	0.00%
3011960	p-bnp	ng/ml (ng/l)	14	14	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Infections, IBD-co-morbidities

1038

1892

4.22

321.59

4.2

2.5

256.28

200.65

ng/l

2.14

960

1740

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1278

4000

3.51

320.20

4.0

3.1

214.99

171.09

ng/l

2.80

1175

3588

Other septicaemia

3082

14226

2.22

319.11

4.6

2.9

351.90

202.96

ng/l

32.16

2874

13044

Amiodarone users

1185

3814

3.96

316.53

6.1

3.1

406.04

216.51

ng/l

18.28

1138

3512

Oedema, not elsewhere classified

2496

11052

2.40

314.18

3.5

2.7

226.62

199.00

ng/l

2.03

2261

10167

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

1331

4351

3.35

310.22

4.0

3.1

217.31

173.86

ng/l

2.83

1221

3908

Angina pectoris

5246

11365

3.49

307.65

3.9

2.2

228.99

144.32

ng/l

25.92

4925

10237

Cerebrovascular diseases (FINNGEN)

1948

2307

6.53

307.65

3.5

1.5

201.26

47.84

ng/l

46.94

1764

2008

Hard cardiovascular diseases

7401

13374

3.67

307.65

3.8

2.2

206.10

128.95

ng/l

33.98

6885

11975

Codeine

5603

15800

2.01

307.65

3.1

2.7

187.69

201.37

ng/l

1.21

5066

14397

Renal tubulo-interstitial diseases

6374

22793

2.19

307.65

4.2

2.6

312.40

162.52

ng/l

73.00

5883

20789

Renal failure

4224

17888

2.21

307.65

5.1

2.9

460.00

198.52

ng/l

84.58

3957

16419

Asthma (mode)

4735

11235

2.34

307.65

3.3

2.3

159.69

166.94

ng/l

0.51

4302

10196

Left ventricular outflow tract obstruction (LVOTO), broad definition

976

2509

4.73

307.65

3.7

2.9

201.10

149.87

ng/l

3.40

924

2242

Other heart diseases

4456

3146

10.69

307.65

4.0

1.6

198.80

44.73

ng/l

109.69

4142

2692

Oral corticosteroids

7234

22520

1.98

307.65

3.9

2.6

194.64

199.44

ng/l

0.37

6600

20495

Cardiac arrhythmias

4785

5759

5.95

307.65

3.6

1.7

187.51

72.68

ng/l

54.09

4438

5054

Ischemic heart diseases

7700

13795

3.76

307.65

3.9

2.2

213.35

131.02

ng/l

38.71

7199

12338

COPD/asthma/ILD related infections

6067

16701

1.90

307.65

3.4

2.4

206.68

172.21

ng/l

6.12

5537

15177

Asthma-related infections

4396

20826

2.20

307.65

4.0

2.9

198.14

213.28

ng/l

1.39

4043

19010

Dizziness and giddiness

5214

21396

2.01

307.65

3.4

2.9

192.13

206.90

ng/l

1.46

4799

19531

Other bacterial diseases

7272

22121

2.34

307.65

3.8

2.7

261.63

170.67

ng/l

39.20

6705

20126

Influenza and pneumonia

7838

20838

2.49

307.65

3.8

2.5

224.31

163.79

ng/l

19.93

7217

18851

Condition for Implicit Sepsis (Organ dysfunction codes)

6919

20143

2.58

307.65

4.0

2.5

254.59

166.74

ng/l

33.89

6406

18261

Bacterial Sepsis

4856

15426

2.95

307.65

4.8

2.6

329.49

192.50

ng/l

42.72

4540

14104

Chronic lower respiratory diseases

7439

22844

1.79

307.65

3.3

2.8

185.34

199.83

ng/l

1.62

6769

20781

Tramadol

5095

15384

2.10

307.65

3.1

2.7

186.90

206.46

ng/l

2.16

4602

14043

Other pulmonary diagnosis

4489

11259

2.09

307.65

3.2

2.3

185.40

164.48

ng/l

2.52

4072

10217

Non-rheumatic valve diseases

5085

8136

5.30

307.65

3.9

1.9

273.59

79.15

ng/l

121.95

4820

7260

Bacterial infection, other or unspecified

4454

17644

2.32

307.65

4.1

2.8

313.54

190.07

ng/l

33.32

4101

16170

Cardiovascular diseases (excluding rheumatic etc)

3709

3737

6.13

307.65

3.4

1.6

138.94

44.25

ng/l

47.98

3317

3178

Erysipelas

4377

18660

2.18

307.65

3.7

2.8

280.02

184.94

ng/l

22.55

4016

17074

Asthma (only as main-diagnosis), excluding more controls

4270

8999

2.79

307.65

3.4

1.9

159.70

91.18

ng/l

26.39

3869

8089

Asthma, excluding more controls

4687

8999

2.85

307.65

3.3

1.9

157.82

91.18

ng/l

28.08

4245

8089

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

6756

16701

2.54

307.65

3.8

2.4

227.76

172.21

ng/l

14.07

6250

15177

Pacemaker

4487

14851

3.39

307.65

5.2

2.9

362.98

222.81

ng/l

44.87

4281

13624

Heart failure and bmi 25plus

3798

8483

3.54

307.65

5.0

2.3

378.14

111.44

ng/l

142.79

3617

7727

Other septicaemia, including avohilmo

3165

14427

2.24

307.65

4.5

2.9

347.59

202.07

ng/l

32.06

2951

13224

Septicaemia

3522

15279

2.29

307.65

4.5

2.9

340.60

198.24

ng/l

35.45

3279

14009

Anaemias

1192

757

10.94

307.65

4.2

1.4

215.19

40.03

ng/l

31.63

1083

661

Other bacterial diseases, including avohilmo

7330

21604

2.26

307.65

3.7

2.7

241.37

164.98

ng/l

31.12

6739

19608

Depression medications

896

800

5.85

307.65

2.7

1.4

95.97

33.08

ng/l

9.03

765

691

Opioids

5534

15933

1.86

307.65

3.1

2.7

183.52

202.10

ng/l

2.08

5005

14506

Heart failure, not strict

8284

14723

4.47

307.65

4.4

2.0

298.67

89.19

ng/l

215.79

7763

13381

Bacterial pneumoniae

4165

12668

3.30

307.65

4.7

2.6

252.19

195.86

ng/l

10.05

3890

11573

Continuous positive airway pressure

1249

1978

5.87

307.65

3.7

1.7

466.75

83.21

ng/l

50.46

1154

1750

Bacterial pneumonia (organism specified)

4343

15625

2.83

307.65

4.7

2.8

251.02

226.44

ng/l

2.49

4052

14271

Explicit Sepsis, including avohilmo

3683

15326

2.37

307.65

4.5

2.6

334.43

190.48

ng/l

38.95

3432

13991

Viral Sepsis

1974

7377

3.05

307.65

5.4

2.7

264.96

196.24

ng/l

7.92

1839

6716

Implicit viral Sepsis, including avohilmo

2713

11143

2.71

307.65

4.7

2.7

256.73

189.92

ng/l

10.65

2530

10193

Valvular heart disease excluding rheumatic fever

5146

8175

5.35

307.65

3.9

1.9

273.53

79.33

ng/l

123.13

4880

7290

Asthma, hospital admissions 3, pneumonia

3211

14255

2.48

307.65

4.4

3.1

227.33

238.70

ng/l

0.66

2988

13043

Asthma, unspecified (mode)

3989

10815

2.88

307.65

3.5

2.3

182.63

167.36

ng/l

1.36

3666

9838

Asthma-related pneumonia

3210

14224

2.48

307.65

4.4

3.1

227.31

238.67

ng/l

0.66

2987

13013

Metabolic disorders

6711

19093

2.25

307.65

3.3

2.8

208.58

187.69

ng/l

2.62

6150

17295

Non-ischemic cardiomyopathy

3306

7402

4.21

307.65

4.3

2.1

346.40

107.88

ng/l

109.69

3116

6701

Hypothyroidism and >3 levothyroxin purchases

815

764

6.23

307.65

3.3

1.4

110.42

34.62

ng/l

13.22

715

661

Excluding asthma or asthma-COPD overlap

4460

11259

2.07

307.65

3.2

2.3

182.57

164.48

ng/l

2.01

4041

10217

Cardiomyopathy (excluding other)

1782

2847

8.57

307.65

5.9

1.9

428.23

85.76

ng/l

81.19

1729

2515

Diseases of arteries, arterioles and capillaries (FINNGEN)

2081

1802

9.29

307.65

3.3

1.6

282.49

52.05

ng/l

61.55

1947

1574

General symptoms and signs

6508

17052

2.00

307.65

3.3

2.6

196.93

181.35

ng/l

1.62

5914

15521

Abnormalities of heart beat

2856

9175

3.33

307.65

3.8

2.4

204.52

199.45

ng/l

0.23

2618

8378

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

7101

20217

2.37

307.65

4.2

2.4

237.56

163.16

ng/l

27.89

6602

18207

Hypertensive diseases

4778

11214

2.55

307.65

3.3

2.5

180.83

144.92

ng/l

6.30

4356

10081

Asthma

4975

11163

2.44

307.65

3.3

2.3

161.79

164.96

ng/l

0.20

4520

10134

Symptoms and signs involving cognition, perception, emotional state and behaviour

6628

23148

2.02

307.65

3.3

2.9

190.58

200.18

ng/l

0.80

6078

21067

Abnormalities of breathing

7199

12909

3.49

307.65

3.7

2.5

208.22

188.04

ng/l

2.21

6585

11665

Haemorrhage from respiratory passages

2888

9359

3.03

307.65

3.9

2.5

272.18

214.59

ng/l

6.48

2668

8553

First line medication for Crohn's disease

6669

20877

1.79

307.65

3.8

2.6

203.35

196.52

ng/l

0.54

6048

18979

Symptoms and signs involving the circulatory and respiratory systems

6618

12920

2.73

307.65

3.2

2.5

187.96

187.93

ng/l

0.00

5957

11674

All pneumoniae

7706

21431

2.51

307.65

3.9

2.5

232.16

165.15

ng/l

24.09

7128

19377

Pure hypercholesterolaemia

6120

17413

2.42

307.65

3.3

2.8

195.51

196.46

ng/l

0.05

5669

15865

Type 2 diabetes, wide definition

5351

18507

1.93

307.65

3.5

2.7

222.33

188.58

ng/l

5.54

4889

16929

Asthma, hospital admission 2, infections

4396

20826

2.20

307.65

4.0

2.9

198.14

213.28

ng/l

1.39

4043

19010

Ischaemic heart disease, wide definition

6610

15571

2.90

307.65

3.7

2.5

220.99

154.52

ng/l

21.31

6178

14124

Myocarditis

426

423

12.21

307.65

7.0

1.6

242.98

53.08

ng/l

3.63

396

362

Pain in throat and chest

6489

12788

3.26

307.65

3.3

2.5

187.15

188.14

ng/l

0.05

5912

11560

Disorders of lipoprotein metabolism and other lipidaemias

6170

17985

2.23

307.65

3.1

2.8

206.07

193.97

ng/l

1.00

5679

16346

Asthma (only as main-diagnosis)

4496

11163

2.38

307.65

3.5

2.3

164.16

164.96

ng/l

0.04

4079

10134

STROKE

3763

8795

3.13

307.65

3.5

2.0

206.43

115.45

ng/l

23.70

3428

7885

Complications of medical and surgical care

5138

25021

1.96

307.65

3.6

2.9

225.70

199.42

ng/l

3.45

4746

22854

Codeine or tramadol medication

6914

22490

1.74

307.65

3.2

2.9

189.30

204.90

ng/l

1.73

6278

20519

Any reimbursement code in KELA

2478

4737

2.73

307.65

3.2

1.8

149.62

93.53

ng/l

8.24

2208

4148

Syncope and collapse

3428

13320

2.31

307.65

3.6

2.7

251.00

203.18

ng/l

4.35

3177

12221

All kidney diseases

6603

22884

2.04

307.65

3.9

2.6

277.27

157.14

ng/l

56.88

6069

20795

Malaise and fatigue

4291

14042

2.62

307.65

3.7

2.7

260.00

198.29

ng/l

9.13

3911

12880

Pain in limb

5246

18405

1.90

307.65

3.2

2.9

196.93

210.99

ng/l

1.23

4782

16806

Hypertensive Heart Disease

2245

5689

3.42

307.65

3.6

2.6

351.94

198.09

ng/l

25.46

2116

5205

Bleeding

5852

22758

1.91

307.65

3.7

2.9

261.63

194.27

ng/l

16.96

5387

20805

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2147

2943

4.91

307.65

3.0

1.5

153.61

44.62

ng/l

34.11

1948

2543

Congenital malformations of heart and great arteries

1140

2953

4.41

307.65

4.2

3.1

190.75

173.09

ng/l

0.70

1046

2645

ILD differential diagnosis

4437

11235

2.07

307.65

3.2

2.3

181.95

166.94

ng/l

1.41

4021

10196

Other CVD (FINNGEN)

906

1075

7.44

307.65

4.0

1.6

254.78

58.94

ng/l

28.04

835

957

Persons encountering health services for specific procedures and health care

8297

19788

2.67

307.65

3.6

2.6

210.49

178.95

ng/l

6.43

7589

17903

Cardiac arrest

590

680

8.75

307.65

5.1

1.6

351.60

63.30

ng/l

24.79

557

593

Congenital malformations of the circulatory system

1188

3418

3.89

307.65

4.0

3.1

184.04

171.45

ng/l

0.46

1088

3061

Hypothyroidism, drug reimbursement

595

511

8.68

307.65

3.3

1.4

128.08

35.46

ng/l

10.91

536

450

Heart failure and coronary heart disease

5389

9960

4.69

307.65

5.5

2.4

451.88

163.23

ng/l

171.32

5144

9006

Non-invasive ventilation

4626

2463

23.41

307.65

3.9

1.6

153.37

70.28

ng/l

30.99

4398

2174

Bacterial pneumonia, not elsewhere classified

4072

12081

3.41

307.65

4.8

2.6

251.99

198.77

ng/l

8.81

3806

11045

Implicit Sepsis, including avohilmo

6898

20366

2.64

307.65

4.1

2.5

262.22

169.43

ng/l

36.58

6384

18480

Asthma, unspecified (mode), excluding more controls

3795

8696

3.40

307.65

3.5

1.9

178.15

92.67

ng/l

34.44

3485

7833

Asthma-related pneumonia or sepsis

3211

14255

2.48

307.65

4.4

3.1

227.33

238.70

ng/l

0.66

2988

13043

Myocardial infarction

4267

10458

3.22

307.65

4.0

2.2

318.30

146.71

ng/l

63.19

3993

9414

Implicit bacterial Sepsis

4428

14357

3.03

307.65

4.9

2.7

337.19

197.37

ng/l

39.22

4151

13133

ILD medications

6990

21675

1.81

307.65

3.9

2.6

207.73

194.26

ng/l

1.45

6336

19722

Hypertensive heart and/or renal disease

2410

5957

3.36

307.65

3.7

2.6

360.85

197.81

ng/l

25.54

2272

5439

Asthma (diagnoses ohter than nonallergic)

5910

25921

1.94

307.65

3.5

2.9

178.95

205.62

ng/l

4.88

5396

23636

Cardiodefibrillation

3417

14853

2.62

307.65

4.1

3.1

323.10

213.13

ng/l

30.58

3197

13709

Diseases of arteries, arterioles and capillaries

5319

20441

2.06

307.65

3.6

3.0

306.89

196.90

ng/l

36.07

4945

18732

Valvular operations

1825

3234

7.36

307.65

4.2

2.0

312.90

85.62

ng/l

67.40

1740

2874

Antihypertensive medication - note that there are other indications

2680

4167

3.52

307.65

3.3

1.9

149.49

72.41

ng/l

14.91

2384

3609

Pneumonia, organism unspecified

6858

20360

2.48

307.65

4.0

2.5

245.35

166.10

ng/l

27.72

6355

18438

COPD/asthma related infections

6067

16701

1.90

307.65

3.4

2.4

206.68

172.21

ng/l

6.12

5537

15177

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

930

1528

4.90

307.65

4.3

2.3

206.90

228.33

ng/l

0.53

869

1414

Other heart diseases, wide

8037

11751

4.63

307.65

3.7

1.9

201.02

68.97

ng/l

128.95

7429

10341

ILD medications: prednisolone, methylprednisolone, prednisone

6984

21529

1.89

307.65

3.9

2.6

206.60

194.85

ng/l

1.18

6348

19592

Calcific aortic valvular stenosis, including rheumatic fever

3186

13165

2.69

307.65

4.0

3.1

328.01

247.68

ng/l

12.06

3023

12109

Operations 2 for CAVS

3181

13121

2.70

307.65

4.0

3.1

328.26

247.87

ng/l

12.05

3019

12069

Heart failure and antihypertensive medication

3141

2293

11.38

307.65

5.3

1.9

380.34

89.71

ng/l

75.38

3003

2047

Inflammatory bowel disease treatment related agents

7258

22801

1.85

307.65

3.9

2.6

196.51

198.30

ng/l

0.12

6610

20733

Dyspnoea

8263

22507

2.93

307.65

4.0

2.6

235.60

189.31

ng/l

11.58

7621

20476

Fever of other and unknown origin

3659

15526

2.16

307.65

3.8

2.7

232.93

190.24

ng/l

4.90

3364

14179

Calcific aortic valvular stenosis, diagnosis (helper)

3181

13121

2.70

307.65

4.0

3.1

328.26

247.87

ng/l

12.05

3019

12069

COPD (mode)

2551

7991

2.76

307.65

3.8

2.4

286.08

192.62

ng/l

11.01

2379

7330

Heart failure,strict

6429

11707

4.68

307.65

5.0

2.0

405.43

96.65

ng/l

261.47

6114

10681

All-cause Heart Failure

6867

15117

3.78

307.65

4.9

2.3

409.66

117.21

ng/l

249.00

6507

13797

COPD differential diagnosis

4440

11240

2.07

307.65

3.2

2.3

182.85

166.95

ng/l

1.54

4026

10199

6756

16701

2.54

307.65

3.8

2.4

227.76

172.21

ng/l

14.07

6250

15177

Cardiovascular diseases

3134

2925

6.07

307.65

3.4

1.5

128.58

45.46

ng/l

33.96

2780

2484

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

7596

21633

2.52

307.65

3.9

2.5

234.32

165.99

ng/l

24.23

7037

19565

Speech therapy

2196

9314

2.65

307.65

3.4

3.0

199.68

200.48

ng/l

0.02

1965

8552

Presence of cardiac and vascular implants and grafts

5750

13111

3.93

307.65

5.1

2.6

334.16

204.31

ng/l

42.36

5483

11955

Coronary atherosclerosis

5712

12092

3.36

307.65

3.7

2.2

253.07

139.74

ng/l

42.50

5341

10878

Hypertension

4761

11213

2.54

307.65

3.3

2.5

180.58

144.90

ng/l

6.22

4341

10080

Emergency coronary revascularization (for ACS)

8721

15860

3.80

307.65

4.0

2.3

239.94

155.35

ng/l

39.17

8187

14233

Hypothyroidism, levothyroxine purchases

815

764

6.23

307.65

3.3

1.4

110.42

34.62

ng/l

13.22

715

661

Calcific aortic valvular stenosis

3192

13138

2.71

307.65

4.0

3.1

327.56

247.75

ng/l

11.95

3030

12086

Hypertension, essential

4846

11019

2.65

307.65

2.9

2.4

177.42

145.37

ng/l

5.30

4417

9911

Hypothyroidism (congenital or acquired)

823

768

6.26

307.65

3.3

1.4

111.54

34.57

ng/l

13.64

721

663

All influenza

2063

8210

2.77

307.65

4.4

2.6

251.59

191.47

ng/l

5.97

1876

7431

Heart failure, strict

7060

15367

3.83

307.65

5.0

2.3

413.00

117.56

ng/l

256.26

6699

14035

Myocardial infarction, without ST-elevation

3672

16299

2.25

307.65

4.1

3.0

368.25

227.02

ng/l

29.58

3437

14995

Cardiomyopathy, other and unspecified

1074

1573

9.52

307.65

5.1

1.9

363.81

84.21

ng/l

36.23

1044

1394

AV-block

1837

4108

4.49

307.65

5.0

1.9

325.31

88.63

ng/l

61.62

1745

3705

Paroxysmal tachycardia

1835

1971

8.91

307.65

4.6

1.6

261.22

49.55

ng/l

53.08

1709

1721

Nonischemic cardiomyopathy

1122

2712

5.18

307.65

5.0

2.5

357.38

149.57

ng/l

27.71

1072

2449

Atrial fibrillation and flutter with reimbursement

2581

1819

10.75

307.65

4.0

1.6

245.98

51.56

ng/l

112.52

2455

1593

Major coronary heart disease event

8070

14889

3.68

307.65

3.9

2.3

226.71

139.33

ng/l

42.22

7576

13352

Percutaneous Coronary Intervention

7989

13524

4.14

307.65

4.0

2.2

227.31

132.55

ng/l

48.28

7510

12115

Coronary artery bypass grafting

2225

6017

3.11

307.65

4.2

2.4

414.75

167.17

ng/l

48.54

2086

5462

Erysipelas, including avohilmo

5521

19941

2.20

307.65

3.6

2.7

268.81

173.30

ng/l

27.31

5066

18183

Atrial fibrillation and flutter

2949

2166

10.34

307.65

3.9

1.6

230.40

48.89

ng/l

119.05

2787

1887

Care involving use of rehabilitation procedures

6188

18436

3.40

307.65

3.9

2.6

180.10

183.45

ng/l

0.21

5696

16769

Myocardial infarction, strict

3936

10010

3.13

307.65

4.0

2.3

311.59

148.88

ng/l

53.05

3686

9017

Other arrhythmias

5507

10567

4.36

307.65

3.6

1.9

201.18

71.14

ng/l

82.57

5137

9368

Coronary revascularization (ANGIO or CABG)

7918

13527

4.09

307.65

4.0

2.2

226.76

132.52

ng/l

47.25

7446

12118

Unstable angina pectoris

3176

9504

2.95

307.65

4.2

2.4

282.17

166.34

ng/l

22.27

2949

8603

Implicit Sepsis

6669

20043

2.70

307.65

4.3

2.6

277.42

174.01

ng/l

37.13

6184

18236

Dilated cardiomyopathy

1587

4212

5.06

307.65

6.1

3.0

437.78

206.56

ng/l

31.43

1538

3860

Hypertensive diseases (excluding secondary)

2910

3153

5.81

307.65

3.4

1.5

162.07

44.03

ng/l

48.70

2632

2702

Adjustment and management of implanted device

2384

7014

4.28

307.65

4.3

2.9

338.69

239.44

ng/l

15.17

2246

6470

Asthma/COPD (KELA code 203)

6009

22830

1.84

307.65

3.4

2.8

171.53

199.77

ng/l

5.65

5482

20769

Bacterial infection, other or unspecified, including avohilmo

4814

18364

2.34

307.65

4.0

2.8

305.16

187.08

ng/l

33.58

4438

16809

Cardiomyopathy

2445

3895

8.41

307.65

5.4

1.9

402.55

80.51

ng/l

103.51

2372

3443

Calcific aortic valvular stenosis, operated

3192

13138

2.71

307.65

4.0

3.1

327.56

247.75

ng/l

11.95

3030

12086

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

7121

23812

2.15

307.65

3.9

2.7

259.26

178.78

ng/l

28.25

6531

21686

All chronic kidney diseases

4266

16897

2.17

307.65

4.6

2.7

414.89

179.32

ng/l

77.49

3974

15464

Conduction disorders

2750

5969

4.24

307.65

4.4

1.9

296.66

81.34

ng/l

87.03

2601

5344

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

6830

19760

2.51

307.65

3.9

2.5

239.57

162.33

ng/l

28.87

6297

17861

Explicit Sepsis

3599

15128

2.36

307.65

4.5

2.6

338.26

191.01

ng/l

39.26

3353

13812

Complications of surgical and medical care, not elsewhere classified

6681

24989

1.88

307.65

3.5

2.8

232.67

193.43

ng/l

7.40

6171

22736

Cardiomyopathies, Primary/intrinsic

1758

2593

9.41

307.65

5.9

1.9

429.56

86.52

ng/l

79.42

1705

2288

Pneumonias (Asthma/COPD co-morbidities)

7673

21469

2.51

307.65

3.9

2.5

232.27

164.99

ng/l

24.23

7103

19410

Implicit bacterial Sepsis, including avohilmo

4788

15189

2.99

307.65

4.8

2.6

329.64

194.03

ng/l

39.74

4479

13899

Implicit viral Sepsis

1973

7370

3.05

307.65

5.4

2.7

265.10

196.34

ng/l

7.92

1838

6710

Major coronary heart disease event excluding revascularizations

5312

12566

3.13

307.65

4.0

2.3

295.91

151.32

ng/l

56.35

4953

11325

Aortic valve malfunction, age under 60 years

879

2352

4.51

301.88

3.5

2.9

203.74

147.64

ng/l

3.61

832

2112

Complications of procedures, not elsewhere classified

5209

24433

1.80

299.83

3.5

2.9

236.36

192.36

ng/l

7.19

4811

22260

Diseases of oesophagus, stomach and duodenum

6487

23264

1.71

298.80

3.4

2.9

200.91

198.56

ng/l

0.14

5885

21230

Statin medication

3371

9326

2.12

297.06

3.4

2.5

197.98

158.60

ng/l

4.54

3045

8379

Covid-19 confirmed case

2973

14800

2.18

296.65

4.5

3.0

205.29

224.46

ng/l

1.71

2797

13562

Other special examinations and investigations of persons without complaint or reported diagnosis

3935

10297

2.02

296.24

3.4

2.7

192.20

211.73

ng/l

1.69

3559

9371

Asthma, including avohilmo

7151

24526

1.66

293.41

3.3

2.9

176.30

208.96

ng/l

7.50

6504

22354

Type 2 diabetes

5871

20220

1.75

290.94

3.3

2.7

210.84

179.64

ng/l

5.68

5325

18404

Other soft tissue disorders, not elsewhere classified

5589

18643

1.77

290.22

3.3

2.9

194.15

211.37

ng/l

1.73

5064

17007

2903

14277

2.14

287.11

3.9

2.9

175.23

199.24

ng/l

2.45

2632

12974

Parasetamol

3787

9876

2.01

283.48

3.1

2.5

194.96

202.08

ng/l

0.35

3398

8920

Acute tubulo-interstitial nephritis

4164

19574

1.89

282.57

3.7

2.7

253.50

173.68

ng/l

16.63

3814

17918

Cough

2355

10047

2.31

282.11

3.4

2.5

191.27

193.39

ng/l

0.07

2144

9172

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4149

22872

1.88

281.01

3.6

2.9

228.95

200.55

ng/l

3.26

3834

20948

Diabetes, varying definitions

5909

20645

1.72

278.64

3.3

2.7

210.09

178.55

ng/l

5.79

5362

18756

Diabetes mellitus

5917

20658

1.72

275.34

3.3

2.7

210.15

178.37

ng/l

5.88

5368

18765

Early onset COPD, excluding more controls

1448

5437

2.93

275.22

3.8

2.3

227.83

183.29

ng/l

2.28

1324

4959

Endocrine, nutritional and metabolic diseases

3945

10545

1.96

273.61

3.2

2.5

188.00

164.41

ng/l

2.52

3539

9507

Other intervertebral disc disorders

5115

17813

1.79

273.41

3.0

2.9

148.13

220.71

ng/l

29.19

4685

16245

Conotruncal defects

242

188

23.84

273.04

6.0

4.4

164.35

183.56

ng/l

0.22

227

167

Oxycodone

2890

12431

2.13

270.23

3.5

2.8

217.14

229.06

ng/l

0.65

2675

11454

COPD

3457

15044

2.01

269.34

3.8

2.9

278.07

230.60

ng/l

4.51

3209

13843

Polyarthropathies

4111

14591

1.89

269.09

3.6

2.9

270.21

201.51

ng/l

10.64

3730

13323

Aplastic and other anaemias

3677

18561

1.95

266.81

4.0

3.0

325.83

222.20

ng/l

22.11

3396

17073

Type 2 diabetes, definitions combined

5665

19913

1.72

265.73

3.3

2.7

205.43

181.17

ng/l

3.59

5131

18147

Intracranial trauma

3140

10764

2.06

265.60

3.3

2.7

193.17

208.43

ng/l

0.95

2832

9842

Type 2 diabetes, strict (exclude DM1)

5684

20015

1.72

264.90

3.3

2.7

205.36

181.76

ng/l

3.43

5149

18242

Headache

3681

15415

1.92

264.00

3.1

2.6

135.43

175.33

ng/l

7.54

3326

14025

Congenital malformations of cardiac chambers and connections

158

94.87

263.02

6.9

7.0

154.30

163.15

ng/l

0.05

149

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4631

23763

1.79

261.07

3.7

2.9

203.94

214.23

ng/l

0.82

4325

21744

Other symptoms and signs involving cognitive functions and awareness

3486

16857

1.96

258.65

3.3

3.0

217.81

227.15

ng/l

0.47

3198

15494

Other chronic obstructive pulmonary disease

3331

14637

2.01

258.48

3.9

2.9

280.41

232.65

ng/l

4.41

3096

13465

Status post-ami

1908

6263

2.54

255.99

4.9

2.4

430.40

168.22

ng/l

46.67

1794

5676

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1600

2947

2.83

254.00

3.1

2.1

173.54

170.68

ng/l

0.09

1437

2632

Acute renal failure

1980

9051

2.45

251.74

5.5

2.9

439.76

197.29

ng/l

42.23

1863

8284

Type 2 diabetes, definitions combined, including avohilmo

5584

19731

1.70

250.01

3.3

2.7

202.43

180.97

ng/l

3.00

5054

17970

Pulmonary heart disease, diseases of pulmonary circulation

2600

13195

2.15

248.39

4.1

3.1

219.17

228.89

ng/l

0.50

2393

12113

Asthma, hospital admissions , main diagnosis only

4941

26061

1.72

246.59

3.5

2.9

170.75

203.75

ng/l

6.30

4494

23762

COPD-related respiratory insufficiency

1225

4584

3.18

245.42

4.9

3.0

313.61

242.43

ng/l

3.78

1166

4227

Other and unspecified anaemias

3414

17764

1.94

245.26

4.1

3.0

322.59

225.37

ng/l

19.49

3155

16354

Other neurological diseases

4908

23079

1.73

243.90

3.6

2.9

215.69

216.87

ng/l

0.06

4537

21131

Other anaemias

3431

17858

1.93

243.67

4.0

3.0

322.40

225.03

ng/l

19.60

3170

16439

Other diseases of pleura

3511

17051

1.92

242.61

4.5

3.0

302.93

228.16

ng/l

9.01

3296

15662

Non-allergic asthma (mode), excluding more controls

1193

4269

3.00

241.66

3.5

2.0

180.34

104.11

ng/l

9.62

1089

3870

Concussion

2733

10701

2.07

241.53

3.4

2.7

191.59

209.23

ng/l

0.89

2464

9783

Left ventricular outflow tract obstruction, narrow definition

526

1142

5.87

239.56

4.2

3.0

167.96

169.96

ng/l

0.04

493

1026

Cerebrovascular diseases

5029

21324

1.72

237.92

3.5

2.9

253.86

203.60

ng/l

9.22

4634

19591

Other disorders of fluid, electrolyte and acid-base balance

2390

11202

2.18

236.23

4.2

2.9

308.17

217.67

ng/l

10.06

2223

10260

6689

21795

1.61

236.04

3.6

2.7

207.24

201.65

ng/l

0.40

6086

19892

Other disorders of skin and subcutaneous tissue

4751

24419

1.72

234.50

3.4

3.0

252.39

200.93

ng/l

8.68

4362

22360

Transplanted organ and tissue status

785

2311

3.94

231.42

8.0

2.4

407.12

138.69

ng/l

19.68

758

2076

Certain infectious and parasitic diseases

5338

16310

1.69

231.36

3.4

2.5

212.86

169.18

ng/l

8.81

4871

14828

Provisional assignment of new diseases of uncertain etiology

3470

19455

1.87

230.42

4.3

2.9

202.95

208.78

ng/l

0.36

3234

17764

Codes for special purposes

3474

19483

1.87

230.38

4.3

2.9

202.91

208.74

ng/l

0.36

3238

17788

Any death

4346

18121

1.78

228.74

3.9

2.7

350.26

138.59

ng/l

75.05

4020

16676

Low back pain

4503

18120

1.74

228.45

3.2

2.9

167.09

216.83

ng/l

8.96

4097

16508

Other acute lower respiratory infections

3561

19333

1.85

228.08

4.2

3.0

231.73

217.07

ng/l

1.11

3221

17664

Vocal cord dysfunction

668

1488

4.23

228.07

3.4

1.6

157.25

72.81

ng/l

8.42

616

1325

Endocarditis

393

691

7.33

225.64

4.2

1.9

387.92

82.37

ng/l

13.96

377

612

Diseases of the respiratory system

3462

9396

1.92

225.40

3.2

2.4

192.77

173.28

ng/l

1.81

3149

8566

Other chronic obstructive pulmonary disease, including avohilmo

3921

18919

1.81

224.47

3.7

3.0

268.17

217.48

ng/l

5.92

3624

17418

Any gastric operation

4084

11689

1.81

223.96

3.3

2.5

197.66

175.74

ng/l

1.97

3678

10635

GASTRO-related operations

4084

11689

1.81

223.96

3.3

2.5

197.66

175.74

ng/l

1.97

3678

10635

Obesity related asthma

2257

11231

2.15

223.27

3.5

2.8

146.49

181.98

ng/l

4.57

2050

10276

Congenital malformations of cardiac septa

562

1293

4.99

222.51

4.4

3.3

207.04

177.11

ng/l

0.71

511

1160

Disorders of thyroid, IBD co-morbidities

927

1955

3.45

220.51

4.1

2.4

240.85

193.24

ng/l

1.04

851

1788

Chronic kidney disease

2648

13556

2.05

219.09

5.4

3.0

509.42

212.45

ng/l

60.97

2487

12443

Pain, not elsewhere classified

1791

8201

2.33

218.52

3.1

2.7

175.30

174.43

ng/l

0.03

1623

7507

Episodal and paroxysmal disorders

6119

19905

1.61

217.41

3.3

2.9

169.50

219.58

ng/l

14.37

5526

18176

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3776

22243

1.79

216.08

3.6

2.9

227.34

201.86

ng/l

2.60

3488

20405

Congenital malformations of aortic and mitral valves

445

921

6.18

214.40

4.2

2.9

157.03

171.79

ng/l

0.34

420

829

Gout

2244

9672

2.17

214.28

4.4

3.0

372.07

242.28

ng/l

14.57

2071

8902

Medical observation and evaluation for suspected diseases and conditions

3601

10294

1.86

213.16

3.2

2.7

210.94

211.28

ng/l

0.01

3278

9368

Other medical care

3150

14750

1.89

213.05

3.8

2.7

248.47

203.03

ng/l

5.38

2906

13506

Nerve, nerve root and plexus disorders

6317

24880

1.58

212.19

3.2

2.9

163.79

212.44

ng/l

15.98

5773

22703

Other diseases of intestines

5764

20550

1.61

210.69

3.2

2.9

197.66

194.80

ng/l

0.16

5217

18722

COPD related to multimorbidity

3098

14728

1.92

209.84

4.1

3.0

301.58

233.66

ng/l

7.19

2880

13596

Other nutritional deficiencies

3732

20100

1.77

208.36

3.2

2.8

165.99

174.32

ng/l

0.61

3317

18362

Bronchitis

6386

25287

1.56

207.41

3.7

2.7

212.90

198.69

ng/l

1.55

5781

23094

Secondary hypertension

420

803

5.67

207.34

3.4

1.7

408.24

55.08

ng/l

17.47

383

702

Dialysis, with operation codes

1064

4010

3.04

206.39

6.8

2.8

617.18

165.50

ng/l

37.70

1026

3654

Other dorsopathies, not elsewhere classified

5571

18450

1.62

203.96

3.0

2.9

165.73

218.71

ng/l

15.65

5048

16785

Later onset COPD, excluding more controls

1724

6064

2.40

201.76

3.8

2.5

311.34

216.03

ng/l

7.53

1624

5600

Obesity and other hyperalimentation

3518

19446

1.77

199.47

3.1

2.8

159.80

171.10

ng/l

1.03

3119

17760

Obesity

3501

19360

1.77

199.32

3.1

2.8

159.82

171.02

ng/l

1.01

3103

17682

Transient ischemic attack

3751

17886

1.77

199.17

3.8

2.9

229.89

222.38

ng/l

0.41

3478

16440

Short Achilles tendon (acquired)

341

596

7.67

198.75

3.8

2.9

102.37

178.40

ng/l

4.05

332

535

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

5306

20120

1.62

198.67

3.4

2.7

207.56

181.16

ng/l

3.96

4829

18309

Finngen Rheumatological endpoints

5148

18481

1.63

198.64

3.2

2.8

191.86

194.07

ng/l

0.12

4659

16784

Diverticular disease of intestine

4577

17681

1.68

198.28

3.1

2.9

223.67

210.82

ng/l

0.89

4178

16253

COPD, early/later onset

3373

16564

1.83

197.90

3.9

3.0

283.00

226.09

ng/l

6.01

3133

15263

COPD, hospital admissions

3346

16461

1.83

197.81

3.9

3.0

279.01

226.81

ng/l

5.17

3108

15164

Dorsalgia

5431

18437

1.61

195.63

3.1

2.9

167.42

218.87

ng/l

11.97

4922

16773

Symptoms and signs involving the nervous and musculoskeletal systems

3689

22237

1.74

194.73

3.3

3.0

181.83

208.15

ng/l

2.15

3351

20410

Dental caries

1692

7492

2.29

193.14

4.5

2.9

276.54

212.77

ng/l

4.58

1575

6854

Venous thromboembolism

3714

21711

1.74

191.54

3.4

3.0

202.98

223.29

ng/l

1.75

3405

19940

Congenital malformations of great arteries

236

277

11.37

190.93

5.2

5.1

197.65

198.36

ng/l

0.01

216

250

Pulmonary embolism

2246

11879

2.05

189.60

3.6

3.1

184.79

225.50

ng/l

4.86

2055

10883

COPD, hospital admission 2, with asthma infections

2547

11997

1.98

189.50

4.3

3.1

287.93

243.68

ng/l

3.56

2386

11042

ILD medications: immunosuppressive drugs

3525

19082

1.74

186.65

4.2

2.5

204.90

175.16

ng/l

3.26

3240

17409

Left bundle-branch block

591

1664

4.10

185.99

3.3

1.9

266.43

87.97

ng/l

13.92

556

1486

Ulcer of lower limb, not elsewhere classified

1312

5761

2.59

185.06

3.6

3.2

424.24

228.44

ng/l

17.35

1209

5301

Pulmonary heart disease

2246

11978

2.03

184.92

3.6

3.1

184.79

228.87

ng/l

5.59

2055

10983

Dipeptidyl peptidase 4 (DPP-4) inhibitors

3809

18279

1.73

184.86

3.9

2.9

273.49

212.97

ng/l

10.12

3525

16848

Nutritional anaemias

3448

19763

1.76

184.02

4.3

3.0

296.68

217.59

ng/l

14.78

3181

18141

Caries of dentine

1521

6743

2.34

183.85

4.6

2.9

279.74

207.85

ng/l

5.14

1414

6158

Neurological diseases

4304

13235

1.68

183.19

3.1

2.8

164.95

225.57

ng/l

13.25

3882

12079

Peripheral artery disease

3275

15328

1.80

181.79

3.9

3.1

390.67

220.75

ng/l

36.40

3047

14106

Use of hypnotics and sedatives

6041

23125

1.54

181.77

3.1

2.9

198.33

196.84

ng/l

0.08

5527

21075

Non-allergic asthma (mode)

1193

4925

2.58

181.30

3.5

2.3

180.34

180.81

ng/l

0.01

1089

4491

Viral pneumonia

994

3835

2.89

181.25

4.9

2.6

258.14

182.48

ng/l

5.07

927

3471

Stroke, excluding SAH

4110

18525

1.69

181.03

3.6

2.9

261.74

219.89

ng/l

5.56

3793

17033

Diabetes medication

5801

22554

1.55

180.11

3.3

2.8

202.77

188.39

ng/l

1.58

5257

20539

Atherosclerosis, excluding cerebral and coronary sclerosis

3156

14601

1.82

179.42

3.9

3.1

402.43

224.45

ng/l

36.92

2943

13454

Stroke, including SAH

4228

19115

1.67

178.95

3.6

2.9

261.36

214.91

ng/l

6.85

3890

17574

Lower back pain or/and sciatica

6147

25849

1.52

178.87

3.1

2.9

163.78

206.23

ng/l

9.97

5602

23574

L04AD Calcineurin inhibitors

781

2676

3.30

178.53

8.3

2.8

378.42

148.93

ng/l

16.44

749

2411

Constipation

5359

24001

1.57

178.29

3.2

3.0

192.83

209.09

ng/l

1.67

4865

21991

COPD, hospital admissions 3, with asthma pneumonia sepsis

2240

10321

2.03

176.77

4.5

3.1

296.52

251.71

ng/l

3.17

2103

9504

Other (not insulin) diabetes medications

5614

21895

1.55

176.53

3.3

2.8

198.24

191.48

ng/l

0.53

5085

19993

Fall on same level

6160

22124

1.53

176.46

3.1

2.9

204.99

181.26

ng/l

3.56

5628

20107

Iron deficiency anaemia

2994

17225

1.81

176.40

4.4

3.0

300.51

214.46

ng/l

16.04

2767

15818

Spinal stenosis

3440

15277

1.75

174.34

3.3

2.9

194.80

241.01

ng/l

7.00

3180

14045

Other functional intestinal disorders

2933

15503

1.80

173.53

3.6

3.0

205.90

218.24

ng/l

0.53

2702

14243

Symptoms and signs involving the urinary system

4713

23111

1.60

173.19

3.3

3.0

222.14

205.26

ng/l

1.53

4302

21151

Obesity due to excess calories

2569

14434

1.86

173.10

3.1

2.8

159.67

165.46

ng/l

0.33

2284

13188

Intestinal infectious diseases

5392

26766

1.54

172.74

3.9

2.8

228.57

194.32

ng/l

4.52

4914

24388

Nephropathy related operations

990

3949

2.86

171.51

6.7

3.1

616.93

195.82

ng/l

30.06

954

3606

Biguanides

5511

22197

1.55

171.21

3.3

2.8

199.41

195.45

ng/l

0.27

4982

20305

Abnormal findings on diagnostic imaging of lung

3389

19616

1.73

170.81

3.8

3.0

212.79

226.44

ng/l

0.96

3175

18004

Mouth breathing

2360

13012

1.92

170.64

3.1

3.0

149.48

182.78

ng/l

4.68

2135

11906

Thoracic aortic aneurysm

1191

5189

2.59

170.44

2.8

3.0

209.24

190.91

ng/l

0.74

1120

4761

Respiratory insufficiency

726

2463

3.38

169.37

5.8

2.5

268.81

241.52

ng/l

0.67

685

2252

DVT of lower extremities and pulmonary embolism

2957

17449

1.79

169.07

3.4

3.1

195.64

230.90

ng/l

3.93

2712

16033

Other disorders of urethra and urinary system

4143

18219

1.64

168.66

3.1

2.9

193.60

210.23

ng/l

1.54

3783

16687

Lumbar disc prolapse

3656

16661

1.69

167.92

2.9

137.30

207.44

ng/l

24.57

3347

15211

Hypertrophic cardiomyopathy

482

1309

4.80

166.97

5.4

3.1

355.37

218.94

ng/l

4.94

471

1201

Ischaemic Stroke, excluding all haemorrhages

3894

18058

1.67

166.29

3.7

2.9

268.60

222.67

ng/l

6.24

3597

16598

Pain in joint

3204

11598

1.76

166.11

2.9

2.8

166.57

209.41

ng/l

6.03

2863

10681

Examination and observation for other reasons

3093

10158

1.78

163.97

2.9

2.6

231.99

207.56

ng/l

1.50

2763

9249

Spondylopathies

4536

17349

1.60

161.90

3.1

2.9

175.92

227.26

ng/l

12.48

4182

15844

Other diseases of pericardium

386

886

5.20

161.62

4.4

1.9

304.24

88.67

ng/l

4.75

367

778

Diabetes, insulin treatment (Kela reimbursement)

5731

23257

1.51

159.34

3.5

2.8

213.69

191.71

ng/l

3.05

5222

21207

Congenital malformations of pulmonary and tricuspid valves

123

29.27

158.41

6.6

5.3

155.06

129.17

ng/l

0.23

117

Persons encountering health services for examination and investigation

3422

10297

1.72

157.85

3.2

2.7

207.52

211.73

ng/l

0.19

3071

9371

Congenital malformations, deformations and chromosomal abnormalities

2905

16387

1.74

156.92

3.2

2.9

185.02

166.99

ng/l

1.06

2633

14793

Other antidepressants

5730

19920

1.51

154.88

3.1

3.0

181.04

217.36

ng/l

7.24

5178

18262

Diarrhoea and gastroenteritis of presumed infectious origin

4007

23099

1.60

154.55

3.9

2.8

233.53

196.57

ng/l

4.36

3658

21027

Other or ill-defined heart diseases

395

948

4.75

153.97

5.0

1.8

298.34

85.85

ng/l

9.18

367

829

Acute bronchitis

2654

15306

1.79

153.65

4.1

3.0

243.44

224.03

ng/l

1.26

2394

13996

Other and unspecified nerve root and plexus disorders, also in other diseases

1344

6359

2.28

152.81

3.3

2.9

96.66

173.77

ng/l

23.72

1249

5797

Pain (limb, back, neck, head abdominally)

3918

12306

1.64

152.66

3.3

2.9

201.38

224.00

ng/l

1.95

3534

11307

Obesity, other/unspecified

1785

9328

2.01

151.44

2.9

2.8

140.25

161.90

ng/l

2.07

1545

8476

ILD, hospital admission 2, with pulmonary infections

849

3346

2.89

150.83

4.9

2.7

235.23

222.42

ng/l

0.36

795

3087

Neurological diseases, wide definition

1171

2412

2.52

150.65

3.3

2.6

145.81

180.67

ng/l

1.81

1022

2191

Undetermined asthma, excluding more controls

768

2827

2.93

150.29

3.4

1.9

152.73

101.17

ng/l

4.15

704

2568

Right ventricular outflow tract obstruction

133

102

22.35

150.01

7.6

4.8

180.03

200.43

ng/l

0.14

127

Other symptoms and signs involving the nervous and musculoskeletal systems

2497

14541

1.80

149.94

3.4

3.0

150.87

198.53

ng/l

4.53

2272

13331

Gastro-oesophageal reflux disease

3958

21645

1.60

149.39

3.3

2.9

167.71

197.57

ng/l

4.16

3570

19853

Injuries to the head

6136

25482

1.47

147.99

3.3

2.9

213.41

193.50

ng/l

2.24

5611

23197

Gout, FINNGEN

2244

12749

1.88

147.66

4.4

3.0

372.07

230.57

ng/l

17.72

2071

11761

Gout, idiopatic and unspecified

1944

10695

1.98

146.76

4.5

3.1

366.33

228.75

ng/l

15.70

1798

9859

Abdominal and pelvic pain

5457

18662

1.51

146.60

3.4

2.8

191.02

209.83

ng/l

1.94

4917

17043

Disorders of gallbladder, biliary tract and pancreas

5639

24312

1.49

145.98

3.2

2.9

199.57

202.66

ng/l

0.19

5144

22252

Sleep apnoea

5312

22989

1.50

144.62

3.2

2.9

153.68

199.08

ng/l

12.88

4798

21065

Allergic asthma (mode), excluding more controls

972

3947

2.51

144.61

3.0

1.8

127.00

87.06

ng/l

3.56

863

3514

Symptoms and signs involving the digestive system and abdomen

5454

18665

1.50

144.46

3.5

2.8

194.09

209.83

ng/l

1.51

4937

17046

Insulin medication

3597

19127

1.62

143.11

4.0

2.9

272.02

205.85

ng/l

11.33

3334

17489

Aortic aneurysm

1768

9310

2.02

142.49

3.0

3.1

255.56

232.02

ng/l

1.17

1659

8574

Abnormal findings on examination of blood, without diagnosis

3065

17270

1.69

141.62

3.5

3.1

227.75

223.45

ng/l

0.17

2829

15858

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

5458

23903

1.49

141.55

3.2

2.9

207.22

203.18

ng/l

0.24

4971

21851

Bicuspidal aortic valve syndrome

348

834

5.13

139.49

3.2

3.0

163.95

175.01

ng/l

0.21

329

754

Falls/tendency to fall

5477

18896

1.49

138.45

3.1

2.9

193.11

182.93

ng/l

0.87

4984

17186

Other respiratory diseases principally affecting the interstitium

1451

7409

2.16

137.99

4.4

3.1

260.87

238.16

ng/l

0.98

1361

6836

Other specific joint derangements/joint disorders

3683

14704

1.61

137.19

2.8

2.9

159.60

184.10

ng/l

3.36

3298

13391

Soft tissue disorders

5337

18786

1.49

137.15

3.1

2.9

186.73

212.88

ng/l

4.10

4807

17124

Other respiratory disorders and diseases

1577

8287

2.07

136.68

5.0

3.1

273.12

247.81

ng/l

1.20

1475

7598

Other diseases of the respiratory system

1577

8287

2.07

136.68

5.0

3.1

273.12

247.81

ng/l

1.20

1475

7598

Dorsopathies

5317

18503

1.49

136.33

3.0

2.9

167.39

218.57

ng/l

14.03

4784

16834

Unspecified acute lower respiratory infection

1070

4857

2.40

135.80

4.9

3.0

224.99

201.22

ng/l

1.01

963

4403

Factors influencing health status and contact with health services

1495

3614

2.16

134.62

3.2

2.1

221.51

188.55

ng/l

1.54

1361

3269

Other headache syndromes

2185

12557

1.81

134.22

3.0

2.7

125.28

186.63

ng/l

17.00

1978

11497

Atrial septal defect

314

707

5.30

133.59

3.7

3.5

225.11

178.34

ng/l

0.74

279

634

Certain infectious and parasitic diseases, including avohilmo

3795

12217

1.60

133.24

3.2

2.6

209.06

173.25

ng/l

5.00

3470

11137

COPD, hospital admissions 1, only main diagnosis

2499

12923

1.77

133.18

4.1

3.1

283.51

242.44

ng/l

2.51

2330

11910

Septal defects

445

1264

3.94

133.01

4.1

3.7

190.36

184.73

ng/l

0.09

401

1139

Other and unspecified iron deficiency

2293

13500

1.79

132.90

4.2

3.0

296.75

211.85

ng/l

12.24

2119

12381

Early onset COPD

1448

7464

2.09

131.43

3.8

2.9

227.83

194.01

ng/l

1.52

1324

6825

Hernia

5157

23892

1.48

130.37

3.2

2.9

209.68

195.68

ng/l

1.28

4682

21794

Peripheral arterial reconstruction

1428

7412

2.13

130.34

4.2

3.2

411.87

252.26

ng/l

18.51

1341

6825

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

3143

18205

1.62

129.39

3.2

2.9

186.18

167.86

ng/l

1.18

2845

16487

Other pulmonary heart/vessel disease

499

1633

3.80

129.04

7.1

3.2

384.09

242.00

ng/l

5.98

476

1507

Secondary right heart disease

461

1447

4.01

127.98

7.3

3.2

385.91

244.24

ng/l

5.54

439

1334

Diseases of the skin and subcutaneous tissue

5278

18442

1.47

126.34

3.2

2.9

209.66

198.25

ng/l

0.88

4790

16803

Exposure to unspecified factor

5542

26801

1.44

125.84

3.0

202.92

196.30

ng/l

0.47

4989

24495

Gonarthrosis [arthrosis of knee](FG)

4283

16615

1.53

125.75

3.0

2.8

177.51

206.06

ng/l

4.37

3939

15212

Disorders of lens

3741

15279

1.57

125.08

3.3

2.8

222.23

191.75

ng/l

3.33

3461

13978

Unspecified haematuria

2795

14257

1.68

124.02

3.5

3.1

263.82

227.95

ng/l

2.82

2584

13072

Shoulder lesions

4251

17240

1.52

123.32

3.1

2.9

159.06

213.94

ng/l

14.44

3872

15803

Sleep apnoea, including avohilmo

5397

23123

1.45

122.76

3.1

2.9

152.85

200.06

ng/l

14.01

4892

21175

Intestinal infectious diseases, including avohilmo, including avohilmo

6289

25408

1.41

122.32

3.6

2.8

221.61

195.81

ng/l

3.21

5738

23201

ILD, hospital admissions 3, with pneumonia sepsis

741

3036

2.79

122.09

5.1

2.8

247.30

220.06

ng/l

0.92

693

2791

Osteopathies and chondropathies

3338

20044

1.58

120.93

3.6

3.0

213.87

199.35

ng/l

0.82

3084

18336

Disorders of eyelid, lacrimal system and orbit

4900

25306

1.46

119.06

3.2

3.0

174.52

209.52

ng/l

6.88

4461

23178

Gonarthrosis

3654

13623

1.57

118.43

3.0

2.9

180.53

209.06

ng/l

3.90

3365

12490

Gout, strict definition

1433

7681

2.05

118.26

4.8

3.1

372.55

230.04

ng/l

12.29

1341

7081

Gout, unspecified

1558

8606

1.97

116.32

4.6

3.1

379.15

223.10

ng/l

14.65

1448

7930

Senile cataract

3543

14266

1.57

115.44

3.4

2.8

224.37

198.70

ng/l

2.41

3287

13074

Diseases of the digestive system

2930

18860

1.61

114.94

3.9

3.1

264.55

227.85

ng/l

3.38

2703

17290

ILD-related respiratory insufficiency

395

1219

4.23

114.20

6.1

3.1

254.20

239.35

ng/l

0.24

374

1127

Systemic sclerosis (FG)

244

522

5.97

113.47

4.7

2.7

114.00

172.84

ng/l

2.20

235

478

Undetermined asthma

768

3247

2.54

113.21

3.4

2.3

152.73

169.10

ng/l

0.59

704

2961

Sciatica+with lumbago

2780

15708

1.62

113.11

2.9

2.8

146.33

207.15

ng/l

13.03

2543

14364

Hernia of abdominal wall, postoperative

1156

5733

2.13

113.00

3.6

2.5

225.71

177.34

ng/l

2.63

1049

5278

GI-bleeding

2247

13794

1.72

112.62

4.1

3.1

296.32

242.58

ng/l

4.54

2088

12660

General examination and investigation of persons without complaint and reported diagnosis

3094

10257

1.61

112.38

3.8

2.6

184.66

209.89

ng/l

2.30

2828

9339

Insulin, intermediate and long-acting

3325

21451

1.56

112.22

3.9

3.0

270.41

209.34

ng/l

9.34

3081

19599

Certain disorders involving the immune mechanism

1168

5910

2.13

111.42

4.6

3.0

187.63

179.98

ng/l

0.24

1061

5378

Other symptoms and signs involving the circulatory and respiratory systems

442

1426

3.44

111.18

4.5

2.5

152.87

187.31

ng/l

1.04

404

1296

Disorders of choroid and retina

4756

23649

1.45

110.59

3.3

3.0

236.72

206.53

ng/l

3.82

4366

21679

Gastrointestinal diseases

2622

8060

1.67

110.55

3.1

2.6

182.08

176.52

ng/l

0.26

2328

7389

All influenza (not pneumonia)

865

3900

2.38

110.32

4.1

2.7

216.86

172.23

ng/l

1.82

773

3496

Dental operations

3650

12533

1.55

109.97

3.2

3.0

223.63

254.09

ng/l

2.84

3315

11496

Unspecified kidney failure

902

4209

2.40

109.95

4.4

2.9

507.45

211.75

ng/l

19.15

853

3855

Tetralogy of Fallot, a congenital heart defect.

35.81

109.73

3.2

3.7

173.55

102.80

ng/l

0.94

Heart failure and hypertrophic cardiomyopathy

247

566

6.26

109.36

7.6

3.3

508.29

231.89

ng/l

6.40

242

515

L04AA Selective immunosuppressants

1258

6557

2.04

109.17

5.8

2.8

283.74

157.80

ng/l

11.53

1186

5943

Allergic asthma (mode)

972

4452

2.22

109.01

3.0

2.2

127.00

143.71

ng/l

0.78

863

3994

ILD, hospital admissions

1184

6123

2.13

108.94

4.3

3.2

224.28

237.27

ng/l

0.46

1116

5654

Other diseases of the digestive system

2225

13759

1.71

108.39

4.1

3.1

294.01

240.66

ng/l

4.56

2068

12635

Nausea and vomiting

1692

9432

1.84

108.36

3.9

2.9

233.63

223.06

ng/l

0.35

1555

8647

Other/unspecified dorsalgia

2083

12436

1.72

107.99

3.2

2.9

176.52

220.08

ng/l

5.58

1895

11386

Cholelithiasis, broad definition with cholecystitis

4859

23095

1.44

107.98

3.2

2.9

204.06

206.48

ng/l

0.13

4423

21172

Arthrosis

3816

14167

1.52

107.78

3.0

2.9

180.23

204.75

ng/l

3.04

3493

12947

Any mental disorder

5739

20909

1.41

107.41

3.2

2.9

179.63

201.21

ng/l

3.01

5229

19134

Other interstitial pulmonary diseases

1197

6246

2.11

107.19

4.3

3.1

225.45

235.38

ng/l

0.33

1127

5769

Explicit bacterial Sepsis, including avohilmo

781

3446

2.49

106.71

4.6

2.7

321.47

187.34

ng/l

9.37

721

3131

Interstitial lung disease

1197

6259

2.10

106.54

4.3

3.2

225.45

237.53

ng/l

0.42

1127

5783

Interstitial lung disease endpoints

1197

6259

2.10

106.54

4.3

3.2

225.45

237.53

ng/l

0.42

1127

5783

Other external causes of accidental injury

4054

13898

1.50

106.10

3.1

2.9

202.39

187.31

ng/l

1.24

3672

12710

795

3538

2.40

104.41

4.4

2.8

220.05

153.32

ng/l

2.80

713

3202

Intracranial injury

3353

21188

1.52

103.91

3.6

3.0

225.85

207.88

ng/l

1.14

3030

19356

Other CVD

1573

9011

1.89

103.82

4.2

3.2

271.31

250.85

ng/l

0.91

1455

8299

Ventricular septal defect, a heart condition

190

346

6.69

103.76

5.0

4.5

183.79

189.98

ng/l

0.06

176

309

Autoimmune diseases excluding thyroid diseases

5507

21746

1.40

103.69

3.3

2.9

213.13

200.20

ng/l

1.07

5042

19774

Hypokalaemia

851

3949

2.35

102.95

3.9

2.8

250.12

199.85

ng/l

1.69

782

3584

ILD, hospital admissions 1, main diag only

1068

5445

2.17

102.68

4.4

3.1

226.87

232.70

ng/l

0.16

1004

5027

Explicit bacterial Sepsis

759

3369

2.47

102.27

4.6

2.7

327.70

186.19

ng/l

9.90

700

3062

Visual disturbances

2799

18431

1.58

101.96

3.4

3.0

172.81

199.18

ng/l

3.11

2557

16925

Accidents

4022

13898

1.48

101.08

3.1

2.9

200.44

187.31

ng/l

1.02

3649

12710

Benign neoplasm of colon, rectum, anus and anal canal

3928

23362

1.47

100.37

3.3

3.0

232.34

212.98

ng/l

1.62

3605

21527

Other degenerative diseases of the nervous system

1714

7230

1.81

100.07

3.1

2.7

180.03

247.83

ng/l

9.43

1584

6679

Implicit fungal Sepsis, including avohilmo

562

2214

2.87

99.75

4.8

2.7

251.05

172.57

ng/l

2.69

532

2024

Other arthrosis

2967

13124

1.57

99.58

2.9

161.62

199.94

ng/l

6.23

2716

12053

Other diseases of intestine

1065

5446

2.11

99.18

3.4

2.9

217.87

195.44

ng/l

0.95

974

5007

Other systemic involvement of connective tissue (FG)

1540

8639

1.85

99.15

3.3

2.8

182.93

204.96

ng/l

1.32

1405

7935

Streptococcal septicaemia, including avohilmo

700

3055

2.55

99.09

4.6

2.7

326.81

189.82

ng/l

8.48

647

2786

Insulin, combination of fast acting with intermediate-acting or long-acting

3606

22743

1.49

98.34

4.0

3.0

272.15

212.25

ng/l

9.71

3342

20755

Systemic connective tissue disorders

2122

13263

1.68

98.13

3.4

3.0

188.46

205.67

ng/l

1.12

1943

12157

Lung transplantation

118

143

13.47

98.08

8.0

3.7

138.39

171.73

ng/l

0.47

113

125

Cholelithiasis

4635

22805

1.42

97.98

3.2

2.9

204.74

207.45

ng/l

0.14

4222

20915

Other cataract

2586

12425

1.61

97.98

3.3

2.8

241.02

207.83

ng/l

2.33

2369

11382

Other diseases of urinary system

5149

21066

1.40

97.61

3.2

2.9

210.11

203.49

ng/l

0.43

4710

19240

Autoimmune diseases excluding thyroid diseases, strict definition

5300

21098

1.40

97.13

3.3

2.9

213.19

198.94

ng/l

1.20

4857

19179

Systemic sclerosis

244

594

5.20

96.97

4.7

3.0

114.00

175.90

ng/l

2.51

235

540

Infections of the skin and subcutaneous tissue

3055

20304

1.53

96.92

3.5

2.9

221.53

185.08

ng/l

4.00

2760

18493

Lung transplant status

117

143

13.34

96.60

8.1

3.7

138.84

171.73

ng/l

0.46

112

125

Streptococcal septicaemia

682

2978

2.55

96.44

4.6

2.8

332.59

188.39

ng/l

8.94

629

2715

Diseases of the musculoskeletal system and connective tissue

2403

7491

1.65

96.20

3.1

2.9

178.29

214.27

ng/l

3.57

2157

6780

Sequelae of external causes of morbidity and mortality

1621

9518

1.80

96.05

3.9

3.0

219.53

199.95

ng/l

1.16

1502

8686

Systemic sclerosis, icd10

241

588

5.19

95.53

4.7

3.1

114.13

172.15

ng/l

2.25

233

538

Operations for atrial fibrillation

198

426

6.86

94.97

3.1

2.9

286.91

202.44

ng/l

1.90

186

387

Functional dyspepsia

1539

8909

1.82

94.81

3.5

2.8

155.72

182.50

ng/l

1.62

1406

8169

Other joint disorders

4180

15346

1.45

94.75

2.8

2.9

178.13

195.95

ng/l

1.79

3761

13953

Sleep disorders (combined)

5835

22733

1.37

94.20

3.1

3.0

172.04

213.12

ng/l

10.10

5326

20796

Pericarditis

248

610

4.66

94.15

3.9

1.8

211.40

83.82

ng/l

5.24

229

536

Care involving dialysis

548

2187

2.79

93.98

5.4

2.7

812.87

187.71

ng/l

23.72

527

1988

Hypertension, Pulmonary Arterial

121

158

11.46

93.68

9.7

2.8

310.67

231.27

ng/l

0.73

116

141

Visual disturbances and blindness

2992

20309

1.52

93.49

3.4

3.0

182.26

205.98

ng/l

2.53

2732

18632

Diagnoses used for exclusion with ILD

1647

9806

1.78

92.91

4.5

3.1

205.80

228.21

ng/l

1.27

1510

8961

Sarcoidosis

841

4053

2.26

92.35

4.9

3.0

156.43

182.87

ng/l

1.27

766

3693

Coxarthrosis [arthrosis of hip](FG)

3217

15154

1.51

91.27

3.3

2.9

197.09

216.40

ng/l

1.72

2957

13922

Psychiatric diseases

5072

18653

1.39

89.79

3.2

2.9

183.12

203.28

ng/l

2.32

4634

17057

Injuries to the knee and lower leg

6192

25389

1.34

89.62

3.0

192.68

199.41

ng/l

0.55

5657

23140

Symptoms and signs involving the skin and subcutaneous tissue

3858

26071

1.44

89.31

3.1

2.9

169.32

200.63

ng/l

5.45

3517

23839

Enlarged lymph nodes

880

4339

2.15

89.07

3.7

2.7

199.38

174.08

ng/l

0.91

806

3965

Dronedarone medication

243

626

4.70

88.46

3.6

1.8

256.10

89.48

ng/l

14.61

229

551

Rotator cuff syndrome

3431

16465

1.48

88.27

3.0

2.9

158.60

212.31

ng/l

12.40

3119

15139

Other retinal disorders

3866

21032

1.44

87.60

3.5

3.0

259.05

218.90

ng/l

4.61

3545

19305

Personality disorders, excluding more controls

1033

5375

1.99

87.29

2.6

117.11

141.11

ng/l

1.46

918

4836

Deforming dorsopathies

1515

8927

1.77

87.03

3.2

2.8

157.85

197.55

ng/l

1.76

1393

8171

Coarctation of the aorta

122

177

9.53

85.25

4.9

3.5

166.62

172.93

ng/l

0.05

108

162

Missing teeth due to accident, extraction or parodontitis

3607

23022

1.45

84.79

3.5

2.9

165.89

205.57

ng/l

8.15

3343

21139

Dysphagia

1585

9574

1.74

84.20

3.7

2.8

181.25

220.66

ng/l

3.53

1464

8811

Persons encountering health services for other counselling and medical advice, not elsewhere classified

5865

23666

1.34

84.05

3.2

2.9

202.51

196.36

ng/l

0.47

5309

21670

Retention of urine

2223

11699

1.61

83.92

3.3

3.1

278.08

241.10

ng/l

2.23

2040

10742

Hypo-osmolality and hyponatraemia

1182

6546

1.91

83.88

4.0

2.9

259.59

222.90

ng/l

1.77

1100

5986

Other disorders of ear

4917

23661

1.37

83.85

3.2

2.9

171.21

212.55

ng/l

10.54

4524

21565

Coxarthrosis

2903

12754

1.52

83.71

3.3

2.9

198.97

217.34

ng/l

1.52

2663

11724

Asthma and allergy, excluding more controls

452

1681

2.76

83.00

2.6

1.8

81.57

73.05

ng/l

0.39

397

1487

Sequelae of cerebrovascular disease

2440

13926

1.57

82.74

4.0

3.1

285.02

236.89

ng/l

4.50

2243

12822

Gonarthrosis,primary

5088

23008

1.37

82.61

3.0

176.13

218.74

ng/l

11.63

4683

21103

Injuries to the abdomen, lower back, lumbar spine and pelvis

2408

15917

1.55

80.45

3.5

3.0

238.13

217.57

ng/l

1.15

2202

14547

Arthropathies

4201

15380

1.41

80.29

2.9

190.28

196.39

ng/l

0.36

3757

13981

Atrial septal defect, secundum type

215

541

4.67

79.65

3.3

4.2

193.06

204.34

ng/l

0.14

201

494

Hypotension

1339

7905

1.82

79.61

4.1

3.2

272.28

254.59

ng/l

0.66

1241

7281

Subjective visual disturbances

1454

8707

1.75

79.53

3.2

2.9

155.64

183.07

ng/l

1.99

1329

7966

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

677

3206

2.32

78.53

4.1

3.1

249.73

205.31

ng/l

1.15

623

2928

Unspecified fall

2914

19978

1.48

78.48

3.3

3.1

213.41

212.13

ng/l

0.05

2656

18280

Other pleural conditions

788

3977

2.18

77.78

4.3

3.0

379.18

245.54

ng/l

4.92

747

3674

External causes of morbidity and mortality

3074

10618

1.48

77.53

3.1

2.8

194.49

184.92

ng/l

0.58

2797

9709

Abnormal serum enzyme levels

1890

11747

1.63

77.27

3.1

203.08

234.15

ng/l

2.11

1738

10832

Special screening examination for other diseases and disorders

664

3106

2.27

76.94

3.4

2.7

201.33

184.94

ng/l

0.44

557

2833

Sequelae with surgical and medical care as external cause

1275

7469

1.81

76.70

3.8

3.0

222.22

196.82

ng/l

1.48

1189

6843

Other bacterial intestinal infections

1159

6604

1.87

76.60

4.2

2.9

287.62

212.76

ng/l

4.21

1070

6028

Familial hypercholesterolemia, with ischemic heart disease

647

3045

2.35

76.58

3.8

2.7

295.90

193.85

ng/l

3.91

604

2782

Other diseases of anus and rectum

1825

11622

1.63

76.47

3.4

2.9

235.54

220.86

ng/l

0.58

1695

10696

Hyperlipidaemia, other/unspecified

2267

13616

1.56

76.37

3.1

2.9

264.82

213.42

ng/l

4.43

2119

12473

Liquid cancers, including Hilmo

2216

13022

1.57

75.82

3.3

3.2

225.48

223.47

ng/l

0.07

2054

11954

Disorders of synovium and tendon

2668

15565

1.49

75.53

3.1

2.8

163.51

199.19

ng/l

2.69

2454

14249

Diseases of oral cavity, salivary glands and jaws

3340

12156

1.46

75.52

3.2

3.1

231.16

252.01

ng/l

1.42

3040

11147

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

574

2577

2.43

75.24

4.1

3.0

190.30

187.53

ng/l

0.06

527

2336

Other gastritis (incl. Duodenitis)

1369

8205

1.76

75.23

3.6

2.9

221.31

210.19

ng/l

0.42

1274

7542

Viral and other specified intestinal infections, including avohilmo

1227

6806

1.79

74.74

4.6

2.8

168.93

169.53

ng/l

0.02

1103

6063

Carpal tunnel syndrome

3192

19732

1.44

74.65

3.2

2.8

154.40

200.53

ng/l

9.45

2898

18082

Benign neoplasm: Colon

3302

22387

1.43

73.89

3.4

3.0

231.87

216.11

ng/l

1.05

3027

20646

Chronic sinusitis

2111

13991

1.56

73.49

3.0

2.9

152.83

189.52

ng/l

4.25

1921

12810

Migraine with aura

971

5255

1.91

73.19

2.9

2.5

96.89

154.75

ng/l

8.88

862

4776

Benzodiazepine use

5177

26748

1.33

73.12

3.1

2.9

185.86

202.87

ng/l

1.86

4678

24427

Diseases of the eye and adnexa

3367

11965

1.44

72.47

3.2

2.7

175.39

179.60

ng/l

0.21

3030

10789

Diseases of liver

1924

12615

1.59

72.02

3.5

3.0

248.63

193.75

ng/l

3.06

1754

11547

Benign neoplasms

4772

19624

1.35

70.86

3.2

3.0

198.33

200.12

ng/l

0.09

4335

17825

Idiopathic pulmonary fibrosis

650

3186

2.30

70.78

4.7

3.2

220.34

257.40

ng/l

1.30

616

2937

Other arthritis (FG)

1594

10049

1.65

70.29

3.3

2.8

236.63

188.78

ng/l

3.45

1455

9191

Injuries to the thorax

2671

18770

1.47

69.96

3.4

3.1

222.34

220.51

ng/l

0.05

2451

17190

Viral and other specified intestinal infections

923

4873

1.92

69.80

5.3

2.8

175.21

178.26

ng/l

0.08

833

4311

Other bacterial intestinal infections, including avohilmo

1370

8360

1.72

69.79

4.1

2.9

267.26

204.70

ng/l

3.94

1266

7618

Cholecystectomy

3811

24030

1.38

69.66

3.1

3.0

187.15

210.46

ng/l

2.52

3474

22038

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

5178

25563

1.32

69.54

3.5

2.8

215.14

195.80

ng/l

1.91

4691

23343

Convulsions, not elsewhere classified

1103

6246

1.81

69.20

3.2

2.7

208.24

182.91

ng/l

0.98

995

5658

Other specified/unspecified arthritis

1405

8630

1.69

69.01

3.4

2.8

236.34

190.65

ng/l

3.03

1283

7918

CR(E)ST syndrome

159

363

5.64

68.89

4.0

2.8

98.78

150.42

ng/l

1.77

154

336

Other and unspecified drugs and medicaments

545

2494

2.39

68.52

4.1

3.1

188.61

189.25

ng/l

0.01

499

2268

Asthma and allergy

452

1849

2.50

68.21

2.6

2.2

81.57

117.04

ng/l

2.44

397

1655

Chronic gastritis

1696

10984

1.62

67.99

3.2

3.0

245.19

225.29

ng/l

0.84

1542

10142

Diaphragmatic hernia

2139

14540

1.53

67.82

3.0

212.88

206.65

ng/l

0.23

1948

13387

Peripheral artery operations in Hilmo

901

4959

1.96

67.67

4.3

3.1

458.98

232.98

ng/l

18.14

846

4551

Idiopathic gout

711

3660

2.15

66.76

3.9

3.0

367.77

216.60

ng/l

5.81

657

3385

Fungal Sepsis

337

1262

3.06

66.73

5.5

2.8

255.23

184.21

ng/l

2.14

319

1157

Implicit fungal Sepsis

316

1150

3.17

66.17

5.6

2.8

253.56

180.10

ng/l

2.14

300

1052

Conductive and sensorineural hearing loss

4355

21955

1.35

65.86

3.3

2.9

181.87

220.93

ng/l

8.15

4044

20081

Pleural effusion

1058

6166

1.84

65.59

4.5

2.9

353.40

239.89

ng/l

8.82

995

5677

Used for control exclusion in common control thyroid runs

5207

20271

1.32

65.35

3.4

2.9

201.77

199.20

ng/l

0.15

4730

18420

Organic, including symptomatic, mental disorders

3291

16960

1.41

65.32

3.2

3.1

218.18

240.15

ng/l

1.63

3047

15643

Alzheimer disease, excluding more controls

1209

4625

1.79

65.06

3.2

2.7

191.32

257.07

ng/l

6.39

1130

4292

Substance abuse, excluding more controls

2699

15980

1.45

64.92

3.1

2.9

235.31

203.21

ng/l

1.46

2428

14629

Genitourinary diseases

2634

9153

1.47

64.82

3.5

2.7

206.79

167.30

ng/l

4.35

2396

8250

Glucagon-like peptide-1 (GLP-1) analogues

1511

9617

1.63

64.13

3.1

2.8

123.15

158.31

ng/l

5.61

1352

8830

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1511

9617

1.63

64.13

3.1

2.8

123.15

158.31

ng/l

5.61

1352

8830

Bacterial intestinal infections, IBD co-morbidities

1144

6839

1.77

63.78

4.3

3.1

294.01

219.10

ng/l

4.05

1055

6251

Artrosis, including avohilmo

4111

16926

1.36

63.58

3.0

183.81

219.82

ng/l

5.81

3745

15450

Superficial injury of head

1405

8818

1.66

63.46

3.6

3.0

232.67

214.74

ng/l

0.75

1302

8033

Cardiac murmurs and other cardiac sounds

422

1744

2.53

63.37

3.3

2.8

160.86

174.65

ng/l

0.27

387

1572

Soft tissue disorders related to use, overuse and pressure

1510

9666

1.63

62.83

3.2

2.9

179.55

203.96

ng/l

1.62

1369

8877

L04AX Other immunosuppressants

2731

19597

1.43

62.77

3.7

2.9

174.28

179.09

ng/l

0.24

2494

17890

Injuries to the shoulder and upper arm

4491

26661

1.33

62.68

3.0

197.23

202.07

ng/l

0.25

4091

24345

Fibromyalgia

448

1941

2.45

62.66

3.0

2.8

82.37

146.42

ng/l

4.76

411

1755

Chronic rhinitis, nasopharyngitis and pharyngitis

1563

10064

1.61

62.64

2.6

2.9

130.33

178.24

ng/l

6.62

1381

9207

Injury, poisoning and certain other consequences of external causes

2443

8419

1.49

62.52

3.1

2.8

192.71

181.54

ng/l

0.65

2217

7688

Persons encountering health services in other circumstances, wide

5887

23895

1.29

62.34

3.3

3.0

211.83

200.17

ng/l

1.00

5321

21863

Second line medication for Crohn's disease

2782

20039

1.42

62.26

3.6

2.9

172.94

178.11

ng/l

0.26

2539

18282

Presence of other devices

1522

9648

1.63

62.10

3.4

2.7

220.27

215.96

ng/l

0.15

1396

8840

Mood disorders, excluding more controls

4517

20330

1.33

62.08

3.0

2.9

150.27

196.21

ng/l

10.49

4062

18597

Periodontitis

5097

25347

1.31

62.02

3.0

2.9

181.14

194.56

ng/l

1.24

4620

23187

Iron deficiency anaemia secondary to blood loss (chronic)

1048

6179

1.80

61.87

5.1

3.0

331.79

217.94

ng/l

8.93

970

5660

Varicose veins

3375

18890

1.39

61.80

3.3

2.9

206.33

218.18

ng/l

0.77

3094

17366

Chronic periodontitis, including avohilmo

5085

25349

1.30

61.27

3.0

2.9

182.03

194.52

ng/l

1.10

4611

23190

Anxiety disorders, excluding more controls

3825

18357

1.36

61.08

3.2

2.8

143.60

186.34

ng/l

8.76

3433

16749

Surgical ablation of atrial fibrillation

131

11.10

60.90

3.2

3.3

238.89

159.80

ng/l

1.09

117

Fracture of rib(s), sternum and thoracic spine

1858

12571

1.54

60.39

3.6

3.1

226.32

223.88

ng/l

0.06

1711

11506

Spondylosis

2853

16154

1.42

60.20

3.0

2.9

155.35

222.68

ng/l

19.10

2608

14809

Follow-up examination after treatment for conditions other than malignant neoplasms

1956

8735

1.53

60.20

2.3

2.6

192.49

204.68

ng/l

0.55

1770

7969

Injuries to the hip and thigh

2904

19014

1.41

60.18

3.4

3.1

269.04

226.66

ng/l

4.08

2648

17438

Unspecified privation

642

3281

2.10

59.99

2.8

3.1

316.26

201.45

ng/l

4.96

585

2981

Primary gonarthrosis, bilateral

3026

18626

1.40

59.83

3.0

171.99

225.20

ng/l

11.91

2792

17155

Disturbances of skin sensation

1281

7963

1.67

59.74

2.9

2.8

114.18

165.46

ng/l

9.42

1133

7232

ILD medications: azathioprine

695

3636

2.01

59.33

5.7

2.6

229.10

156.60

ng/l

2.94

645

3289

Rheumatoid arthritis

1666

9734

1.57

59.06

3.2

2.8

201.84

204.72

ng/l

0.11

1534

8963

Neoplasms

3179

12159

1.39

58.86

3.0

2.9

172.24

186.92

ng/l

1.03

2845

10941

Cervical disc disorders

1852

12564

1.52

58.51

3.0

2.9

128.04

214.84

ng/l

24.59

1714

11533

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1040

6060

1.74

58.36

3.0

2.7

130.32

157.87

ng/l

1.42

915

5474

Depression or dysthymia

3278

13181

1.39

58.31

3.0

2.9

165.78

211.39

ng/l

6.58

2968

12095

Personality disorders

1033

6100

1.75

58.23

2.6

2.8

117.11

135.56

ng/l

1.02

918

5459

Caries of dentine, including avohilmo

4244

16581

1.34

58.22

3.1

216.47

227.83

ng/l

0.76

3853

15212

Procreative management

1345

6958

1.64

57.69

3.4

2.8

111.92

136.00

ng/l

2.05

1212

6207

Selective serotonin reuptake inhibitors

4929

19996

1.30

57.50

3.0

168.65

217.48

ng/l

12.50

4459

18336

Migraine

1934

10205

1.51

57.49

3.0

2.6

108.11

155.97

ng/l

8.19

1706

9260

Other systemic involvement of connective tissue

1557

10260

1.58

57.36

3.2

3.0

182.35

202.53

ng/l

1.21

1420

9426

Autoimmune diseases

5449

21844

1.29

57.33

3.4

2.9

199.88

199.97

ng/l

0.00

4958

19855

Enterocolitis due to Clostridium difficile

740

4041

1.98

57.24

5.1

3.1

337.56

238.34

ng/l

3.94

687

3687

Amputation

722

3920

2.00

57.15

4.7

3.1

474.97

237.17

ng/l

15.83

677

3605

Presence of other functional implants

3110

15729

1.39

57.07

3.3

2.5

218.36

189.12

ng/l

2.89

2882

14344

Disorders of adult personality and behaviour

1070

6417

1.72

56.86

2.6

2.8

113.36

134.95

ng/l

1.36

946

5737

Neuromuscular dysfunction of bladder

584

2949

2.14

56.85

3.3

3.1

166.18

208.38

ng/l

2.19

527

2699

Meniscus derangement

2775

13346

1.41

56.79

2.9

178.08

198.48

ng/l

1.64

2532

12251

Azathioprine

695

3693

1.97

56.65

5.7

2.7

229.10

162.46

ng/l

2.54

645

3331

Autoimmune diseases related-to ILD

4155

26861

1.32

55.81

3.2

2.9

189.89

197.50

ng/l

0.51

3765

24466

Cutaneous abscess, furuncle and carbuncle

1281

8110

1.64

55.61

3.5

2.9

211.11

171.58

ng/l

2.59

1168

7359

Disorders of lacrimal system

2305

16170

1.44

55.47

3.4

2.9

165.93

198.79

ng/l

3.70

2094

14843

Sensorineural hearing loss

4154

21424

1.32

55.04

3.3

2.9

184.84

224.46

ng/l

7.92

3867

19622

Other diseases of upper respiratory tract

5628

23402

1.27

54.74

2.9

3.1

172.24

218.11

ng/l

13.37

5111

21400

Abnormal findings on diagnostic imaging of other body structures

847

4872

1.85

54.42

3.6

2.9

161.36

183.11

ng/l

1.09

792

4454

Insulin, fast-acting

1869

12888

1.50

54.28

4.2

3.0

273.67

200.81

ng/l

7.16

1739

11722

Specific personality disorders

888

5132

1.79

54.19

2.6

2.7

117.66

135.35

ng/l

0.82

795

4607

Polyuria

1345

8708

1.62

54.14

3.2

3.1

221.69

223.63

ng/l

0.04

1231

8014

Artificial opening status

366

1570

2.59

54.12

3.1

2.6

220.40

171.44

ng/l

1.48

329

1430

Hyperkalaemia

440

2045

2.38

54.05

5.6

3.0

508.53

227.82

ng/l

11.37

413

1872

Diseases of pulp and periapical tissues and dental caries

3670

14259

1.35

53.83

3.1

228.87

238.35

ng/l

0.50

3335

13105

Urinary track infection

2309

8095

1.46

53.79

3.0

2.6

159.67

149.15

ng/l

0.64

2090

7381

Embolic stroke with flimmer

229

786

3.40

53.58

4.1

2.5

358.40

198.03

ng/l

4.47

213

711

Dental caries, including avohilmo

4014

15780

1.33

53.42

3.1

218.97

231.44

ng/l

0.83

3642

14497

Fracture of lumbar spine and pelvis

1456

9620

1.58

53.02

3.7

3.1

256.69

232.28

ng/l

1.06

1342

8830

Somatoform disorder

780

4390

1.86

52.99

3.1

2.8

122.69

163.21

ng/l

2.87

696

3983

Benign neoplasm: Colon, unspecified

1546

10376

1.56

52.95

3.3

3.1

237.80

219.11

ng/l

0.77

1418

9572

Acute sinusitis

2302

14977

1.43

52.75

3.2

2.7

148.68

172.87

ng/l

2.25

2067

13596

Spondylolisthesis/Spondylolysis

971

5832

1.75

52.68

3.2

2.7

144.34

196.26

ng/l

5.53

888

5344

Reimbursement for rheumatic diseases

2822

20838

1.38

52.55

3.1

2.9

186.58

191.92

ng/l

0.26

2577

19065

Sequelae of injuries, of poisoning and of other consequences of external causes

1161

7288

1.66

52.49

3.0

2.9

144.76

173.58

ng/l

2.49

1058

6605

Post-traumatic stress disorder

302

1177

2.68

52.42

2.8

2.5

88.23

111.62

ng/l

0.59

271

1037

Artificial joint operation, meniscal resection

4853

24611

1.29

52.30

3.0

170.29

213.08

ng/l

11.46

4459

22530

Other specified congenital malformation syndromes affecting multiple systems

117

255

5.37

52.16

3.8

5.2

147.19

160.64

ng/l

0.16

110

227

Later onset COPD

1956

11043

1.49

51.59

4.0

3.1

322.33

258.50

ng/l

4.10

1837

10205

Familial hypercholesterolemia

922

5520

1.77

51.47

3.4

2.9

260.16

228.16

ng/l

0.90

861

5043

Open wound of lower leg

864

5070

1.80

51.36

3.6

3.1

254.71

201.58

ng/l

3.05

778

4584

Other disorders of lacrimal gland

1893

13237

1.48

51.24

3.4

2.9

153.38

190.10

ng/l

4.21

1712

12141

Acute upper respiratory infections of multiple and unspecified sites

3668

20568

1.32

50.96

3.6

2.9

187.33

197.58

ng/l

0.71

3322

18737

Malignant neoplasm, including Hilmo

4102

18553

1.31

50.94

2.9

3.0

178.71

191.09

ng/l

1.06

3742

16863

Viral hepatitis, IBD co-morbidity

201

639

3.31

50.83

3.4

2.2

176.48

148.56

ng/l

0.36

181

564

Osteoporosis

1690

10674

1.52

50.67

4.0

2.9

214.05

219.41

ng/l

0.20

1584

9799

Poisoning by drugs, medicaments and biological substances

960

5780

1.72

50.60

3.3

2.8

151.25

153.96

ng/l

0.08

867

5168

Viral pneumonia (known virus, not influenza)

230

820

3.26

50.35

6.2

3.4

238.97

213.16

ng/l

0.39

214

756

Other disorders of the musculoskeletal system and connective tissue

873

5185

1.79

50.19

3.3

3.0

154.88

198.21

ng/l

3.63

811

4745

Invasive ventilation

469

2293

2.23

50.19

3.3

3.1

365.35

214.18

ng/l

4.90

437

2111

Complications of internal orthopaedic prosthetic devices, implants and grafts

1395

9271

1.58

50.07

3.4

3.0

216.14

212.78

ng/l

0.11

1305

8545

Other specified/unspecified systemic involvement of connective tissue

337

1439

2.56

49.92

3.5

3.0

154.71

178.56

ng/l

0.52

319

1300

Malignant neoplasm, wide definition

4103

18597

1.31

49.91

2.9

3.0

178.51

191.12

ng/l

1.09

3743

16902

Pain in thoracic spine

751

4260

1.84

49.69

3.4

2.8

131.37

188.96

ng/l

6.32

696

3870

Other diseases of hard tissues of teeth

3077

11914

1.37

49.66

3.1

200.29

245.95

ng/l

5.90

2800

10941

Malignant neoplasm

4041

18415

1.31

49.58

2.9

3.0

179.44

192.14

ng/l

1.09

3688

16749

Malignant neoplasm

4036

18394

1.31

49.46

2.9

3.0

179.46

192.18

ng/l

1.09

3683

16731

Irritable bowel syndrome

1250

8082

1.60

49.27

2.8

2.7

130.31

174.31

ng/l

4.76

1127

7380

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2480

17573

1.39

49.17

3.0

2.9

154.06

194.17

ng/l

3.27

2255

16116

Postprocedural musculoskeletal disorders, not elsewhere classified

490

2465

2.19

49.00

3.9

3.1

180.84

210.88

ng/l

0.98

461

2260

Hallux valgus (acquired)

1640

7977

1.52

48.54

2.9

2.8

182.63

194.03

ng/l

0.31

1520

7340

Maze procedure for atrial fibrillation

110

10.76

48.50

2.7

3.9

323.38

267.92

ng/l

0.36

102

Cervicobrachial syndrome

1035

6440

1.67

48.30

3.0

2.7

110.20

190.58

ng/l

16.02

926

5870

Paralytic ileus and intestinal obstruction

1489

10065

1.54

48.28

3.2

3.0

203.34

227.52

ng/l

1.38

1373

9270

Myocardial infarction, with ST-elevation

1140

7323

1.65

48.15

4.1

3.3

369.64

254.66

ng/l

5.25

1060

6714

Congenital malformations of trachea and bronchus

104

227

6.04

47.96

5.1

3.3

143.36

232.14

ng/l

1.52

204

Polyarthrosis

1165

6724

1.63

47.92

3.3

2.9

197.95

206.71

ng/l

0.15

1081

6212

Misadventures to patients during surgical and medical care

810

4767

1.79

47.87

3.6

2.9

228.96

192.05

ng/l

1.69

757

4354

Liquid cancers

1744

11528

1.49

47.81

3.4

3.2

240.45

227.91

ng/l

0.55

1618

10599

Fall on same level involving ice and snow

2903

21958

1.35

47.77

2.9

3.0

184.82

191.02

ng/l

0.32

2660

20092

Hernia of abdominal wall

2401

17701

1.40

47.67

3.4

3.0

222.37

204.43

ng/l

0.97

2190

16237

Fracture of lower leg, including ankle

2712

19943

1.37

47.66

3.0

2.9

201.64

191.97

ng/l

0.53

2486

18209

Emphysema

502

2568

2.13

47.52

4.2

3.0

214.04

245.99

ng/l

0.80

470

2359

Congenital aortic valve stenosis

11.75

47.43

4.6

4.3

122.79

146.98

ng/l

0.28

Osteoporosis with pathological fracture (FG)

521

2713

2.10

47.21

4.7

2.9

206.51

225.28

ng/l

0.47

487

2497

Delirium, not induced by alcohol and other psychoactive substances

883

5355

1.76

47.14

3.7

3.3

331.19

269.91

ng/l

2.02

816

4921

Other peripheral vascular diseases

458

2261

2.17

47.13

3.5

3.0

181.47

175.71

ng/l

0.11

419

2046

Vascular disorders of the intestines

506

2612

2.12

46.92

4.5

3.0

393.25

244.76

ng/l

5.75

472

2403

Poisoning by medicine

856

5104

1.73

46.87

3.3

2.8

147.11

150.04

ng/l

0.09

776

4573

Haemorrhage, not elsewhere classified

298

1251

2.68

46.67

4.6

3.0

362.88

224.05

ng/l

4.08

274

1158

Any event in cancer register

4198

19306

1.29

46.62

2.8

3.0

176.76

191.13

ng/l

1.39

3822

17556

Other skin changes

1175

7640

1.61

46.51

3.8

3.0

187.76

211.81

ng/l

1.46

1109

7039

Chronic ulcer of skin, not elsewhere classified

479

2434

2.15

46.44

4.1

3.0

357.47

230.24

ng/l

2.83

437

2228

Dermatitis

3162

23763

1.33

46.37

3.2

2.9

189.63

200.03

ng/l

0.63

2878

21749

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1638

11360

1.49

46.31

3.6

2.9

204.70

176.21

ng/l

1.57

1485

10366

Abnormalities of gait and mobility

775

4574

1.81

46.12

2.9

3.1

274.69

223.78

ng/l

1.35

704

4214

Superficial injury of lower leg

1265

8334

1.57

46.03

3.3

2.9

202.66

183.35

ng/l

0.78

1148

7549

Schizophrenia or delusion, excluding more controls

1266

8218

1.56

45.96

2.9

2.8

150.39

181.89

ng/l

1.83

1134

7422

Cellulitis

1152

7458

1.61

45.83

3.7

3.0

240.96

189.41

ng/l

2.84

1036

6781

Exclusion endpoint for clefts

126

322

4.45

45.52

3.6

4.7

143.83

161.77

ng/l

0.25

119

289

Symptoms and signs concerning food and fluid intake

584

3157

1.95

45.43

3.7

2.7

212.23

187.00

ng/l

0.72

538

2903

Extracorporeal dialysis

390

1851

2.32

45.42

6.3

3.1

815.37

201.16

ng/l

21.10

377

1706

Other disorders of eyelid

2550

18047

1.37

45.09

3.3

3.0

197.13

227.18

ng/l

2.64

2334

16666

Amputation of toe

514

2711

2.08

45.08

4.3

3.1

466.29

234.00

ng/l

10.70

483

2499

Congenital malformations of the respiratory system, including avohilmo

149

437

4.01

45.00

4.7

3.9

134.03

211.52

ng/l

2.28

138

404

Diabetic nephropathy, excluding more controls

913

4570

1.73

44.99

4.2

3.2

455.29

203.15

ng/l

20.41

859

4147

Memory loss

627

3523

1.93

44.91

2.5

3.2

224.26

252.96

ng/l

0.72

577

3231

Diseases of the ear and mastoid process

5372

21839

1.25

44.68

3.1

2.9

166.01

207.06

ng/l

9.33

4857

19819

Insulin, fast-acting or short human

1881

13466

1.44

44.49

4.2

3.0

275.91

206.86

ng/l

6.47

1750

12248

Acute upper respiratory infections

5213

25374

1.25

44.48

3.4

2.9

182.83

208.83

ng/l

3.87

4735

23188

Other metabolic disorders

595

3254

1.91

44.41

4.0

2.6

183.78

152.90

ng/l

0.80

546

2945

Kidney transplant status

291

1229

2.59

44.16

4.5

3.2

582.65

163.38

ng/l

11.44

279

1112

Congenital malformations of the respiratory system

139

396

4.17

43.98

4.6

4.1

133.80

217.10

ng/l

2.31

128

366

Transport accidents

2053

12364

1.41

43.61

3.0

2.8

168.92

176.82

ng/l

0.37

1874

11304

Other infectious diseases, including avohilmo

554

3008

1.97

43.53

4.1

3.2

272.81

227.07

ng/l

1.29

514

2739

Candidiasis, including avohilmo

1434

9813

1.51

43.40

3.4

2.9

189.35

176.42

ng/l

0.47

1302

8955

Other reaction to severe stress, and adjustment disorders

1359

9165

1.51

43.27

3.6

2.7

143.40

146.59

ng/l

0.12

1220

8261

Diseases of pulp and periapical tissues, including avohilmo

5163

21695

1.25

42.80

2.9

3.0

192.20

212.73

ng/l

2.55

4666

19856

Lung cancer and mesothelioma

1022

5519

1.64

42.80

3.0

2.4

213.93

203.84

ng/l

0.31

958

5086

Emotionally unstable personality disorder

400

1925

2.15

42.69

2.4

2.7

82.40

104.05

ng/l

1.18

360

1694

Heartburn

593

3293

1.90

42.54

3.6

2.7

169.40

182.69

ng/l

0.37

540

2995

Other and unspecified polyneuropathies, also in other diseases

1139

7515

1.59

42.47

3.5

3.1

235.76

223.25

ng/l

0.36

1044

6900

Disorders of other endocrine glands

2129

15418

1.39

42.30

3.6

3.0

208.02

195.24

ng/l

0.58

1944

14042

Benign neoplasm of other and ill-defined parts of digestive system

1019

6564

1.63

42.27

3.4

3.0

194.21

199.55

ng/l

0.15

923

6026

Polyneuropathies and other disorders of the peripheral nervous system

1268

8565

1.55

42.09

3.5

3.1

233.32

220.86

ng/l

0.40

1165

7870

Gingivitis and periodontal diseases

5040

21152

1.25

41.86

3.0

188.35

214.17

ng/l

3.54

4550

19400

Any dementia, excluding more controls

2391

12288

1.38

41.76

3.3

3.1

227.24

256.01

ng/l

1.92

2220

11380

Non-selective monoamine reuptake inhibitors

1864

12926

1.42

41.49

3.1

2.9

155.18

217.79

ng/l

8.93

1684

11910

Open wound of head

2868

20739

1.33

41.44

3.3

3.0

236.08

210.79

ng/l

1.95

2637

18934

Cystitis

3998

18915

1.28

41.12

3.1

2.9

208.28

208.54

ng/l

0.01

3653

17317

Anxiety (asthma-related co-morbidities)

2401

13631

1.36

40.99

2.9

2.8

130.46

154.60

ng/l

2.18

2119

12347

Phlebitis and thrombophlebitis (not including DVT)

1175

7840

1.56

40.86

3.0

2.9

185.01

196.49

ng/l

0.43

1082

7176

Disorders of skin appendages

2133

15689

1.38

40.76

3.2

2.8

166.35

172.41

ng/l

0.25

1930

14217

Other hammer toe(s) (acquired)

970

5641

1.64

40.72

3.2

2.8

210.41

207.07

ng/l

0.07

911

5216

Abnormal findings on antenatal screening of mother

225

860

2.71

40.54

1.9

2.4

32.78

68.68

ng/l

3.68

206

760

Degeneration of macula and posterior pole

2953

17660

1.33

40.52

3.3

3.1

236.47

234.68

ng/l

0.07

2705

16301

Other mental disorders due to brain damage and dysfunction and to physical disease

793

4885

1.73

40.32

3.7

3.3

178.90

244.71

ng/l

4.42

747

4483

Ascites

477

2534

2.03

40.31

4.5

2.8

382.97

204.72

ng/l

6.52

451

2322

Mycoses

1400

9699

1.49

40.06

3.8

2.9

200.44

191.32

ng/l

0.36

1280

8841

Traumatic subdural haemorrhage

812

4677

1.71

40.03

3.6

2.8

277.33

282.59

ng/l

0.10

736

4322

Need for immunization against other single viral diseases

143

442

3.78

39.86

3.6

3.1

542.49

186.98

ng/l

2.58

137

403

2589

17843

1.35

39.83

3.5

3.1

232.63

239.34

ng/l

0.34

2408

16474

Alzheimer’s disease (Atypical or mixed), excluding more controls

660

2861

1.84

39.80

3.8

2.9

231.48

309.23

ng/l

4.21

623

2649

Migraine without aura

608

3439

1.81

39.73

2.9

2.5

82.43

131.51

ng/l

3.33

530

3112

Coagulation defects, purpura and other haemorrhagic conditions

996

6452

1.61

39.72

3.6

3.1

279.23

196.28

ng/l

5.82

908

5898

Flat foot [pes planus] (acquired)

488

2610

1.97

39.55

3.4

2.8

174.75

180.24

ng/l

0.04

451

2382

Chronic apical periodontitis

5379

24870

1.23

39.20

3.0

186.07

199.75

ng/l

1.39

4878

22724

Pneumonia due to other infectious organisms, not elsewhere classified

215

840

2.85

38.88

4.7

2.6

174.65

189.70

ng/l

0.23

201

765

Diseases of inner ear

2864

21305

1.32

38.81

3.3

3.0

170.53

210.74

ng/l

5.71

2657

19563

Other complications of surgical and medical care, not elsewhere classified

506

2759

1.94

38.73

3.6

2.9

226.08

180.03

ng/l

0.80

465

2498

Ventral hernia

1289

8867

1.51

38.62

3.6

3.0

222.98

206.18

ng/l

0.57

1177

8156

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

154

497

3.37

38.60

3.6

4.0

129.10

147.24

ng/l

0.33

140

438

Symptoms and signs involving speech and voice

1724

12485

1.42

38.51

3.5

2.9

165.92

204.30

ng/l

4.38

1592

11461

Injuries to the elbow and forearm

3371

22856

1.29

38.51

3.1

3.0

203.77

187.55

ng/l

0.93

3074

20827

Right bundle-branch block

204

775

2.87

38.44

3.7

1.8

257.96

85.15

ng/l

5.33

184

682

Persons encountering health services for specific procedures, not carried out

391

1953

2.11

38.41

2.1

2.6

270.28

164.09

ng/l

3.00

352

1747

Vascular dementia

749

4441

1.74

38.35

4.1

3.5

310.99

328.88

ng/l

0.43

701

4073

Phobic anxiety disorders

433

2226

2.00

38.15

3.0

2.7

123.46

117.34

ng/l

0.15

386

1961

Skin changes due to chronic exposure to nonionizing radiation

2482

17230

1.35

38.12

3.5

3.1

234.52

240.39

ng/l

0.28

2307

15923

Disorder of lipoprotein metabolism, unspecified

750

4603

1.72

38.09

2.8

275.32

225.48

ng/l

1.68

702

4198

Solid cancers, including Hilmo

3949

18440

1.27

38.02

2.8

3.0

178.28

191.67

ng/l

1.16

3602

16772

Solid cancers

3884

18230

1.27

37.80

2.8

3.0

180.66

192.62

ng/l

0.92

3549

16595

Decubitus ulcer and pressure area

445

2372

2.05

37.72

4.3

3.2

331.57

251.86

ng/l

1.68

404

2182

Myalgia

1049

6926

1.56

37.72

3.0

2.8

151.27

182.21

ng/l

1.18

941

6309

Unknown and unspecified causes of morbidity

349

1689

2.19

37.58

3.3

2.8

211.78

192.11

ng/l

0.40

313

1541

Volume depletion

590

3410

1.84

37.55

4.3

3.0

351.76

248.33

ng/l

4.02

540

3099

Fibrosis and cirrhosis of liver

474

2575

1.98

37.51

4.1

3.1

257.97

200.58

ng/l

1.93

441

2371

Other and unspecified injuries of head

455

2440

2.00

37.21

4.3

3.0

205.03

206.58

ng/l

0.03

425

2216

Other viral diseases

1142

7659

1.52

37.20

4.2

2.9

174.91

163.38

ng/l

0.48

1027

6886

Rheumatism, unspecified

658

3920

1.76

37.01

3.1

2.7

136.68

179.64

ng/l

1.91

595

3591

Speech and linguistic disorders, excluding more controls

304

1301

2.28

36.94

5.2

3.2

177.96

187.16

ng/l

0.15

284

1159

Actinic keratosis

2424

16932

1.35

36.93

3.5

3.1

236.82

242.46

ng/l

0.26

2252

15658

Intestinal stricture

1742

12745

1.41

36.86

3.2

3.1

211.08

222.38

ng/l

0.50

1600

11706

Nonorganic sleeping disorders, excluding more controls

811

5073

1.65

36.81

2.8

163.84

168.73

ng/l

0.11

713

4600

Other anxiety disorders

1737

10704

1.40

36.72

2.9

2.7

131.20

152.09

ng/l

1.48

1526

9631

Seropositive rheumatoid arthritis

1247

8553

1.50

36.58

3.2

2.8

209.37

201.48

ng/l

0.28

1161

7849

Sequelae of other external causes

330

1590

2.24

36.54

4.2

2.9

222.18

199.04

ng/l

0.47

306

1446

Any dementia

2598

13873

1.34

36.52

3.3

3.2

232.11

260.11

ng/l

2.01

2412

12843

Extreme obesity with alveolar hypoventilation

258

1131

2.52

36.50

4.8

3.1

184.27

196.95

ng/l

0.22

241

1034

Substance abuse

2699

19465

1.31

36.42

3.1

3.0

235.31

200.23

ng/l

1.69

2428

17750

Gonarthrosis, primary, with knee surgery

3210

19821

1.29

36.24

3.0

177.72

226.92

ng/l

10.73

2955

18255

Epilepsy

1448

10238

1.45

36.07

3.1

3.0

159.40

230.89

ng/l

13.88

1332

9387

Voice disturbances

1333

9344

1.47

35.99

3.2

2.9

149.69

188.22

ng/l

4.02

1221

8587

Other disorders of veins

1993

14679

1.37

35.68

3.0

2.9

212.72

191.40

ng/l

1.44

1800

13484

Anxiety disorders

3964

22012

1.25

35.66

3.2

2.8

141.60

177.28

ng/l

6.63

3546

20052

Disorders of vestibular function (Vertigo)

2481

18666

1.33

35.63

3.2

3.0

170.68

210.53

ng/l

4.82

2310

17155

Other other unspecified disorders of the circulatory system

250

1098

2.54

35.52

5.0

3.1

271.60

215.45

ng/l

1.06

229

1020

Asthma and opportunity respiratory infection

320

1556

2.28

35.47

3.7

3.1

208.54

209.61

ng/l

0.01

291

1427

Fracture of femur

1739

11524

1.41

35.40

3.5

3.2

327.59

250.90

ng/l

5.96

1580

10590

Other diseases of liver

888

5755

1.60

35.37

3.1

2.9

210.67

173.82

ng/l

1.69

803

5248

Neurotic, stress-related and somatoform disorders

3906

21774

1.25

35.24

3.2

2.8

140.07

176.54

ng/l

6.89

3492

19834

Other viral diseases, not elsewhere classified

794

4989

1.64

35.23

4.3

3.0

184.31

179.17

ng/l

0.13

723

4496

Coxarthrosis, primary

3375

22478

1.27

34.95

3.2

3.1

199.92

226.15

ng/l

3.19

3116

20715

Thyrotoxicosis

1205

8330

1.49

34.94

3.9

2.9

255.53

180.43

ng/l

3.16

1103

7613

Mental and behavioural disorders due to psychoactive substance use

2759

19780

1.30

34.82

3.1

3.0

235.70

199.18

ng/l

1.85

2485

18034

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1040

6965

1.53

34.65

3.0

2.7

130.32

147.97

ng/l

0.76

915

6264

Primary_lymphoid and hematopoietic malignant neoplasms

1361

9668

1.46

34.62

3.4

3.1

245.90

224.60

ng/l

0.98

1265

8893

Other disorders of binocular vision

195

4.93

34.62

3.0

2.6

66.95

116.59

ng/l

1.43

170

Bronchiectasis

487

2739

1.91

34.55

3.8

3.0

200.65

212.45

ng/l

0.22

448

2512

All anxiety disorders

2419

14393

1.32

34.55

2.9

2.7

129.99

154.80

ng/l

2.30

2134

13019

Alcohol use disorder, Swedish definition

2600

18406

1.31

34.25

3.2

3.0

236.36

205.82

ng/l

1.75

2355

16794

Other diseases of blood and blood-forming organs, wide

1111

7603

1.52

34.25

3.4

3.0

223.96

192.78

ng/l

1.51

1017

6965

Sequelae of injuries of upper limb

475

2641

1.90

34.15

3.2

2.9

110.26

167.63

ng/l

6.17

442

2395

Gastric ulcer

1029

6959

1.54

33.94

3.8

3.0

285.49

236.98

ng/l

2.15

953

6402

Postprocedural endocrine and metabolic disorders, not elsewhere classified

520

2968

1.82

33.78

3.9

2.6

179.71

151.89

ng/l

0.64

475

2686

Other disorders of eye and adnexa

662

4045

1.70

33.68

3.2

3.0

174.10

177.74

ng/l

0.06

611

3666

Thyrotoxicosis, other and/or unspecified

949

6303

1.56

33.61

4.1

2.9

240.70

179.28

ng/l

2.74

871

5764

Alzheimer’s disease (Late onset), excluding more controls

956

4089

1.59

33.59

3.1

2.7

198.54

274.34

ng/l

7.48

887

3797

Other and unspecified nonorganic psychotic disorders

704

4358

1.66

33.41

2.8

144.69

144.83

ng/l

0.00

611

3867

Migraine with aura and triptan purchases

513

2923

1.80

33.01

2.6

2.7

66.73

122.72

ng/l

11.50

443

2627

Family history of certain disabilities and chronic diseases leading to disablement

193

764

2.67

32.95

2.6

2.2

102.43

103.37

ng/l

0.01

173

682

Gastroduodenal ulcer

1475

10666

1.42

32.91

3.8

3.1

283.95

247.60

ng/l

1.72

1347

9813

Myocardial infarction, unclassifiable

1420

9143

1.44

32.87

4.6

3.3

419.53

276.31

ng/l

11.09

1307

8400

Abnormal blood-pressure reading, without diagnosis

213

888

2.56

32.85

2.8

2.3

177.38

160.85

ng/l

0.23

183

793

Pruritus

582

3471

1.76

32.69

3.3

2.9

213.03

190.44

ng/l

0.56

542

3171

Other coagulation defects

383

2023

2.01

32.54

3.9

3.0

276.88

195.87

ng/l

2.20

344

1838

Injuries to unspecified part of trunk, limb or body region

546

3215

1.79

32.40

3.3

3.0

278.23

201.80

ng/l

2.08

494

2927

Viral pneumonia (unknown virus, not influenza)

357

1847

2.06

32.31

4.3

2.8

236.63

187.20

ng/l

1.12

331

1690

Pneumocystosis

154

567

3.20

32.28

4.5

3.2

182.12

198.22

ng/l

0.22

144

524

Pneumocystosis, including avohilmo

154

567

3.20

32.28

4.5

3.2

182.12

198.22

ng/l

0.22

144

524

Mood [affective] disorders

4712

25097

1.22

32.20

3.0

2.9

149.26

196.07

ng/l

11.30

4220

22928

Other viral diseases, including avohilmo

1413

10059

1.42

32.12

3.9

2.8

160.40

155.87

ng/l

0.18

1267

9061

Vascular dementia (mixed)

200

847

2.79

32.02

4.7

3.5

262.09

316.82

ng/l

0.88

191

778

Mood disorders

4723

25133

1.22

31.99

3.0

2.9

149.08

196.23

ng/l

11.51

4231

22962

DVT of lower extremities

1028

7033

1.52

31.94

3.1

3.0

216.07

219.64

ng/l

0.07

936

6441

Other infectious diseases

448

2515

1.90

31.80

4.1

3.1

287.49

232.03

ng/l

1.40

411

2297

2711

19123

1.29

31.79

3.1

3.0

236.64

204.95

ng/l

1.95

2464

17430

Other viral diseases, not elsewhere classified, including avohilmo

1039

7068

1.50

31.17

3.9

3.0

166.57

165.25

ng/l

0.04

940

6366

Fitting and adjustment of other devices

1889

12587

1.35

31.14

3.1

2.7

199.76

218.87

ng/l

1.29

1706

11576

Other and unspecified coagulation defects

249

1142

2.34

31.07

3.3

3.0

222.09

174.01

ng/l

0.72

221

1039

Trochanteric bursitis

751

4834

1.62

31.01

2.9

2.8

150.91

197.20

ng/l

3.12

678

4432

Disorders of psychological development

386

1898

1.94

31.01

5.2

3.3

164.40

163.39

ng/l

0.02

354

1664

Viral infections characterized by skin and mucous membrane lesions

1991

15194

1.34

31.00

3.6

3.0

194.86

192.58

ng/l

0.06

1805

13884

Other blood glucose lowering drugs, excl. Insulins

903

6071

1.56

30.94

3.4

2.9

217.60

219.33

ng/l

0.04

833

5593

Bipolar affective disorders

666

4149

1.65

30.81

2.8

113.62

144.69

ng/l

1.55

581

3749

Depression

4284

23725

1.22

30.72

3.0

2.9

147.61

189.62

ng/l

8.42

3831

21650

Alcohol abuse, main dg, excluding more controls

636

3933

1.67

30.68

3.4

2.9

198.90

184.22

ng/l

0.37

581

3554

2812

19477

1.28

30.67

3.1

3.0

235.32

203.50

ng/l

2.04

2549

17765

Benign neoplasm: Stomach

560

3385

1.76

30.65

3.7

3.0

197.99

205.26

ng/l

0.15

506

3106

Other and unspecified local infections of skin and subcutaneous tissue

511

3001

1.79

30.62

3.7

3.1

237.73

186.90

ng/l

1.64

463

2728

Other and unspecified dermatitis

2508

19762

1.29

30.60

3.1

2.9

190.74

195.53

ng/l

0.21

2269

18097

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2048

15595

1.33

30.47

3.1

3.0

232.15

201.28

ng/l

1.37

1855

14212

Osteomyelitis

392

2146

1.96

30.38

4.2

3.0

374.70

220.07

ng/l

5.86

368

1971

Cervicalgia

984

6724

1.51

30.30

3.1

2.8

155.02

207.96

ng/l

4.97

894

6151

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

909

6017

1.52

30.19

4.3

2.8

178.72

153.47

ng/l

0.82

820

5408

Kyphosis

108

336

3.79

30.05

4.6

3.4

157.18

217.16

ng/l

1.15

101

313

Glomerular diseases

913

6181

1.54

29.91

3.8

3.1

472.06

203.91

ng/l

17.11

856

5651

Polycystic ovarian syndrome, consortium definition

2821

12821

1.28

29.90

2.9

2.7

135.61

170.52

ng/l

6.28

2588

11647

1977

13056

1.34

29.90

3.5

3.1

249.77

257.16

ng/l

0.26

1816

12071

Other diseases of arteries and capillaries

503

2968

1.79

29.84

3.2

3.0

275.57

196.29

ng/l

2.81

468

2709

Amyloidosis, other/unspecified

145

538

3.12

29.73

5.5

2.9

423.51

225.24

ng/l

3.01

139

500

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

481

2818

1.82

29.66

4.4

3.2

289.08

235.22

ng/l

1.50

449

2585

Other or unspecified ileus, impaction or obstruction

1013

7011

1.50

29.50

3.2

3.0

220.03

229.34

ng/l

0.27

932

6453

Glaucoma

3127

21538

1.26

29.46

3.3

3.1

200.78

229.59

ng/l

3.35

2905

19818

Preparatory care for dialysis

272

1333

2.24

29.43

2.9

3.0

904.58

194.50

ng/l

12.16

262

1225

SLE (Finngen)

186

772

2.62

29.43

4.3

2.9

208.85

174.02

ng/l

0.43

174

699

Fall involving bed

267

1309

2.29

29.43

4.4

3.4

302.41

273.48

ng/l

0.27

249

1207

Cirrhosis of liver, NAS

345

1840

2.04

29.29

4.4

3.1

268.89

210.41

ng/l

1.54

322

1701

Cardiomyopathy in other diseases

6.82

29.07

6.4

1.7

472.11

115.69

ng/l

3.14

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

861

5805

1.55

29.05

3.1

3.2

218.16

220.08

ng/l

0.04

807

5348

Protozoal diseases

193

829

2.60

28.91

4.4

3.1

194.32

200.98

ng/l

0.09

179

756

Other and unspecified effects of external causes

1088

7628

1.46

28.90

3.1

3.0

150.93

166.47

ng/l

0.74

973

6886

Other congenital malformations

340

1786

1.99

28.90

3.4

3.6

145.42

172.79

ng/l

0.68

310

1601

Schizophrenia or delusion

1266

9118

1.42

28.87

2.9

150.39

168.99

ng/l

0.84

1134

8210

Arterial embolism and thrombosis

372

2037

1.97

28.83

4.7

3.0

339.41

234.92

ng/l

3.43

351

1862

Recurrent aphthous stomatitis , including avohilmo

691

4437

1.62

28.82

3.4

3.1

206.37

187.44

ng/l

0.37

623

4046

Dermatitis and eczema

5343

26845

1.19

28.76

3.1

3.0

183.94

202.27

ng/l

2.18

4848

24490

Glaucoma suspect

1987

15367

1.33

28.72

3.5

3.1

174.56

217.51

ng/l

5.95

1853

14175

Speech and linguistic disorders

313

1528

2.04

28.71

5.3

3.6

175.70

181.78

ng/l

0.10

293

1346

Other disorders of kidney and ureter

722

4706

1.61

28.69

3.5

3.1

334.79

207.38

ng/l

7.00

671

4317

Stomatitis and related lesions

898

6102

1.52

28.50

3.3

3.0

199.42

180.19

ng/l

0.48

815

5549

Cytomegalovirus infection, IBD co-morbidity

142

529

3.01

28.40

7.1

3.6

258.62

177.49

ng/l

1.36

132

483

Other local infections of skin and subcutaneous tissue

531

3215

1.73

28.40

3.7

3.0

233.41

186.21

ng/l

1.54

479

2914

Childhood asthma (age<16), excluding more controls

246

877

2.23

28.34

2.8

1.6

57.87

44.26

ng/l

0.63

197

735

Abnormal involuntary movements

676

4343

1.62

28.28

3.6

3.0

170.69

201.08

ng/l

1.40

611

3978

Candidiasis

666

4261

1.62

28.18

4.0

3.0

210.21

178.97

ng/l

1.04

605

3891

Panic disorder

480

2812

1.75

28.10

3.4

2.6

122.17

135.46

ng/l

0.25

421

2505

Type 1 diabetes

1014

7049

1.47

28.04

3.6

2.8

316.52

184.26

ng/l

9.05

949

6348

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

336

1810

2.03

27.95

3.6

3.2

300.93

232.06

ng/l

1.44

305

1674

Alcohol use disorder, ICD-based

1880

14456

1.33

27.94

3.1

3.0

223.50

200.34

ng/l

0.85

1708

13174

Paracetamol or NSAID medication

693

2181

1.64

27.93

3.2

3.1

219.05

285.66

ng/l

2.87

618

1996

Other/unspecified cytomegaloviral diseases

124

434

3.23

27.89

7.4

3.8

251.60

166.98

ng/l

1.59

115

394

Protozoal diseases, including avohilmo

195

855

2.53

27.82

4.4

3.1

192.87

201.31

ng/l

0.12

181

781

ILD medications: pirfenidone

105

344

3.84

27.74

4.9

2.9

135.25

200.48

ng/l

1.55

318

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

783

5234

1.56

27.56

3.8

3.1

282.13

206.06

ng/l

1.86

733

4790

Cytomegaloviral disease

142

537

2.94

27.53

7.1

3.6

258.62

176.79

ng/l

1.39

132

489

Cytomegaloviral disease, including avohilmo

142

538

2.93

27.40

7.1

3.6

258.62

176.79

ng/l

1.39

132

489

Elevated blood glucose level

442

2577

1.81

27.35

3.9

3.0

261.84

204.99

ng/l

0.95

405

2350

Glomerular disorders in diseases classified elsewhere

617

3922

1.65

27.31

3.8

3.0

514.63

203.45

ng/l

18.72

580

3578

Other embolism and thrombosis

670

4336

1.61

27.27

3.1

3.0

195.79

209.61

ng/l

0.35

603

3964

Degenerative diseases of the nervous system

2372

13533

1.30

27.26

3.4

3.3

225.64

270.85

ng/l

5.12

2203

12501

Dislocation, sprain and strain of joints and ligaments of knee

2416

17319

1.28

27.25

2.8

135.43

158.26

ng/l

3.00

2201

15682

Agoraphobia

116

389

3.15

27.15

2.6

2.4

98.78

95.51

ng/l

0.05

106

338

Chronic periodontitis, complicated

2760

21740

1.26

27.13

3.0

2.9

192.98

189.35

ng/l

0.17

2501

19978

Other and unspecified visual disturbances

531

3258

1.71

26.98

3.2

3.0

166.96

185.88

ng/l

0.57

482

2978

Amyloidosis

163

673

2.73

26.81

5.3

2.9

410.59

226.32

ng/l

3.12

154

622

Mental and behavioural disorders due to alcohol

2328

17597

1.28

26.59

3.1

3.0

234.01

202.98

ng/l

1.58

2113

16040

Charcot foot

295

3.61

26.58

3.9

2.2

371.39

108.77

ng/l

4.64

268

Type 1 diabetes, wide definition, subgroup 1

806

5427

1.52

26.37

3.7

2.8

301.68

168.92

ng/l

7.24

748

4882

Systemic lupus erythematosus

186

812

2.48

26.37

4.3

2.9

208.85

176.46

ng/l

0.39

174

739

Malignant neoplasm of digestive organs, including Hilmo

2337

13633

1.29

26.34

3.0

3.2

210.21

224.62

ng/l

0.83

2145

12524

Suppurative and necrotic conditions of lower respiratory tract

335

1831

1.97

26.22

3.9

3.1

307.44

222.85

ng/l

1.42

310

1684

Hyperplasia of prostate

1890

8187

1.33

26.05

3.1

204.24

252.36

ng/l

4.31

1730

7467

Pulmonary oedema

152

619

2.83

26.05

5.8

3.4

538.31

266.24

ng/l

4.89

141

576

Fall on and from stairs and steps

1272

9353

1.40

26.01

2.9

3.0

199.95

194.81

ng/l

0.13

1157

8546

Schizophrenia, schizotypal and delusional disorders

1257

9203

1.40

25.99

2.9

147.60

169.56

ng/l

1.09

1126

8289

Mycoses, including avohilmo

4253

27278

1.20

25.97

3.0

2.9

182.74

192.20

ng/l

0.71

3857

24893

Systemic lupus erythematosus, unspecified

154

622

2.70

25.95

4.0

3.0

211.42

174.03

ng/l

0.42

144

570

Fracture of forearm

2567

18549

1.26

25.86

3.1

2.9

198.25

186.35

ng/l

0.60

2356

16895

Abnormal results of function studies

427

2502

1.79

25.79

3.9

2.9

227.31

184.50

ng/l

1.02

393

2279

Benign paroxysmal vertigo

1529

11587

1.36

25.78

3.3

3.0

149.82

206.38

ng/l

9.68

1417

10638

Fentanyl

578

3656

1.65

25.75

3.7

2.9

213.82

260.09

ng/l

1.98

542

3341

Basal cell carcinoma, including Hilmo

2513

13637

1.27

25.64

3.1

234.06

221.97

ng/l

0.60

2317

12544

Other enthesopathies

1265

9292

1.39

25.63

2.9

2.8

148.69

186.08

ng/l

2.71

1145

8495

Pyothorax

269

1386

2.11

25.32

3.8

3.2

323.94

232.28

ng/l

1.24

248

1265

Unspecified mental disorder

1594

12149

1.34

25.06

2.9

134.17

176.94

ng/l

4.92

1409

10993

Disorders of continuity of bone

444

2648

1.75

24.98

3.1

2.9

180.34

164.30

ng/l

0.12

403

2403

Cholecystitis

784

5348

1.53

24.94

3.6

3.1

214.54

244.37

ng/l

1.19

714

4903

Other specified and unspecified personality disorders

329

1795

1.91

24.93

2.8

151.11

137.50

ng/l

0.22

298

1606

Oter anti-inflammatory and antirheumatic agents, non-steroids

1257

5030

1.41

24.90

3.0

3.4

244.34

314.23

ng/l

4.54

1135

4665

Presbycusis

982

6922

1.46

24.87

3.7

3.2

243.50

291.01

ng/l

3.12

908

6357

Osteonecrosis due to drugs

120

446

3.16

24.84

4.0

3.3

204.69

202.44

ng/l

0.02

112

411

Bronchitis, not specified as acute or chronic

416

2447

1.78

24.75

3.9

2.9

193.78

209.86

ng/l

0.31

370

2222

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2557

13908

1.27

24.74

3.1

230.53

221.30

ng/l

0.42

2359

12786

SLE, ICD10

173

757

2.48

24.45

4.4

3.0

203.95

174.81

ng/l

0.35

161

693

SLE, strict definition

173

757

2.48

24.45

4.4

3.0

203.95

174.81

ng/l

0.35

161

693

Lesion of ulnar nerve

639

4188

1.58

24.37

3.5

2.9

178.33

188.17

ng/l

0.27

584

3826

Asthma mixed form (mode), excluding more controls

200

922

2.27

24.31

3.9

2.0

113.91

113.39

ng/l

0.01

180

826

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

4175

27513

1.19

24.24

3.1

3.0

180.32

194.52

ng/l

1.08

3805

25081

Impotence

331

1849

1.92

24.13

4.5

3.0

216.53

232.22

ng/l

0.27

312

1692

Sulfasalazine

1191

8756

1.39

24.12

2.9

2.5

180.40

181.89

ng/l

0.05

1087

7977

Follicular cysts of skin and subcutaneous tissue

849

5904

1.48

24.11

3.4

2.9

192.05

186.68

ng/l

0.11

768

5379

Disorders of ocular muscles, binocular movement, accommodation and refraction

1955

15245

1.29

24.07

3.2

2.9

149.10

174.90

ng/l

2.46

1773

13857

Alzheimer disease

2179

12428

1.29

23.99

3.4

3.3

235.66

276.59

ng/l

3.81

2023

11491

Diseases of the myoneural junction and muscle

662

4406

1.57

23.90

3.1

3.2

223.37

221.99

ng/l

0.02

602

4020

Diseases of male genital organs

2360

9463

1.28

23.86

3.2

3.1

187.31

234.30

ng/l

5.50

2129

8527

Neuralgia and neuritis, unspecified

262

1356

2.05

23.83

2.9

3.0

159.83

188.94

ng/l

0.55

240

1229

Other disorders of binocular movement

115

418

3.00

23.80

3.0

3.1

154.59

162.59

ng/l

0.07

109

373

Problems related to lifestyle

427

2551

1.73

23.69

3.2

2.9

197.80

157.56

ng/l

1.00

385

2299

Deviated nasal septum

1484

11299

1.34

23.66

2.8

3.1

163.30

203.71

ng/l

1.75

1340

10370

Embolic stroke

316

1755

1.94

23.65

3.8

3.3

346.66

274.87

ng/l

1.11

296

1611

Diabetic retinopathy, excluding more controls

1331

5533

1.39

23.62

3.8

3.1

283.66

194.32

ng/l

7.73

1233

5008

Substance use, excluding alcohol

747

5074

1.51

23.60

2.9

196.40

157.82

ng/l

0.56

650

4547

Malignant neoplasm of digestive organs

2144

13063

1.28

23.59

3.0

3.2

210.77

228.15

ng/l

1.02

1966

12021

Postmenopausal osteoporosis with pathological fracture

435

2656

1.76

23.52

4.6

3.2

213.61

225.03

ng/l

0.22

407

2434

Hepatic failure, not elsewhere classified

223

1104

2.20

23.45

3.7

3.1

310.70

216.96

ng/l

1.47

208

1014

Artificial joint re-operation

422

2554

1.77

23.39

3.3

3.2

185.20

209.00

ng/l

0.66

395

2350

Childhood asthma (age<16)

246

948

2.06

23.34

2.8

2.0

57.87

70.52

ng/l

0.44

197

802

Cervicocranial syndrome

487

3029

1.67

23.27

3.0

2.8

137.95

194.60

ng/l

3.48

446

2753

Basal cell carcinoma

2421

13326

1.26

23.24

3.0

3.1

237.24

223.70

ng/l

0.60

2231

12265

Fracture of shoulder and upper arm

1799

14090

1.30

23.19

3.3

3.1

224.80

206.82

ng/l

0.88

1645

12877

Benign neoplasm: Small intestine

252

1315

2.10

23.11

3.7

3.1

209.24

222.03

ng/l

0.18

228

1215

Impingement syndrome of shoulder

1056

7688

1.41

23.00

3.3

2.8

145.34

190.15

ng/l

4.11

959

7071

Umbilical hernia

1248

9331

1.37

22.91

3.3

3.0

228.05

193.53

ng/l

1.60

1137

8542

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2467

13564

1.26

22.91

3.1

238.30

222.54

ng/l

0.83

2278

12479

Disorders of the thyroid gland

4377

24196

1.19

22.89

3.3

2.9

200.69

205.05

ng/l

0.23

3994

22125

Carbimazole or st.post thyroidectomy, condition for graves disease

883

6241

1.45

22.84

4.1

2.8

219.52

166.07

ng/l

2.06

798

5701

Kela-code for severe mental illness

1441

10987

1.34

22.76

2.9

129.31

177.49

ng/l

5.98

1274

9940

Dialysis

207

1005

2.22

22.72

5.0

3.1

814.38

163.65

ng/l

10.25

194

914

Noninfective enteritis and colitis

2042

16260

1.28

22.67

3.3

3.0

210.26

192.92

ng/l

0.80

1856

14790

Other shoulder lesions

412

2472

1.73

22.64

3.0

2.8

156.17

180.90

ng/l

0.45

372

2243

Suicide or other Intentional self-harm

889

6288

1.45

22.62

3.2

2.8

140.32

154.85

ng/l

0.50

783

5662

Parkinson's disease, strict definition, excluding more controls

678

4264

1.54

22.59

3.2

2.7

204.27

263.04

ng/l

3.33

621

3950

Neuroendocrine tumor and carcinoma of small intestine

111

417

3.10

22.46

3.5

109.34

228.01

ng/l

5.21

102

388

Immunodeficiencies

223

1116

2.13

22.37

4.0

3.0

180.24

182.61

ng/l

0.03

201

1021

Other disorders of adrenal gland

229

1159

2.11

22.33

5.6

3.2

120.73

196.81

ng/l

3.34

212

1057

Nonalcoholic fatty liver disease

427

2598

1.71

22.33

2.6

2.8

148.89

159.46

ng/l

0.22

378

2350

Adverse effects, not elsewhere classified

759

5234

1.49

22.29

3.1

3.0

147.05

165.44

ng/l

0.73

680

4748

Lichen simplex chronicus and prurigo

333

1904

1.85

22.27

3.1

2.9

212.53

190.10

ng/l

0.34

306

1732

Other sleep disorders

493

3109

1.64

22.22

3.1

2.8

177.44

202.85

ng/l

0.48

434

2836

Inguinal hernia

2850

15598

1.23

22.17

3.2

3.1

235.80

214.16

ng/l

1.38

2613

14223

Exclusions for E4_PCOS_BROAD

715

4882

1.51

22.13

3.6

3.1

135.78

175.13

ng/l

2.76

646

4422

Other congenital malformations, including avohilmo

471

2935

1.65

22.08

3.1

3.3

159.47

168.56

ng/l

0.20

424

2639

Striking against or struck by other objects

1351

10238

1.34

22.03

3.3

3.0

168.42

172.72

ng/l

0.15

1201

9239

Pain associated with micturition

590

3893

1.58

22.01

3.3

3.1

151.86

199.21

ng/l

3.28

537

3559

Patent foramen ovale

117

449

2.86

21.97

3.8

3.9

173.41

166.66

ng/l

0.05

410

Caries of enamel

3107

24328

0.83

21.86

2.6

2.9

138.20

175.88

ng/l

9.23

2772

22224

Parkinson's disease, excluding more controls

710

4471

1.51

21.85

3.2

2.7

204.51

258.00

ng/l

2.98

650

4143

Ebstein's anomaly

30.71

21.84

5.6

3.9

153.23

190.95

ng/l

0.23

Mixed connective tissue disease

108

401

3.01

21.84

2.9

3.1

87.77

198.07

ng/l

5.45

100

369

Pneumothorax

374

2222

1.78

21.83

4.0

2.9

279.67

228.30

ng/l

0.40

346

2044

Dissection of aorta

211

1055

2.19

21.81

3.9

3.1

253.18

217.88

ng/l

0.62

201

964

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

537

3457

1.59

21.81

3.0

2.8

124.93

136.90

ng/l

0.37

477

3084

Ptosis of eyelid

623

4185

1.56

21.71

2.9

3.0

169.95

209.45

ng/l

1.94

554

3848

Chronic pancreatitis

625

4194

1.55

21.66

3.0

222.74

198.42

ng/l

0.50

575

3829

Injury of unspecified body region

391

2353

1.75

21.65

3.7

3.0

295.25

205.56

ng/l

2.19

356

2135

Nonorganic sleeping disorders

811

5699

1.46

21.46

2.8

3.0

163.84

162.82

ng/l

0.02

713

5144

Other diseases of stomach and duodenum

356

2099

1.80

21.44

3.6

3.0

210.27

200.32

ng/l

0.18

316

1928

Unspecified visual impairment (binocular)

109

413

2.99

21.41

3.7

3.0

275.81

217.04

ng/l

0.52

100

380

Hyperkinetic disorders, excluding more controls

264

1301

1.93

21.39

3.6

2.5

123.63

86.43

ng/l

0.65

219

1129

Pyogenic arthritis

345

2013

1.81

21.39

4.0

3.0

347.52

213.30

ng/l

1.30

319

1847

Adrenocortical insufficiency

192

929

2.23

21.29

6.3

3.3

110.77

190.03

ng/l

3.55

178

848

Mental retardation, excluding more controls

156

663

2.40

21.27

3.2

3.3

159.60

163.36

ng/l

0.03

149

599

Acute posthaemorrhagic anaemia

222

1138

2.12

21.27

4.3

3.2

375.23

221.21

ng/l

3.10

210

1046

Fracture of foot, except ankle

987

7195

1.40

21.13

3.1

2.9

166.47

161.82

ng/l

0.13

891

6512

1423

10269

1.34

21.11

3.6

3.2

243.25

257.63

ng/l

0.49

1321

9469

Malignant neoplasm of small intestine, including Hilmo

197

973

2.23

21.10

3.4

3.2

136.13

218.30

ng/l

4.42

183

898

Malignant neoplasm of skin, including Hilmo

2685

14818

1.23

21.02

3.0

3.1

221.20

214.75

ng/l

0.28

2457

13599

Drug-induced thyroiditis

9.26

21.02

4.7

2.8

250.81

122.44

ng/l

1.58

Other hearing loss

1641

12503

1.30

20.96

3.4

3.1

217.89

262.37

ng/l

3.79

1526

11480

Rheumatoid arthritis, including avohilmo

1819

14479

1.28

20.88

3.1

3.0

193.76

198.98

ng/l

0.23

1667

13276

Disorders of sclera, cornea, iris and ciliary body

2473

20328

1.24

20.79

3.2

3.0

175.04

193.40

ng/l

1.41

2251

18577

Mental and behavioural disorders due to opioids

135

564

2.52

20.76

2.7

2.9

114.13

136.16

ng/l

0.32

115

479

Cerebral palsy and other paralytic syndromes

518

3364

1.60

20.75

3.5

3.1

189.86

204.75

ng/l

0.35

455

3061

Disorders resulting from impaired renal tubular function

208

1051

2.15

20.72

3.5

3.4

580.32

215.62

ng/l

8.15

193

963

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

227

1165

2.02

20.71

3.2

2.9

110.50

135.34

ng/l

0.53

194

1010

Other necrotizing vasculopathies (FG)

325

1890

1.83

20.62

3.5

2.9

204.36

211.49

ng/l

0.10

296

1732

Glucosamine medication

2563

16891

1.24

20.54

3.0

3.1

213.66

226.16

ng/l

0.75

2356

15607

Extrapyramidal and movement disorders

2013

16252

1.27

20.51

3.0

3.1

183.28

218.66

ng/l

4.10

1842

14964

Sequelae of injuries of lower limb

407

2503

1.69

20.50

2.7

2.9

172.80

173.01

ng/l

0.00

363

2262

Diplopia

644

4399

1.52

20.38

3.6

3.0

174.27

201.24

ng/l

0.96

580

4015

Infection of intervertebral disc (pyogenic)

104

397

3.02

20.36

3.7

3.2

320.04

240.06

ng/l

0.67

369

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

270

1482

1.90

20.31

3.3

2.9

177.05

189.30

ng/l

0.22

242

1330

Occupational exposure to risk-factors

194

964

2.19

20.29

4.9

3.0

164.67

198.03

ng/l

0.51

188

877

Zoster [herpes zoster]

979

7209

1.40

20.25

3.7

3.0

232.31

216.19

ng/l

0.27

891

6617

Ocular pain

362

2167

1.74

20.20

3.4

2.9

128.40

171.49

ng/l

2.15

331

1953

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

393

2415

1.71

20.18

3.6

3.1

249.31

206.19

ng/l

1.11

366

2204

Lack of expected normal physiological development

156

3.83

20.18

7.9

4.6

173.23

186.12

ng/l

0.07

130

Pneumonia due to Streptococcus pneumoniae

205

1034

2.11

20.15

4.1

2.6

234.02

194.95

ng/l

0.54

187

936

Raynaud syndrome

372

2245

1.73

20.14

3.1

3.0

136.07

166.00

ng/l

0.73

332

2024

Alzheimer disease, including avohilmo

2381

13529

1.25

20.10

3.2

3.3

230.34

270.79

ng/l

4.20

2197

12523

Immunodeficiency with predominantly antibody defects

127

529

2.60

20.08

4.0

2.9

182.65

171.57

ng/l

0.09

110

483

Other disorders of skin and subcutaneous tissue, not elsewhere classified

710

4955

1.48

20.06

4.1

3.0

297.35

203.06

ng/l

3.09

645

4524

Malignant neoplasm of skin

2578

14395

1.23

20.03

3.0

3.1

227.70

217.71

ng/l

0.46

2364

13223

Mental and behavioural disorders due to sedatives or hypnotics

272

1505

1.89

19.96

2.4

2.8

137.34

164.36

ng/l

0.49

233

1342

Other secondary gonarthrosis

279

1569

1.89

19.88

4.2

3.0

167.50

199.66

ng/l

1.01

264

1430

Somnolence, stupor and coma

220

1144

2.04

19.87

4.0

3.1

233.62

243.90

ng/l

0.13

204

1042

Inflammatory disease of uterus

445

2807

1.63

19.80

2.4

2.7

87.64

135.28

ng/l

4.13

400

2541

Acidosis

127

536

2.61

19.80

3.4

2.9

410.97

204.14

ng/l

2.28

115

493

Malignant neoplasm of small intestine

157

731

2.40

19.76

3.5

3.3

127.23

217.87

ng/l

4.70

146

678

Acute pancreatitis

948

6965

1.40

19.75

3.2

3.0

235.48

212.41

ng/l

0.82

873

6361

Carcinoid syndrome

255

3.61

19.70

4.1

3.1

97.59

204.81

ng/l

3.63

230

Other noninfective gastroenteritis and colitis

1126

8476

1.36

19.69

3.5

3.1

229.84

199.57

ng/l

1.05

1021

7716

Zoster [herpes zoster], including avohilmo

2587

20730

1.22

19.68

3.2

3.0

200.15

207.92

ng/l

0.30

2379

19057

Vascular dementia (subcortical)

274

1555

1.93

19.66

4.0

3.5

292.96

310.14

ng/l

0.22

262

1432

Dermatopolymyositis (FG)

316

3.17

19.65

4.7

3.3

169.71

206.36

ng/l

0.48

300

Haemorrhoids and perianal venous thrombosis

1646

12944

1.29

19.59

3.2

2.9

185.36

216.20

ng/l

2.30

1510

11906

Amputation of foot

181

895

2.25

19.56

4.2

3.2

506.60

238.05

ng/l

5.72

171

823

Other aneurysm

311

1817

1.82

19.52

3.8

3.1

292.07

216.15

ng/l

1.88

293

1678

Hypertensive Renal Disease

206

1056

2.09

19.51

3.4

2.5

593.99

224.48

ng/l

3.78

192

966

Erectile dysfunction

470

3056

1.63

19.47

8.1

3.1

294.42

236.16

ng/l

1.23

439

2830

Diseases of spleen

110

438

2.79

19.45

4.4

3.2

256.04

213.63

ng/l

0.50

104

403

Vascular diseases of the intestine

250

1375

1.96

19.44

4.3

3.1

442.01

224.84

ng/l

5.02

233

1260

Alcohol abuse, main dg

636

4362

1.50

19.43

3.4

3.0

198.90

176.72

ng/l

0.66

581

3928

Urticaria and erythema

1432

11147

1.31

19.41

3.3

2.8

160.21

172.02

ng/l

0.60

1280

10134

Type 1 diabetes, wide definition

826

5923

1.42

19.40

3.7

2.8

314.61

179.68

ng/l

7.43

768

5320

Lyme disease

875

11924

0.72

19.36

2.1

2.9

136.19

174.14

ng/l

4.68

793

10902

Lyme disease, including avohilmo

875

11924

0.72

19.36

2.1

2.9

136.19

174.14

ng/l

4.68

793

10902

Diabetic nephropathy

918

6682

1.41

19.30

4.2

3.5

459.72

236.42

ng/l

16.29

864

6127

Drug-induced adrenocortical insufficiency

109

434

2.79

19.25

7.3

3.8

118.65

190.16

ng/l

1.31

102

394

Social phobias

235

1247

1.93

19.24

2.5

2.6

98.97

110.53

ng/l

0.28

205

1090

Other diseases of lip and oral mucosa

1855

14933

1.26

19.16

2.7

2.9

146.90

177.98

ng/l

3.79

1680

13670

Pneumonia derived septicemia

185

920

2.16

19.13

5.1

3.0

350.81

210.22

ng/l

2.48

170

849

Fibroblastic disorders

1132

8581

1.35

19.08

3.1

3.0

209.52

234.26

ng/l

0.58

1055

7913

Spirochaetal infections, other/unspecified, including avohilmo

884

11996

0.72

19.03

2.2

2.9

136.49

174.45

ng/l

4.71

798

10970

Other inflammation of eyelid

676

4720

1.48

19.01

3.0

2.9

155.71

190.36

ng/l

2.46

616

4314

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

603

2532

1.52

18.98

2.2

53.41

69.91

ng/l

1.55

535

2238

KRA_PSY_EATING, excluding more controls

179

858

2.11

18.94

2.4

58.50

88.48

ng/l

1.84

148

767

Progressive vascular leukoencephalopathy

302

1784

1.85

18.91

2.6

3.3

295.90

254.44

ng/l

1.11

286

1644

Dementia, including avohilmo

2764

15778

1.22

18.88

3.1

215.15

248.86

ng/l

3.10

2542

14628

Panniculitis affecting regions of neck and back

180

888

2.16

18.87

2.7

2.9

152.60

211.30

ng/l

1.49

161

809

Cluster headache, strict

143

641

2.35

18.86

2.3

2.6

87.19

158.09

ng/l

3.32

125

572

Other spirochaetal diseases

888

12024

0.72

18.85

2.2

2.9

136.51

174.30

ng/l

4.70

802

10991

Traumatic subarachnoid haemorrhage

213

1119

2.04

18.84

2.9

2.7

265.68

244.78

ng/l

0.25

190

1018

Ill-defined and unknown causes of mortality

243

4266

0.54

18.84

3.5

3.2

376.06

259.42

ng/l

2.20

226

3929

Acute bronchiolitis

181

794

2.13

18.84

6.0

4.0

215.98

175.90

ng/l

0.56

169

694

Disorders of mineral metabolism

390

2430

1.67

18.75

3.7

2.8

255.47

184.52

ng/l

1.40

350

2214

Specific development disorders of speech and language

226

1157

1.96

18.69

5.2

3.6

185.83

204.83

ng/l

0.35

216

1023

Other dialysis

168

816

2.24

18.68

4.0

3.4

748.98

200.40

ng/l

7.96

158

742

Dementia

2608

14863

1.22

18.67

3.1

217.67

250.60

ng/l

2.76

2402

13750

Assault

432

2747

1.61

18.61

2.7

2.9

129.14

133.47

ng/l

0.09

394

2403

Recurrent or chronic depression

1437

7746

1.30

18.60

2.8

122.26

163.76

ng/l

4.68

1288

7047

Superficial injury of hip and thigh

809

5859

1.42

18.52

3.6

3.2

254.98

230.14

ng/l

0.74

733

5347

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1002

7516

1.38

18.51

2.8

3.2

159.30

217.45

ng/l

5.81

925

6945

Other diseases of oesophagus

501

3325

1.57

18.44

3.7

3.0

205.50

226.73

ng/l

0.58

463

3048

Anankastic personality disorder

143

647

2.32

18.41

2.7

67.42

125.84

ng/l

2.53

131

578

Other extrapyramidal and movement disorders in other diseases

1216

9367

1.33

18.37

3.0

174.44

200.95

ng/l

1.89

1125

8621

Cluster headache, wide

153

716

2.25

18.18

2.5

2.7

94.96

165.67

ng/l

3.50

133

641

Retinal detachments and breaks

1837

14890

1.26

18.16

3.1

3.0

208.68

213.60

ng/l

0.19

1697

13707

Need for other prophylactic measures

272

1559

1.84

18.06

3.0

3.1

176.92

190.93

ng/l

0.24

232

1414

Follow-up examination after treatment for malignant neoplasms

496

3294

1.56

18.03

3.1

2.7

238.05

230.73

ng/l

0.10

465

3050

Other obstetric conditions, not elsewhere classified

620

2653

1.49

18.00

2.2

53.26

70.19

ng/l

1.68

548

2349

Overexertion and strenuous or repetitive movements

417

2666

1.62

17.93

2.7

3.0

144.74

173.90

ng/l

0.97

364

2405

Ovarian cyst

1293

5677

1.32

17.93

2.7

2.8

153.89

196.26

ng/l

2.75

1177

5197

Lung diseases due to external agents

766

5541

1.43

17.87

4.0

3.2

258.66

256.87

ng/l

0.03

707

5095

Scoliosis

332

2006

1.71

17.82

3.2

2.9

141.79

193.15

ng/l

2.91

309

1808

Acquired absence of limb

236

3.46

17.77

5.7

2.7

345.46

177.20

ng/l

2.01

213

Molar incisor enamel hypoplasia

114

450

2.53

17.77

9.1

4.1

228.39

133.71

ng/l

1.08

106

391

Necrosis of pulp, including avohilmo

2294

18773

1.22

17.70

2.7

2.8

135.70

164.97

ng/l

4.68

2062

17045

Other spirochaetal diseases, including avohilmo

906

12113

0.73

17.67

2.2

2.9

135.79

174.83

ng/l

5.09

816

11077

Reactive arthropathies

366

2276

1.67

17.65

2.8

3.0

161.65

181.66

ng/l

0.46

332

2073

Retinal vascular occlusion

699

5003

1.46

17.59

3.4

3.1

258.25

237.39

ng/l

0.54

657

4603

Postprocedural disorders of digestive system, not elsewhere classified

187

965

2.09

17.58

3.1

3.3

215.88

222.36

ng/l

0.07

166

892

Seborrhoeic keratosis

1282

10009

1.31

17.55

3.2

3.0

176.41

201.12

ng/l

1.67

1183

9216

Pure hyperglyceridaemia

128

572

2.44

17.48

3.5

2.8

234.66

191.59

ng/l

0.41

111

517

Disorders of muscles

451

2952

1.58

17.44

3.4

2.9

186.45

194.80

ng/l

0.17

408

2677

Other and unspecified tonsillitis

989

6150

1.35

17.22

3.1

2.7

130.02

136.25

ng/l

0.19

864

5480

Intussusception

120

525

2.49

17.20

2.9

2.7

109.52

170.95

ng/l

1.22

114

488

Fracture of skull and facial bones

913

6804

1.37

17.20

3.3

2.9

214.86

184.33

ng/l

1.10

834

6157

Symptoms and signs involving emotional state

128

571

2.38

17.19

4.7

3.5

243.30

187.23

ng/l

0.61

116

516

Schizoaffective disorder

271

1566

1.79

17.17

2.8

3.0

119.77

145.57

ng/l

0.65

241

1400

Blepharochalasis

1488

11865

1.28

17.15

3.2

2.9

177.51

208.34

ng/l

2.16

1360

10950

Intestinal adhesions without obstruction

448

2953

1.58

17.09

3.1

2.9

201.40

207.39

ng/l

0.11

412

2716

Malignant neoplasm of gum, including Hilmo

288

3.22

17.09

2.2

3.8

173.58

267.04

ng/l

1.07

272

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

465

2650

1.55

17.07

4.3

2.9

114.43

101.30

ng/l

0.32

396

2266

Dermatopolymyositis

347

2.90

17.06

4.6

3.4

169.71

182.78

ng/l

0.15

321

Secondary and unspecified malignant neoplasm of lymph nodes

439

2885

1.59

17.03

3.4

3.3

272.89

213.43

ng/l

1.65

413

2656

Hypotension due to drugs

115

504

2.61

17.03

4.7

3.4

255.76

263.10

ng/l

0.06

103

467

Viral warts

395

2523

1.62

17.00

3.5

3.0

164.97

166.79

ng/l

0.03

364

2282

Other problems related to primary support group, including family circumstances

333

1976

1.68

16.94

5.3

3.1

196.29

136.07

ng/l

1.14

302

1757

Personal history of other diseases and conditions

307

1825

1.71

16.93

5.0

2.3

195.76

115.45

ng/l

2.65

280

1620

Other ill-defined and unspecified causes of mortality

224

3898

0.55

16.90

3.5

3.2

379.48

257.45

ng/l

2.10

207

3586

Ulcer of oesophagus

380

2435

1.65

16.67

4.3

3.0

231.85

222.16

ng/l

0.18

353

2240

Retinal vascular disorders

705

5101

1.44

16.65

3.5

3.1

257.08

238.33

ng/l

0.48

663

4694

Polymyalgia rheumatica

786

5791

1.41

16.64

3.4

3.2

217.41

233.66

ng/l

0.58

725

5330

Combinations of oral blood glucose lowering drugs

1343

10614

1.29

16.62

3.4

2.9

195.42

202.67

ng/l

0.27

1235

9798

Mental retardation, wide definition

170

851

2.09

16.61

3.1

4.0

154.40

181.68

ng/l

0.27

161

762

D07AA Corticosteroids, weak (group I)

554

3805

1.49

16.60

3.0

3.3

172.19

179.46

ng/l

0.16

494

3414

Open wound of ankle and foot

451

2986

1.56

16.60

3.5

3.0

245.72

190.99

ng/l

1.84

411

2696

Hydronephrosis

552

3813

1.50

16.58

3.2

2.7

243.95

186.99

ng/l

2.67

510

3479

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1370

9350

1.29

16.57

2.4

2.5

123.42

122.53

ng/l

0.03

1229

8501

Superficial injury of abdomen, lower back and pelvis

674

4816

1.44

16.56

3.3

3.0

209.28

190.88

ng/l

0.52

614

4342

Mixed and other personality disorders

255

1463

1.80

16.49

2.4

2.9

118.51

124.30

ng/l

0.09

218

1289

Radiculopathy

763

5580

1.41

16.46

3.3

2.9

164.50

232.61

ng/l

7.69

701

5127

Injuries to the neck

900

6736

1.36

16.42

2.8

3.0

174.12

175.71

ng/l

0.02

808

6088

Osteonecrosis

323

1996

1.71

16.40

3.8

2.8

179.56

186.32

ng/l

0.13

293

1814

Infective dermatitis

524

3591

1.51

16.38

3.6

3.0

208.24

195.79

ng/l

0.19

482

3288

Shoulder region

373

2.78

16.32

3.6

3.3

188.39

206.94

ng/l

0.23

339

Other symptoms and signs involving general sensations and perceptions

220

1225

1.91

16.26

3.2

3.4

192.44

249.59

ng/l

1.64

198

1117

Weight loss

515

3531

1.52

16.24

3.8

3.1

223.68

210.48

ng/l

0.27

477

3232

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

391

2532

1.62

16.21

3.3

3.1

238.35

251.25

ng/l

0.22

367

2313

Benign neoplasm of other and unspecified endocrine glands

606

4278

1.46

16.20

3.2

3.0

193.61

180.53

ng/l

0.34

564

3912

Anaemia in chronic diseases classified elsewhere

155

777

2.19

16.09

6.6

3.5

458.97

201.40

ng/l

3.18

144

711

Hypothyroidism, strict autoimmune

3234

18185

1.18

16.06

3.1

2.8

185.94

203.79

ng/l

1.76

2948

16614

Exposure to other specified factors

3463

25678

1.17

16.00

2.8

3.0

178.16

183.82

ng/l

0.34

3092

23436

Family history of malignant neoplasm

368

2342

1.61

15.93

2.5

2.3

145.39

115.42

ng/l

0.27

329

2107

Diseases of peritoneum

488

3322

1.53

15.92

3.5

3.1

330.21

213.93

ng/l

4.09

453

3037

Asthma mixed form (mode)

200

1080

1.93

15.90

3.9

2.5

113.91

206.65

ng/l

5.75

180

977

Urticaria

1103

8528

1.31

15.87

3.5

2.9

155.93

163.85

ng/l

0.31

985

7743

Embedded teeth, including avohilmo

245

1403

1.79

15.81

3.4

2.9

124.21

126.33

ng/l

0.04

222

1227

Benign neoplasm: Other and unspecified parts of small intestine

108

474

2.56

15.80

3.7

3.3

191.39

202.45

ng/l

0.12

100

441

Thyroiditis, ILD-related definition

440

2926

1.55

15.77

2.9

166.65

160.35

ng/l

0.14

403

2668

Other enthesopathy of foot (+metatarsalgia)

421

2775

1.56

15.75

3.0

2.8

115.10

170.12

ng/l

4.03

386

2523

Noninfectious colitis NAS

600

4248

1.45

15.66

3.5

3.0

247.86

196.55

ng/l

1.26

544

3860

Hypoplasia of dental enamel , including avohilmo

105

427

2.46

15.61

8.6

4.3

199.77

138.28

ng/l

0.55

372

Other bursopathies

603

4280

1.45

15.58

3.1

2.9

186.01

207.41

ng/l

0.65

558

3913

Mental retardation

156

775

2.10

15.56

3.2

4.0

159.60

179.36

ng/l

0.17

149

691

Sicca syndrome [Sjögren]

380

2467

1.60

15.51

3.3

3.0

168.34

176.15

ng/l

0.13

339

2252

Hypothyroidism, other/unspecified

3954

22667

1.16

15.50

3.2

2.9

184.63

204.46

ng/l

2.31

3599

20745

Assault by bodily force

246

1422

1.78

15.49

2.8

2.9

128.63

126.40

ng/l

0.03

225

1243

Faecal incontinence

465

3153

1.53

15.49

2.9

2.7

154.94

197.37

ng/l

2.12

425

2884

Cauda equina syndrome

306

2.91

15.43

4.1

3.2

166.27

174.16

ng/l

0.06

283

Other inflammatory liver diseases

304

1876

1.70

15.41

3.6

3.0

248.54

188.81

ng/l

0.78

264

1704

Other female pelvic inflammatory diseases

611

4349

1.44

15.41

2.9

2.8

145.50

156.29

ng/l

0.26

559

3976

Astigmatism

259

1526

1.76

15.39

3.6

3.3

148.32

185.55

ng/l

1.06

241

1382

Event of undetermined intent

250

1460

1.78

15.38

3.0

160.30

174.74

ng/l

0.26

223

1320

Lesion of lateral popliteal nerve

239

1387

1.82

15.32

2.9

153.71

209.08

ng/l

1.66

216

1280

Other fall from one level to another

923

7009

1.34

15.29

3.1

169.07

190.37

ng/l

1.01

824

6340

Hypothyreosis and Thyroxine purchase for inclusion criteria

4124

23651

1.15

15.23

3.2

2.9

184.48

206.01

ng/l

2.70

3749

21655

Reactive arthropathies, FINNGEN

279

1684

1.72

15.21

2.7

2.8

158.64

174.11

ng/l

0.28

252

1534

Acute pancreatitis (for exclusion)

948

7251

1.34

15.20

3.2

3.1

235.48

212.75

ng/l

0.80

873

6628

Arterial embolism and thrombosis of lower extremity artery

213

1205

1.90

15.17

5.4

3.1

337.96

241.28

ng/l

1.95

203

1099

Other and unspecified injuries of lower leg

303

1869

1.68

15.12

3.5

2.9

220.39

174.69

ng/l

0.85

274

1677

Malignant neoplasm of oral cavity, including Hilmo

246

1450

1.80

15.10

2.3

3.4

261.73

210.51

ng/l

0.54

229

1331

Suggestive for eosinophilic asthma

414

2755

1.56

15.06

3.4

2.9

134.78

196.81

ng/l

5.12

371

2517

Fissure and fistula of anal and rectal regions

1002

7716

1.32

15.04

2.7

2.9

184.42

186.25

ng/l

0.04

903

7054

Pneumococcal septicemia

174

924

2.01

15.04

5.1

3.1

328.57

219.96

ng/l

1.76

161

852

Chromosomal abnormalities, not elsewhere classified

305

2.78

15.02

3.6

4.9

116.72

174.72

ng/l

0.96

270

Other localized connective tissue disorders

107

474

2.46

15.01

4.2

3.2

324.96

179.27

ng/l

0.57

438

Congenital malformations and deformations of the musculoskeletal system

278

1667

1.71

15.00

3.1

3.7

149.92

167.90

ng/l

0.32

254

1481

Lesion of plantar nerve

286

1753

1.71

14.98

2.8

2.9

155.54

185.08

ng/l

0.71

268

1605

Acute nasopharyngitis (common cold)

426

2819

1.54

14.96

2.7

2.8

125.59

145.90

ng/l

0.79

396

2507

Polymyositis

185

3.56

14.93

5.1

3.7

166.12

207.54

ng/l

0.51

174

Menorrhagia

1292

5668

1.29

14.92

2.9

154.71

205.53

ng/l

4.23

1192

5191

Injuries to the ankle and foot

2865

20946

1.18

14.88

3.0

2.9

173.13

168.66

ng/l

0.24

2576

19016

Colectomy operation

856

6487

1.36

14.86

3.4

3.1

208.37

216.51

ng/l

0.24

780

5970

Disorders of refraction and accommodation

1022

7862

1.32

14.85

3.0

130.00

157.62

ng/l

2.13

936

7108

Seropositive rheumatoid arthritis, wide

1246

9898

1.29

14.84

3.2

2.9

209.49

196.45

ng/l

0.56

1160

9073

Unspecified misadventure during surgical and medical care

293

1814

1.70

14.84

3.7

3.0

225.64

209.21

ng/l

0.27

269

1659

Fracture at wrist and hand level

1422

11406

1.26

14.79

3.1

3.0

162.33

177.34

ng/l

0.77

1293

10328

Unspecific neurodegenerative disorder

2562

14918

1.20

14.78

3.2

221.18

262.10

ng/l

4.77

2362

13821

Diabetic maculopathy, excluding more controls

478

3287

1.50

14.69

3.9

2.8

366.99

200.29

ng/l

6.56

443

3013

Metatarsalgia

392

2590

1.56

14.58

3.1

2.8

119.15

173.72

ng/l

3.57

360

2360

Other general symptoms and signs

192

1043

1.89

14.54

3.5

3.0

195.89

180.17

ng/l

0.21

170

944

Purpura and other haemorrhagic conditions

618

4462

1.43

14.53

3.5

3.1

290.61

202.87

ng/l

4.20

567

4078

157

823

2.09

14.48

3.8

3.1

280.54

241.40

ng/l

0.29

145

761

Meralgia paraesthetica

168

892

2.00

14.47

3.4

2.9

157.90

187.85

ng/l

0.62

156

818

Benign neoplasm: Adrenal gland

382

2529

1.58

14.44

3.2

3.0

221.56

186.74

ng/l

0.82

360

2324

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1209

9606

1.29

14.40

3.2

2.9

208.81

195.81

ng/l

0.54

1123

8809

Other arterial embolism and thrombosis

167

891

2.02

14.39

4.0

3.2

364.05

230.02

ng/l

2.46

156

812

Haemolytic anaemias

181

989

1.95

14.36

4.6

3.1

315.82

218.45

ng/l

1.61

166

916

Disorders of vitreous body and globe

2493

20085

1.19

14.33

3.1

2.9

186.09

197.21

ng/l

0.59

2307

18509

Non-allergic asthma

387

2565

1.57

14.31

3.6

3.3

171.46

199.57

ng/l

0.65

368

2344

Vascular syndromes of brain in cerebrovascular disorders

269

1653

1.74

14.31

3.6

3.3

222.34

268.08

ng/l

1.05

253

1521

Pregnancy hypertension

1172

8245

1.29

14.30

2.4

2.5

119.90

118.44

ng/l

0.05

1050

7471

Disorders of speech understanding and production

182

971

1.93

14.30

5.6

3.8

198.36

218.83

ng/l

0.34

173

871

Autoimmune hyperthyroidism

245

1454

1.75

14.27

3.0

2.8

187.53

159.24

ng/l

0.63

221

1320

Other/unspecified seropositive rheumatoid arthritis

1229

9798

1.28

14.23

3.2

2.9

210.29

196.42

ng/l

0.60

1143

8984

Arthropathies in other diseases classified elsewhere

171

919

1.97

14.16

3.4

3.0

282.37

191.53

ng/l

1.75

152

840

Benign neoplasm: Duodenum

156

823

2.07

14.08

4.0

3.2

212.42

224.88

ng/l

0.12

141

758

Vitamin B12 deficiency anaemia

554

3958

1.45

14.06

3.5

3.0

273.54

237.42

ng/l

0.73

509

3618

Cramp and spasm

203

1151

1.85

14.04

2.9

3.0

163.51

188.28

ng/l

0.42

177

1052

Abnormal weight loss

476

3312

1.49

14.02

3.8

3.1

218.83

211.38

ng/l

0.14

441

3037

Tubulo-interstitial nephritis, not specified as acute or chronic

330

2126

1.62

13.99

3.6

2.8

259.40

202.82

ng/l

1.20

303

1916

Disorders of calcium metabolism

298

1875

1.66

13.98

3.8

2.8

268.45

194.60

ng/l

1.09

272

1704

L01XE Protein kinase inhibitors

276

1715

1.71

13.95

3.1

168.47

199.18

ng/l

0.95

253

1581

Other necrotizing vasculopathies

372

2472

1.58

13.90

3.5

3.1

230.53

213.13

ng/l

0.29

341

2272

Excessive, frequent and irregular menstruation

1376

5866

1.27

13.88

3.0

2.8

141.05

201.37

ng/l

6.83

1260

5358

Other disorders of white blood cells

258

1576

1.72

13.75

3.9

3.1

261.21

215.47

ng/l

0.77

234

1450

Disorders of tooth development and eruption

593

3461

1.42

13.74

3.7

2.8

169.50

185.73

ng/l

0.48

541

3130

Gingival hyperplasia

175

958

1.94

13.74

6.0

3.1

215.57

185.61

ng/l

0.32

160

880

Coxibs

1306

5453

1.28

13.62

3.0

3.4

222.36

300.24

ng/l

6.16

1171

5026

Specific development disorders of scholastic skills

111

502

2.23

13.49

4.5

3.2

133.04

126.20

ng/l

0.05

100

410

Acetic acid derivatives and related substances

1315

5421

1.27

13.46

2.9

3.4

227.12

301.13

ng/l

5.03

1173

4998

Other disorders involving the immune mechanism, not elsewhere classified

140

716

2.07

13.43

3.9

3.3

368.46

178.78

ng/l

2.33

127

646

Cyst of kidney

382

2576

1.55

13.37

3.1

206.08

210.32

ng/l

0.08

356

2371

Redundant prepuce, phimosis and paraphimosis

849

6396

1.33

13.35

3.3

3.1

156.33

222.76

ng/l

6.57

771

5755

Drug-induced osteoporosis with pathological fracture

103

476

2.40

13.32

5.3

3.4

178.06

217.59

ng/l

0.69

442

Other and unspecified immunodeficiencies with predominantly antibody defects

212

3.10

13.32

4.6

2.9

232.21

159.92

ng/l

0.37

196

Diseases of salivary glands

1360

11033

1.25

13.29

2.9

161.38

179.54

ng/l

0.89

1223

10061

Primary coxarthrosis, bilateral

1548

12763

1.24

13.29

3.4

3.1

202.44

229.83

ng/l

1.93

1426

11785

Hidradenitis suppurativa

126

619

2.12

13.26

3.1

2.8

140.55

116.60

ng/l

0.30

113

546

Ganglion

766

5788

1.35

13.17

2.6

2.7

123.15

173.72

ng/l

5.11

704

5269

Other disorders of glucose regulation and pancreatic internal secretion

374

2509

1.54

13.12

3.5

3.1

377.70

217.83

ng/l

1.70

346

2278

Cerebral cysts

229

1368

1.74

13.09

3.4

2.9

179.51

200.12

ng/l

0.36

204

1246

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

348

2276

1.56

13.06

2.9

3.4

144.17

165.36

ng/l

0.50

316

2028

Certain zoonotic bacterial diseases, including avohilmo

150

796

2.01

13.03

3.3

3.2

219.81

205.70

ng/l

0.19

140

731

Hypertrophic scar

192

1092

1.83

13.02

3.3

2.9

164.67

163.59

ng/l

0.01

169

982

Chondrocostal junction syndrome [Tietze]

175

974

1.90

13.01

3.4

3.0

161.13

195.88

ng/l

0.74

158

889

Orchitis and epididymitis

438

3039

1.49

12.98

3.7

3.1

217.99

249.89

ng/l

0.65

398

2772

Secondary parkinsonism, excluding more controls

135

692

2.09

12.98

3.9

2.8

169.87

242.38

ng/l

2.02

121

623

Chylothorax

6.59

12.95

4.3

2.3

408.42

183.42

ng/l

0.88

Pre-eclampsia or poor fetal growth

771

5810

1.34

12.89

2.5

2.4

127.54

110.45

ng/l

0.67

686

5251

Oesophageal varices

209

1234

1.79

12.80

3.7

3.1

192.62

211.70

ng/l

0.37

193

1131

severe traumatic brain injury, does not include concussion

1171

9412

1.27

12.76

3.4

3.2

261.87

246.44

ng/l

0.51

1057

8640

Cardiomyopathy due to drugs and other external agents

7.24

12.74

4.0

3.2

417.83

163.65

ng/l

1.19

Otitis media, unspecified

340

2055

1.56

12.73

4.4

3.0

127.06

160.22

ng/l

1.13

312

1827

Pre-eclampsia or eclampsia

609

4465

1.39

12.73

2.5

2.6

138.26

121.84

ng/l

0.49

543

4065

Abnormal spermatozoa

335

4966

0.65

12.70

3.4

3.2

227.81

232.65

ng/l

0.03

318

4580

Other viral hepatitis

201

1166

1.78

12.67

3.2

2.9

168.59

139.74

ng/l

0.41

181

1022

Brachial plexus disorders

296

1896

1.60

12.61

2.6

2.8

71.25

143.34

ng/l

8.16

267

1713

Other and unspecified mood [affective] disorders

204

1188

1.76

12.57

3.2

2.9

163.81

136.34

ng/l

0.32

162

1051

Enthesopathies of lower limb, excluding foot

866

6705

1.31

12.52

2.9

2.8

133.23

187.89

ng/l

6.49

783

6123

Olecranon bursitis

298

1928

1.61

12.52

3.2

3.0

252.24

208.23

ng/l

0.80

274

1764

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

249

2.87

12.48

4.4

2.9

188.66

187.03

ng/l

0.01

221

Golimumab

121

600

2.11

12.48

2.0

2.8

73.70

124.97

ng/l

1.84

109

530

Persistent mood disorders

765

5833

1.34

12.47

3.0

2.9

151.41

184.11

ng/l

1.61

693

5304

Kela reimbursement Agammaglobulinemia (D80-84)

145

3.53

12.47

6.0

2.5

206.90

111.70

ng/l

0.44

130

Papulosquamous disorders

1720

14380

1.21

12.46

3.0

185.67

187.51

ng/l

0.06

1560

13167

Superficial injury of ankle and foot

418

2885

1.48

12.45

2.9

3.0

136.59

154.36

ng/l

0.54

376

2586

Lichen simplex chronicus

162

894

1.92

12.44

2.9

3.0

146.65

195.78

ng/l

0.95

148

822

Other and unspecified vascular occlusions

530

3850

1.43

12.41

3.5

3.2

250.04

236.57

ng/l

0.26

494

3532

Muscular dystrophy

184

3.28

12.41

3.2

2.8

159.41

210.75

ng/l

0.40

164

Disorders of vitreous body

2400

19627

1.18

12.40

3.0

2.9

185.08

196.15

ng/l

0.57

2218

18098

Amenorrhoea

173

963

1.84

12.40

2.9

95.70

146.28

ng/l

2.25

153

865

Visual field defects

410

2841

1.50

12.38

3.7

3.0

252.40

214.49

ng/l

0.90

373

2605

Other viral hepatitis, including avohilmo

209

1234

1.75

12.36

3.2

2.9

165.26

141.28

ng/l

0.33

186

1080

Generalized anxiety disorder

432

2994

1.46

12.32

2.5

2.7

76.26

127.91

ng/l

5.53

371

2661

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1232

9688

1.26

12.30

2.8

3.2

163.14

218.81

ng/l

5.04

1134

8952

Tooth eruption problems

334

2124

1.54

12.27

3.7

3.1

124.72

126.11

ng/l

0.03

300

1836

Postprocedural disorders of nervous system

209

1237

1.74

12.21

2.4

2.6

105.46

132.22

ng/l

0.47

188

1107

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

128

657

2.06

12.19

3.6

3.3

379.21

180.76

ng/l

2.22

117

589

Other symptoms and signs involving the urinary system

490

3513

1.44

12.18

2.8

3.1

220.46

214.36

ng/l

0.10

439

3243

Non-Hodgkin lymphoma, all, including Hilmo

671

5064

1.37

12.13

3.2

258.45

226.26

ng/l

0.96

627

4654

Other epidermal thickening

219

1327

1.73

12.11

3.8

3.0

229.66

202.51

ng/l

0.31

206

1211

Acute laryngitis and tracheitis

323

2089

1.55

12.11

3.6

2.8

132.05

141.83

ng/l

0.19

289

1840

Disorders of parathyroid gland

1047

8265

1.28

12.08

3.4

3.0

261.63

216.17

ng/l

1.89

963

7573

Cluster headache, strict, including avohilmo

169

947

1.85

12.07

2.2

3.1

94.18

139.10

ng/l

1.38

145

845

Malignant neoplasm of oral cavity

190

1114

1.82

12.04

2.3

3.2

270.69

205.83

ng/l

0.56

178

1025

Gestational [pregnancy-induced] hypertension

648

4825

1.36

12.02

2.4

2.5

104.07

112.37

ng/l

0.29

582

4367

Other disorders starting during childhood or adolecense, excluding more controls

103

460

2.19

12.02

7.6

3.5

132.14

126.49

ng/l

0.07

400

Other diseases of pancreas

405

2817

1.49

12.01

3.1

3.0

215.50

202.01

ng/l

0.22

377

2583

Other specified/unspecified dorsopathies

159

881

1.90

12.00

2.6

2.9

159.49

219.37

ng/l

1.12

142

792

Other (seronegative) rheumatoid arthritis, wide

870

6803

1.31

11.96

3.4

3.0

206.90

197.52

ng/l

0.29

791

6227

Other/unspecified rheumatoid arthritis

604

4499

1.39

11.93

3.6

3.1

234.61

211.58

ng/l

0.63

552

4116

Vitreous haemorrhage

482

3461

1.44

11.93

3.4

3.1

333.27

209.48

ng/l

3.19

452

3162

Thyrotoxicosis with diffuse goitre

528

3836

1.41

11.90

3.4

2.8

206.74

164.94

ng/l

0.61

475

3498

Other specified and unspecified disorders of eye and adnexa

177

1017

1.84

11.89

2.9

3.1

316.65

199.81

ng/l

0.95

161

924

Use of other anti-dementia drugs

1775

12042

1.21

11.89

3.3

231.00

282.36

ng/l

5.90

1646

11147

Use of memantine

1775

12042

1.21

11.89

3.3

231.00

282.36

ng/l

5.90

1646

11147

Wet age-related macular degeneration

1103

8579

1.28

11.88

3.5

3.2

252.13

260.35

ng/l

0.26

1010

7891

Other and unspecified myopathies

455

3242

1.46

11.87

3.1

3.2

255.23

233.15

ng/l

0.38

418

2968

Hypoglycaemia, other or unspecified

294

1916

1.59

11.87

3.6

3.2

418.84

228.52

ng/l

1.55

272

1748

Myopia

397

2738

1.48

11.86

2.9

126.80

146.85

ng/l

0.61

362

2439

Internal derangement of knee

1468

12012

1.22

11.86

2.7

2.9

191.47

190.41

ng/l

0.03

1338

10982

Other noninflammatory disorders of uterus, except cervix

963

5054

1.30

11.85

3.0

2.9

160.55

218.80

ng/l

6.08

880

4652

Other secondary coxarthrosis

167

946

1.87

11.84

3.4

3.1

162.65

199.56

ng/l

0.80

153

864

Excessive vomiting in pregnancy

211

1262

1.71

11.81

1.9

2.8

65.45

106.63

ng/l

3.89

184

1135

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1315

10770

1.24

11.80

3.7

3.0

189.90

191.63

ng/l

0.05

1227

9775

Discitis, unspecified

104

506

2.25

11.80

4.9

3.1

310.68

227.77

ng/l

0.83

468

Female genital prolapse

1200

5363

1.26

11.78

2.8

2.9

136.11

214.52

ng/l

9.96

1108

4917

Complications following infusion, transfusion and therapeutic injection

342

2.52

11.77

5.7

3.0

268.43

207.08

ng/l

0.51

312

Chronic hepatitis, not elsewhere classified

150

822

1.93

11.75

2.7

3.0

139.87

174.11

ng/l

0.80

141

749

Ectropion of eyelid

261

1675

1.66

11.72

4.0

3.3

260.52

278.07

ng/l

0.18

245

1545

Abnormal findings in nipple discharge synovial fluid wound secretions

324

2.55

11.69

2.7

3.5

263.73

169.31

ng/l

0.58

294

Chronic viral hepatitis

161

897

1.86

11.68

3.0

2.9

165.27

133.58

ng/l

0.40

145

773

Keratitis

1504

12495

1.22

11.66

3.3

2.9

177.48

189.61

ng/l

0.49

1360

11379

Dislocation, sprain and strain of joints and ligaments at neck level

496

3574

1.41

11.64

2.5

2.8

101.48

151.68

ng/l

5.92

441

3193

Lichen planus

597

4453

1.38

11.63

3.0

167.73

188.22

ng/l

0.70

554

4083

Car occupant injured in other and unspecified transport accidents

663

5002

1.35

11.62

3.1

2.9

146.86

170.30

ng/l

1.08

596

4510

Abdominal aortic aneurysm (AAA)

550

4023

1.40

11.60

3.2

3.3

347.62

272.80

ng/l

2.30

512

3719

5-aminosalicylic acid

728

5564

1.33

11.59

3.1

2.6

172.57

163.10

ng/l

0.24

652

5033

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

666

5041

1.35

11.57

2.5

3.1

202.19

188.94

ng/l

0.34

620

4603

Pre-eclampsia

545

3989

1.39

11.55

2.6

2.5

130.03

120.43

ng/l

0.24

485

3641

In situ neoplasms

1940

16516

1.19

11.54

3.0

3.1

230.00

218.12

ng/l

0.59

1768

15222

Other/unspecified reactive arthropathies

259

1652

1.63

11.49

2.7

2.9

142.60

185.85

ng/l

1.32

233

1495

Ovarian dysfunction

171

971

1.80

11.48

2.6

2.5

72.14

92.20

ng/l

0.90

155

862

Glomerulonephritis

419

2953

1.46

11.48

3.9

3.2

410.57

205.29

ng/l

4.46

392

2696

Migraine without aura and triptan purchases

416

2908

1.45

11.47

2.5

2.6

48.65

113.34

ng/l

20.19

363

2601

Manic episode

117

594

2.07

11.41

2.8

3.1

144.82

168.12

ng/l

0.24

531

Other postsurgical states

266

1710

1.61

11.40

5.4

2.5

168.70

157.30

ng/l

0.21

246

1542

Use of pramipexole

1053

8476

1.27

11.39

3.2

3.0

229.56

206.79

ng/l

0.50

960

7787

Superficial injury of thorax

670

5091

1.35

11.37

3.4

3.0

210.67

205.98

ng/l

0.08

617

4622

Hydrocele

568

4221

1.38

11.32

3.3

3.2

256.19

280.06

ng/l

0.36

537

3858

Hyperhidrosis

110

547

2.09

11.27

3.2

2.8

96.93

154.15

ng/l

2.47

101

487

Methotrexate

558

4130

1.38

11.26

2.7

2.6

175.47

176.50

ng/l

0.02

512

3775

Alzheimer’s disease (Atypical or mixed)

716

5456

1.34

11.25

3.8

3.4

231.51

308.64

ng/l

5.81

677

5011

Autoimmune hepatitis, wide definition

194

1160

1.75

11.20

3.8

2.9

257.77

177.36

ng/l

0.77

171

1050

Anxious personality disorder

266

2.61

11.19

2.1

2.6

97.62

114.96

ng/l

0.22

234

Other and unspecified disorders of white blood cells

190

1135

1.76

11.16

3.0

3.1

253.25

211.73

ng/l

0.54

169

1044

Personal history of risk-factors, not elsewhere classified

192

2.94

11.13

3.5

2.4

164.92

129.07

ng/l

0.20

173

Other injuries of lower limb, level unspecified

218

2.90

11.09

2.4

3.2

190.67

182.12

ng/l

0.06

202

Other superficial mycoses

446

2.23

11.06

3.9

3.0

181.65

164.55

ng/l

0.19

392

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

194

1167

1.74

11.02

3.1

2.9

133.51

189.00

ng/l

1.81

187

1060

Alcohol dependence

1122

9112

1.25

11.01

3.0

222.39

206.27

ng/l

0.31

1019

8320

Nummular dermatitis

392

2755

1.47

11.00

3.6

3.0

175.68

202.94

ng/l

0.82

373

2531

Tinnitus

1014

8156

1.27

10.93

2.8

2.9

130.67

189.02

ng/l

8.92

927

7453

Benign thyroid growths and nodules

1493

11591

1.22

10.92

3.0

2.9

189.62

194.62

ng/l

0.19

1366

10685

Mixed hyperlipidaemia

187

1119

1.76

10.88

3.2

2.8

354.59

206.08

ng/l

1.75

169

1020

Other specified and unspecified retinal disorders

183

1092

1.77

10.88

3.2

3.1

220.64

214.43

ng/l

0.08

159

1012

Acute gastritis

347

2389

1.51

10.86

4.2

3.0

230.95

216.67

ng/l

0.25

326

2198

Acquired haemolytic anaemia

133

725

1.97

10.85

4.1

3.2

358.67

216.69

ng/l

2.05

124

671

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

746

5787

1.32

10.85

2.5

3.1

197.82

189.98

ng/l

0.20

689

5269

Obsessive-compulsive disorder

166

951

1.78

10.84

2.7

2.6

91.54

122.79

ng/l

0.54

145

830

Acute pharyngitis

434

3061

1.43

10.81

3.3

2.7

132.11

137.86

ng/l

0.12

381

2708

Hypertrophic disorders of skin

202

1229

1.70

10.80

3.3

2.9

160.52

165.62

ng/l

0.07

177

1096

Dependence on enabling machines and devices, not elsewhere classified

243

2.74

10.78

7.5

2.7

540.00

184.14

ng/l

2.12

223

Schizophrenia

545

4043

1.37

10.77

3.1

2.9

122.59

155.67

ng/l

1.70

482

3621

Other benign neoplasms of connective and other soft tissue

410

2912

1.45

10.76

2.9

3.0

149.96

184.39

ng/l

1.47

378

2661

Other and unspecified urticaria

691

5304

1.33

10.76

3.6

3.0

160.82

163.34

ng/l

0.06

622

4821

Mild mental retardation

471

2.17

10.74

2.8

3.8

100.75

171.67

ng/l

1.72

427

Other bursitis of elbow

229

2.85

10.72

4.0

3.7

192.07

216.05

ng/l

0.24

206

Cluster headache, wide,, including avohilmo

179

1058

1.75

10.68

2.4

3.0

100.57

147.59

ng/l

1.58

153

941

Other specified/unspecified bacterial intestinal infections

302

2032

1.54

10.65

3.1

207.42

201.34

ng/l

0.08

275

1859

Pneumonitis due to solids and liquids

442

3197

1.43

10.61

3.9

3.2

265.92

264.54

ng/l

0.02

402

2941

Exposure to other and unspecified inanimate mechanical forces

294

1962

1.54

10.61

3.3

3.0

192.72

175.81

ng/l

0.28

264

1776

Rheumatic fever incl heart disease

168

987

1.81

10.60

3.5

3.3

304.10

253.12

ng/l

0.63

154

903

Hyperkinetic disorders

273

1735

1.55

10.58

3.6

3.0

122.79

92.13

ng/l

0.52

225

1480

Viral hepatitis

234

1484

1.62

10.55

3.2

2.8

169.99

155.32

ng/l

0.20

211

1316

Dissociative [conversion] disorders

119

624

1.97

10.49

2.5

2.9

115.61

169.38

ng/l

0.86

105

560

Other benign neoplasms of skin

1735

14758

1.19

10.47

3.1

3.0

205.87

207.20

ng/l

0.03

1582

13538

Focal brain injury

271

1783

1.57

10.47

3.0

2.7

235.87

250.81

ng/l

0.20

242

1631

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

549

4106

1.37

10.46

3.0

2.9

129.67

173.63

ng/l

3.40

497

3743

Other and unspecified abdominal hernia

208

1296

1.69

10.46

4.2

3.0

241.89

208.97

ng/l

0.39

189

1197

Disease of hard tissues of teeth, NOS

2484

11279

1.16

10.44

2.9

3.0

142.10

229.18

ng/l

29.73

2266

10371

Inflammatory diseases of female pelvic organs

2246

13262

1.17

10.44

2.7

131.57

160.83

ng/l

3.25

2031

12097

Unspecified lump in breast

614

4667

1.35

10.42

2.7

2.9

181.96

163.99

ng/l

0.55

555

4281

Other inflammation of eyelid, including avohilmo

1643

13889

1.20

10.41

2.8

144.58

168.08

ng/l

2.37

1472

12608

Atypical facial pain

214

1339

1.66

10.39

2.9

3.1

108.21

185.56

ng/l

3.36

191

1208

Delayed milestone in childhood

235

2.59

10.38

10.2

7.1

193.35

229.90

ng/l

0.24

214

Other nonautoimmune haemolytic anaemias

6.16

10.36

4.8

2.2

251.64

281.03

ng/l

0.11

Iron deficiency

435

2.17

10.34

4.1

2.8

187.16

138.67

ng/l

0.63

395

Acute peritonitis

300

2030

1.54

10.34

3.8

3.1

431.11

226.90

ng/l

5.36

279

1861

Cushing syndrome

232

2.73

10.27

2.2

2.7

186.08

180.15

ng/l

0.05

211

Respiratory conditions due to other external agents

118

632

2.02

10.25

4.5

3.1

284.15

223.74

ng/l

0.57

110

589

Thyroiditis

267

1760

1.57

10.25

3.0

2.9

134.12

170.86

ng/l

1.32

247

1596

Trigger finger

577

4359

1.35

10.19

3.3

2.8

169.67

186.96

ng/l

0.53

534

3985

Special screening examination for neoplasms

259

1697

1.57

10.19

2.8

2.6

220.84

190.22

ng/l

0.47

237

1556

Seronegative rheumatoid arthritis

484

3567

1.39

10.17

3.3

2.8

185.05

192.17

ng/l

0.17

441

3269

Diffuse large B-cell lymphoma, helper endpoint

261

1728

1.59

10.16

4.0

3.3

253.37

222.52

ng/l

0.55

247

1597

Diffuse large B-cell lymphoma, including Hilmo

261

1728

1.59

10.16

4.0

3.3

253.37

222.52

ng/l

0.55

247

1597

Diffuse large B-cell lymphoma

261

1728

1.59

10.16

4.0

3.3

253.37

222.52

ng/l

0.55

247

1597

Other and unspecified primary disorders of muscles

154

3.21

10.15

3.3

3.6

134.47

196.64

ng/l

0.50

140

Viral haemorrhagic fevers, not elsewhere classified/unspecified

327

2257

1.50

10.11

2.9

3.0

145.08

182.99

ng/l

1.08

304

2060

Crushed, pushed or stepped on by crowd or human stampede

230

1467

1.61

10.08

3.1

3.0

156.88

161.82

ng/l

0.08

199

1303

Other and unspecified injuries of abdomen, lower back and pelvis

333

2.38

10.05

5.4

3.1

200.16

199.83

ng/l

0.00

301

Drug-induced osteoporosis

330

2.42

9.97

4.5

3.5

228.85

191.02

ng/l

0.19

303

Eating disorder

179

1071

1.70

9.93

2.4

3.1

58.50

99.75

ng/l

3.14

148

926

Non-follicular lymphoma

479

3553

1.40

9.91

3.3

3.1

268.91

215.51

ng/l

1.47

445

3279

Biomechanical lesions, not elsewhere classified

240

1566

1.60

9.87

2.3

3.0

124.46

203.95

ng/l

6.96

221

1435

Benign neoplasm: Oesophagus

300

2.49

9.86

3.2

3.4

208.92

214.12

ng/l

0.04

272

Other disorders of bone

709

5529

1.30

9.86

3.1

2.9

157.09

163.94

ng/l

0.20

641

4995

Other/unspecified enthesopathies of lower limb, excluding foot

260

1719

1.56

9.80

3.1

2.8

130.60

180.53

ng/l

2.43

232

1553

Viral hepatitis, including avohilmo

240

1559

1.58

9.77

3.2

2.9

167.76

154.86

ng/l

0.18

215

1381

Family history of other conditions

194

2.77

9.76

2.4

2.2

161.60

113.10

ng/l

0.19

176

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

119

650

1.97

9.73

2.0

3.5

237.46

219.95

ng/l

0.14

111

607

Other follicular disorders

258

1706

1.55

9.71

3.3

2.8

195.70

157.85

ng/l

0.57

234

1527

Secondary uncertain malignant neoplasm

673

5244

1.32

9.70

3.3

265.35

236.24

ng/l

0.73

629

4813

Early lumbar disc prolapse, operated

239

1548

1.57

9.70

2.5

2.8

73.21

100.53

ng/l

0.93

207

1360

Arthropod-borne viral fevers and viral haemorrhagic fevers

394

2834

1.43

9.70

3.0

148.02

185.33

ng/l

1.30

364

2586

Spondyloarthritis

713

5584

1.30

9.62

3.3

3.0

196.10

202.36

ng/l

0.15

655

5069

Malignant neoplasm of other and unspecified parts of tongue

436

2.21

9.61

1.9

3.5

226.54

235.67

ng/l

0.05

404

Disturbance of activity and attention

254

1627

1.54

9.59

3.7

2.8

126.11

91.66

ng/l

0.56

209

1386

Hypothyroidism, strict autoimmune, 3 medication purchases required

3618

21765

1.12

9.58

3.1

2.9

182.96

204.59

ng/l

2.71

3302

19933

Thyrotoxicosis with toxic multinodular goitre

293

2008

1.52

9.57

3.3

3.0

264.79

208.74

ng/l

0.94

261

1843

Myotonic dystrophy (Steinert)

5.16

9.54

1.6

2.4

135.71

107.36

ng/l

0.16

Eating disorders

251

1648

1.55

9.51

2.5

3.1

136.04

139.69

ng/l

0.04

212

1464

Iridocyclitis

936

7583

1.26

9.50

3.5

3.0

182.94

186.00

ng/l

0.07

869

6904

Complications of other internal prosthetic devices, implants and grafts

213

1367

1.64

9.50

3.1

2.9

208.38

209.49

ng/l

0.01

191

1242

Other disorders of pigmentation

211

1349

1.63

9.49

3.4

3.0

153.41

196.56

ng/l

1.58

195

1237

Right hemicolectomy

307

2131

1.51

9.47

3.8

3.2

230.99

239.56

ng/l

0.12

277

1959

Other/unspecified disorders of vestibular function

206

1314

1.65

9.44

3.3

3.1

209.49

227.64

ng/l

0.14

190

1210

Coxarthrosis, primary, with hip surgery

2429

19799

1.15

9.42

3.1

203.81

228.69

ng/l

2.39

2254

18262

Adhesive capsulitis of shoulder

689

5394

1.30

9.41

3.1

2.8

160.70

200.72

ng/l

2.34

631

4944

Other strabismus

759

5980

1.28

9.39

3.4

3.0

152.92

167.74

ng/l

0.46

677

5410

Complications of labour and delivery

1484

9765

0.84

9.38

2.4

2.6

109.66

135.70

ng/l

3.00

1355

8911

Additional codes for the location of defect, injury or illness

251

1671

1.56

9.35

3.6

3.1

157.68

200.28

ng/l

1.47

231

1519

Perforation of tympanic membrane

413

3012

1.41

9.34

3.3

3.0

167.15

195.36

ng/l

0.92

376

2742

Rheumatic valve diseases

124

694

1.91

9.33

3.7

3.3

339.54

271.12

ng/l

0.65

114

636

Budesonide

506

3801

1.36

9.29

3.1

2.6

143.86

170.96

ng/l

0.99

457

3459

Other bursitis of hip

107

572

1.99

9.26

3.1

3.2

155.16

215.73

ng/l

1.42

522

Injury of intra-abdominal organs

103

541

2.00

9.26

3.3

171.84

208.63

ng/l

0.51

490

Lichen planus, including avohilmo

837

6727

1.27

9.25

2.7

2.9

173.88

181.67

ng/l

0.19

769

6159

Otitis externa

901

7290

1.26

9.23

3.2

2.9

168.40

180.08

ng/l

0.37

805

6625

Type of accident

1210

10084

1.22

9.23

3.6

3.0

184.04

192.73

ng/l

0.38

1132

9152

Nonhereditary hypogammaglobulinemia

202

2.74

9.22

4.4

2.5

148.77

145.34

ng/l

0.02

182

Palmar fascial fibromatosis [Dupuytren]

738

5852

1.29

9.22

3.3

3.1

252.83

257.91

ng/l

0.06

691

5411

Etanercept

218

1408

1.59

9.17

2.6

2.9

116.14

153.02

ng/l

1.35

195

1261

Other disorders of penis

427

3140

1.40

9.13

3.9

3.2

155.86

232.44

ng/l

5.48

389

2851

Diabetic retinopathy

1778

9484

1.18

9.11

3.9

3.4

298.04

230.63

ng/l

5.30

1648

8681

Nail disorders

322

2258

1.47

9.10

3.3

3.0

227.21

178.12

ng/l

0.83

298

2045

Haemorrhagic disorder due to circulating anticoagulants

489

2.12

9.10

5.8

3.3

442.28

276.47

ng/l

2.23

454

Plantar fascial fibromatosis

370

2658

1.43

9.08

2.6

2.8

110.70

177.28

ng/l

6.00

340

2407

Carcinoma in situ of skin of other and unspecified parts of face

523

3996

1.36

9.06

3.1

3.3

307.70

250.99

ng/l

1.59

474

3678

Other prurigo

292

2.44

9.05

3.4

306.63

216.48

ng/l

0.49

267

Spondylopathies (FG)

449

3326

1.37

9.03

2.7

2.8

143.55

160.11

ng/l

0.49

408

3011

Other abnormal uterine and vaginal bleeding

908

5269

1.26

9.03

3.2

2.9

183.68

216.14

ng/l

1.39

825

4831

Crohn's disease NAS

223

1454

1.58

9.02

2.9

160.12

178.13

ng/l

0.26

199

1311

Benign neoplasm: Skin of upper limb, including shoulder

478

2.07

9.01

2.6

3.1

167.17

198.38

ng/l

0.31

436

Agranulocytosis

462

3451

1.37

9.00

3.0

191.87

183.21

ng/l

0.15

421

3158

Other misadventures during surgical and medical care

116

643

1.92

8.97

3.4

3.1

151.41

202.50

ng/l

1.50

111

592

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

130

741

1.83

8.96

2.4

3.1

82.95

163.87

ng/l

5.20

117

669

Prurigo nodularis

127

725

1.87

8.96

3.0

3.1

312.91

212.39

ng/l

0.87

115

678

Algoneurodystrophy

113

617

1.91

8.95

2.9

2.7

68.70

135.75

ng/l

4.47

101

558

Polyarthritis, unspecified

154

923

1.74

8.95

3.7

3.1

265.91

192.42

ng/l

0.82

139

848

Barrett oesophagus

246

1652

1.56

8.94

3.7

2.9

167.71

196.79

ng/l

0.83

232

1528

Other and unspecified diseases of blood and blood-forming organs

128

733

1.85

8.90

3.4

3.0

230.68

211.24

ng/l

0.20

119

678

Other eating disorders

106

564

1.92

8.87

2.5

3.6

62.05

99.93

ng/l

1.61

491

Myotonic disorders

154

3.00

8.87

1.9

3.6

129.51

118.16

ng/l

0.10

141

Myeloid leukaemia

142

840

1.80

8.87

3.9

3.2

217.39

230.49

ng/l

0.19

135

777

Biological medication for rheuma

538

4101

1.33

8.87

2.6

2.8

114.30

136.41

ng/l

1.15

480

3676

Other and/or unspecified nontoxic goitre

360

2596

1.43

8.82

3.0

2.9

153.46

186.23

ng/l

1.62

327

2372

conjunctival haemorrhage

371

2693

1.43

8.82

4.0

3.1

235.19

211.66

ng/l

0.43

340

2482

Convalescence

195

1241

1.62

8.82

4.1

2.5

219.77

162.60

ng/l

0.79

172

1117

Amputation of ankle bones

123

702

1.88

8.75

5.7

3.2

512.33

237.98

ng/l

5.05

117

647

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

238

1581

1.54

8.75

2.3

2.9

105.54

143.77

ng/l

1.89

209

1414

Other disorders of bladder

567

4383

1.33

8.74

3.0

3.1

188.86

222.67

ng/l

1.28

529

4032

Cholangitis (primary sclerosing, PSC)

293

2042

1.49

8.74

3.0

219.02

227.66

ng/l

0.13

275

1865

Other diseases of spinal cord

132

765

1.81

8.73

3.5

3.0

197.28

210.16

ng/l

0.12

121

701

Vitamin deficiency, wide

207

1343

1.60

8.71

3.6

3.0

267.84

218.55

ng/l

0.43

185

1227

Vitamin deficiency

207

1343

1.60

8.71

3.6

3.0

267.84

218.55

ng/l

0.43

185

1227

Diseases of tongue

263

1793

1.51

8.70

3.0

174.14

206.17

ng/l

0.74

239

1638

Mandibular prognathia

256

2.44

8.68

3.1

3.3

122.96

151.26

ng/l

0.26

235

Conjunctivitis (acute, non atopic)

1047

8617

1.23

8.65

3.7

3.0

152.76

173.95

ng/l

1.19

957

7822

Colorectal cancer, including Hilmo

1377

10894

1.20

8.65

2.9

3.2

215.55

235.05

ng/l

1.00

1260

10036

Benign neoplasm: Sigmoid colon

911

7457

1.25

8.61

3.0

3.1

210.88

213.39

ng/l

0.06

830

6863

Hypermetropia

273

1875

1.50

8.60

3.3

3.2

146.89

185.45

ng/l

1.49

252

1691

Psychotic depression

210

1365

1.58

8.60

3.3

2.8

122.93

179.13

ng/l

1.99

191

1230

Benign lipomatous neoplasm

1259

10610

1.20

8.59

3.0

177.11

192.96

ng/l

0.69

1138

9703

Hepatocellular carcinoma, including Hilmo

168

1049

1.70

8.58

2.9

3.3

215.00

259.70

ng/l

0.88

157

982

Other congenital malformations of urinary system

3.88

8.57

3.2

3.1

207.41

190.88

ng/l

0.11

Other specified/unspecified inflammatory spondylopathies

148

884

1.72

8.56

2.5

2.9

76.94

174.18

ng/l

6.69

139

789

Localized swelling, mass and lump of skin and subcutaneous tissue

1354

11480

1.20

8.56

3.1

2.9

189.95

199.12

ng/l

0.33

1234

10498

Other specified disorders of muscle

130

756

1.80

8.49

3.3

3.1

228.90

220.25

ng/l

0.07

125

688

Disorders of breast

1775

13506

1.17

8.46

2.4

2.8

146.67

161.90

ng/l

1.06

1586

12365

Corns and callosities

293

2054

1.48

8.46

3.5

3.0

224.56

191.79

ng/l

0.65

268

1875

Injury of muscle and tendon at shoulder and upper arm level

1601

13780

1.18

8.46

2.9

3.0

155.07

201.91

ng/l

6.35

1458

12650

Vasculitis limited to skin, not elsewhere classified

131

768

1.81

8.43

4.1

3.2

230.32

214.99

ng/l

0.18

121

704

Inflammatory diseases of prostate (prostatitis)

576

4482

1.32

8.42

3.5

3.1

151.88

251.71

ng/l

10.27

536

4103

Ulcerative colitis

903

7380

1.24

8.42

3.3

2.9

199.43

178.47

ng/l

0.64

819

6685

Irregular menses

1401

8911

1.19

8.41

2.6

2.5

98.96

136.03

ng/l

6.37

1264

8049

Hyperparathyroidism

905

7337

1.25

8.41

3.2

3.1

273.84

220.35

ng/l

2.00

828

6712

Attention to artificial openings

194

1254

1.62

8.39

3.8

2.9

244.43

215.23

ng/l

0.38

176

1155

Other disorders of nervous system

289

2024

1.48

8.39

3.9

2.8

142.54

194.49

ng/l

2.28

274

1852

Disorders of conjunctiva

3456

24124

1.12

8.35

3.1

2.9

166.08

186.40

ng/l

2.25

3089

22011

Impetigo

147

883

1.72

8.34

3.6

3.3

138.95

165.01

ng/l

0.34

131

798

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

161

1003

1.71

8.33

4.0

3.2

264.17

247.94

ng/l

0.16

148

928

Multiple myeloma

161

1003

1.71

8.33

4.0

3.2

264.17

247.94

ng/l

0.16

148

928

Disorders of oesophagus in diseases classified elsewhere

113

638

1.89

8.33

3.2

3.0

268.31

218.20

ng/l

0.38

104

599

Other noninflammatory disorders of vulva and perineum

338

2427

1.42

8.33

2.8

2.9

163.02

187.90

ng/l

0.49

300

2220

Pleural plaque

510

3926

1.34

8.31

4.0

3.0

197.12

262.10

ng/l

4.36

480

3653

Periapical abscess

1852

16122

1.16

8.27

2.8

2.9

166.90

176.29

ng/l

0.44

1691

14689

Alcohol-induced chronic pancreatitis

260

1790

1.50

8.26

3.2

3.0

226.62

184.99

ng/l

0.68

234

1633

Injury of muscle and tendon at lower leg level

589

4602

1.30

8.24

2.9

3.0

157.92

182.24

ng/l

1.19

546

4180

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

225

2.51

8.23

3.1

3.0

176.98

146.58

ng/l

0.17

208

Vasomotor and allergic rhinitis

1248

10282

1.20

8.22

2.7

3.0

126.22

166.97

ng/l

4.71

1106

9346

Dermatophytosis

606

4760

1.30

8.22

3.5

3.0

194.87

202.01

ng/l

0.18

560

4347

Congenital malformations of the urinary system

210

1384

1.57

8.19

2.8

3.4

363.20

189.65

ng/l

3.98

198

1253

Acute alcohol intoxication, ICD10

743

5969

1.26

8.17

3.1

3.0

244.68

185.55

ng/l

1.13

680

5381

Pedestrian injured in transport accident

283

1982

1.47

8.16

2.9

3.0

220.21

191.80

ng/l

0.50

258

1799

Benign neoplasm: Parathyroid gland

293

2.36

8.16

3.5

3.3

231.50

221.68

ng/l

0.05

271

Hyperaldosteronism

134

798

1.77

8.15

2.9

3.1

269.71

192.31

ng/l

0.66

128

735

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

170

1063

1.63

8.14

2.3

2.6

87.34

79.17

ng/l

0.11

151

956

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

389

2882

1.39

8.11

2.6

3.0

210.58

187.36

ng/l

0.45

358

2636

Open wound of forearm

400

2972

1.38

8.09

3.5

3.0

218.64

207.40

ng/l

0.16

356

2697

Other maltreatment syndromes

507

1.94

8.08

2.0

2.7

102.39

115.23

ng/l

0.18

448

Ethmoidectomy

465

3529

1.34

8.08

3.0

2.9

108.96

162.11

ng/l

4.19

427

3196

Dislocation, sprain and strain of joints and ligaments of thorax

145

880

1.72

8.07

2.8

3.1

159.31

205.71

ng/l

0.92

134

807

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1197

9942

1.20

8.07

2.8

151.25

147.61

ng/l

0.12

1056

8925

Intracerebral haemorrhage

648

5151

1.29

8.04

3.7

3.1

239.65

257.09

ng/l

0.49

589

4728

Other congenital malformations of the digestive system, including avohilmo

187

1197

1.60

8.03

3.4

3.7

186.19

192.32

ng/l

0.08

171

1087

Malignant neoplasm of head and neck, including Hilmo

469

3578

1.35

8.01

2.6

3.2

272.63

235.80

ng/l

0.60

432

3296

Car occupant injured in noncollision transport accident

126

736

1.78

8.01

2.9

3.0

183.65

174.85

ng/l

0.07

116

665

Adult respiratory distress syndrome

355

2.20

8.00

4.3

3.2

262.24

214.19

ng/l

0.26

324

Other diseases of blood and blood-forming organs

303

2162

1.45

7.97

3.2

3.1

240.80

200.57

ng/l

0.94

277

1982

Lateral epicondylitis

451

3413

1.35

7.95

2.6

2.8

124.75

157.58

ng/l

1.14

407

3094

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

265

2.44

7.94

3.0

3.7

300.84

249.42

ng/l

0.29

246

Allergic urticaria

278

1947

1.46

7.93

4.1

3.1

138.28

177.58

ng/l

1.49

247

1755

Multiple myeloma, including Hilmo

241

1657

1.52

7.92

4.1

3.2

278.70

239.17

ng/l

0.58

222

1533

Early complications of trauma

189

1230

1.60

7.90

3.6

3.0

300.08

213.62

ng/l

1.27

177

1124

!Aliquae complicationes praecoces traumatis

189

1230

1.60

7.90

3.6

3.0

300.08

213.62

ng/l

1.27

177

1124

Background retinopathy and retinal vascular changes

110

627

1.87

7.86

4.2

3.3

374.56

231.79

ng/l

1.30

100

585

Haemorrhage in early pregnancy

729

5688

1.26

7.85

2.5

2.6

101.43

123.08

ng/l

0.99

665

5163

Other specified and unspecified disorders of conjunctiva

219

2.52

7.85

5.2

3.2

264.55

201.22

ng/l

0.34

201

Other congenital malformations of the digestive system

157

970

1.66

7.85

3.5

3.8

197.52

199.77

ng/l

0.02

143

888

Melanocytic naevi

1163

9806

1.20

7.84

3.2

2.9

156.44

175.69

ng/l

1.30

1084

8932

Ulcerative colitis, NAS

491

3770

1.33

7.83

3.7

3.0

192.10

176.10

ng/l

0.30

444

3397

Injury of nerves at lower leg level

176

2.69

7.81

2.8

2.5

126.69

175.25

ng/l

0.67

155

Contusion of toe(s) without damage to nail

478

1.96

7.81

2.5

3.1

129.12

155.90

ng/l

0.31

426

Carcinoma in situ of skin of trunk

204

1367

1.59

7.80

3.1

3.2

292.91

256.29

ng/l

0.46

191

1263

Hypocalcemia

108

613

1.86

7.78

4.6

3.1

380.43

203.75

ng/l

1.12

559

Congenital malformations of the urinary system, including avohilmo

223

1506

1.53

7.76

2.9

3.3

359.63

185.78

ng/l

4.24

209

1364

Other and unspecified erythematous conditions

144

884

1.71

7.76

2.3

3.1

168.57

196.10

ng/l

0.41

135

813

Seborrhoeic dermatitis

419

3158

1.36

7.75

4.0

3.0

178.11

196.91

ng/l

0.33

381

2889

Vascular dementia (undefined)

262

1818

1.49

7.75

4.1

3.6

362.58

366.99

ng/l

0.05

238

1649

Total colectomy

160

1006

1.65

7.74

3.9

3.0

166.19

189.89

ng/l

0.35

141

915

Total colectomy operation

160

1006

1.65

7.74

3.9

3.0

166.19

189.89

ng/l

0.35

141

915

Localized scleroderma [morphea]

331

2.20

7.72

4.6

3.2

134.62

171.27

ng/l

0.41

306

Emotional disorders starting during childhood or adolecense, excluding more controls

393

2.01

7.71

3.9

2.9

81.31

102.60

ng/l

0.35

342

Intentional self-harm by sharp object

314

2.17

7.70

2.7

2.8

92.25

123.89

ng/l

0.55

275

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

122

695

1.75

7.69

6.8

3.5

140.96

125.02

ng/l

0.22

109

599

Chronic lymphocytic leukaemia

165

1055

1.66

7.69

2.7

3.3

228.99

234.71

ng/l

0.06

149

973

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

165

1055

1.66

7.69

2.7

3.3

228.99

234.71

ng/l

0.06

149

973

Chronic lymphocytic leukaemia, helper endpoint

165

1055

1.66

7.69

2.7

3.3

228.99

234.71

ng/l

0.06

149

973

Pulmonary eosinophilia, not elsewhere classified

334

2.22

7.68

3.4

3.3

224.71

216.92

ng/l

0.04

308

Malignant neoplasm of tongue, including Hilmo

133

805

1.75

7.67

2.0

3.3

245.35

221.45

ng/l

0.20

125

746

Anomalies of pupillary function

412

2.04

7.67

2.9

3.0

92.36

171.61

ng/l

2.67

377

Certain conditions originating in the perinatal period

174

981

1.60

7.65

3.2

4.1

95.10

141.10

ng/l

2.05

155

848

Noise effects on inner ear

184

1202

1.60

7.64

3.3

3.0

186.26

207.52

ng/l

0.30

168

1100

Colorectal cancer

1231

10047

1.19

7.62

2.9

3.3

221.52

239.64

ng/l

0.79

1126

9261

Thiazolidinediones

531

4155

1.31

7.57

3.4

2.9

246.84

211.34

ng/l

1.02

488

3850

Neuroendocrine tumor and carcinoma of pancreas

163

2.82

7.57

3.5

124.47

223.90

ng/l

1.39

153

Other specified/unspecified soft tissue disorders

212

1428

1.54

7.56

3.7

3.1

220.99

227.94

ng/l

0.07

191

1297

Delivery

1175

7328

0.84

7.55

2.9

161.61

190.61

ng/l

1.87

1076

6701

Single delivery by forceps and vacuum extractor

133

1303

0.60

7.54

2.1

2.5

35.97

93.30

ng/l

8.79

116

1137

Carcinoma in situ of skin of ear and external auricular canal

107

619

1.89

7.53

2.9

3.3

320.84

265.53

ng/l

0.54

566

Sacrococcygeal disorders, not elsewhere classified

109

623

1.82

7.50

2.2

3.1

114.29

204.12

ng/l

2.22

555

Other abnormalities of plasma proteins

462

2.00

7.50

4.7

3.3

251.73

224.93

ng/l

0.23

425

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

719

5776

1.26

7.50

3.5

297.22

276.10

ng/l

0.51

662

5329

Abscess of anal and rectal regions

301

2162

1.42

7.48

2.8

187.50

161.80

ng/l

0.49

267

1957

Late syphilis, including avohilmo

412

2.05

7.45

3.1

3.3

306.15

175.56

ng/l

1.44

371

Benign neoplasm of middle ear and respiratory system

343

2528

1.40

7.45

3.1

277.94

206.22

ng/l

0.54

318

2311

Temporomandibular joint disorders, including avohilmo

1424

11854

1.17

7.44

2.7

93.31

145.84

ng/l

9.75

1274

10709

Coeliac disease

441

3364

1.34

7.44

3.5

3.0

148.97

176.95

ng/l

1.50

397

3060

Alzheimer’s disease (Late onset)

1458

10371

1.18

7.38

3.3

3.4

236.36

291.47

ng/l

5.02

1352

9573

Pedal cyclist injured in transport accident

815

6690

1.23

7.36

3.0

160.40

169.06

ng/l

0.30

757

6046

Lichen ruber planus, wide definition including periferal and oral lichen planus

960

8019

1.22

7.35

2.7

2.9

163.45

180.25

ng/l

0.58

875

7358

Other and unspecified intracranial injuries

142

882

1.69

7.33

3.4

3.1

222.06

232.35

ng/l

0.10

132

805

Melanocytic naevi of upper limb, including shoulder

549

1.87

7.32

3.1

219.34

204.32

ng/l

0.13

500

Malignant neoplasm of endocrine gland, including Hilmo

322

2353

1.40

7.31

3.5

3.2

170.26

184.06

ng/l

0.26

293

2142

Tobacco use

194

1290

1.55

7.31

2.7

2.8

191.46

159.42

ng/l

0.47

183

1176

Acute and transient psychotic disorders

379

2836

1.36

7.27

2.6

2.9

145.01

161.47

ng/l

0.35

329

2540

Nasal polyp

792

6500

1.24

7.26

2.9

3.1

136.35

210.42

ng/l

11.45

724

5957

Benign neoplasm: Kidney

170

1107

1.61

7.25

3.0

3.1

157.41

211.45

ng/l

1.05

155

1017

Trigeminal neuralgia

239

1662

1.48

7.24

3.4

3.1

140.98

201.04

ng/l

1.88

209

1511

Alzheimer’s disease, strict definition

1546

10842

1.17

7.23

3.2

3.3

235.13

286.52

ng/l

4.67

1427

10010

Benign neoplasm: Rectosigmoid junction

202

1368

1.55

7.20

2.9

3.2

220.64

224.08

ng/l

0.04

188

1265

Bruxism

291

2.19

7.18

2.8

2.9

71.48

124.55

ng/l

1.58

264

Burn and corrosion of trunk

122

732

1.74

7.17

3.0

3.2

171.62

199.62

ng/l

0.34

110

664

Problems related to social environment

127

771

1.72

7.13

4.5

3.0

192.04

230.20

ng/l

0.70

116

710

Focal epilepsy

870

7217

1.22

7.11

3.1

3.2

161.39

208.85

ng/l

4.30

799

6574

Maternal care for other conditions predominantly related to pregnancy

415

3065

1.33

7.10

2.2

2.4

78.45

88.97

ng/l

0.37

358

2743

Congenital malformations of the musculoskeletal system, not elsewhere classified

221

2.38

7.09

1.8

2.7

80.55

110.49

ng/l

0.50

201

Other disorders of Eustachian tube

122

734

1.73

7.09

3.0

145.53

171.13

ng/l

0.33

117

674

Exclusions for E4_PCOS_CONSORTIUM

2651

14813

1.12

7.09

2.8

2.9

165.85

170.53

ng/l

0.21

2387

13453

Inflammatory bowel disease

1140

9683

1.19

7.08

3.1

2.9

186.38

175.07

ng/l

0.36

1031

8769

Open wound of abdomen, lower back and pelvis

112

657

1.77

7.08

3.0

3.2

346.53

184.05

ng/l

0.90

100

587

Other neurotic disorders

200

1351

1.53

7.08

3.0

2.9

210.10

213.51

ng/l

0.03

183

1234

Nonsuppurative otitis media

675

4716

1.25

7.07

3.4

2.9

153.87

167.33

ng/l

0.44

595

4204

Hypothyroidism due to medicaments and other exogenous substances

303

2.21

7.06

4.1

2.9

191.81

198.26

ng/l

0.05

270

Benign neoplasm of eye and adnexa

461

3574

1.32

7.05

3.7

3.1

182.43

198.34

ng/l

0.34

422

3281

Myositis

117

699

1.76

7.05

3.0

3.1

148.56

220.70

ng/l

1.91

104

643

Erosion of teeth , including avohilmo

865

7169

1.22

7.04

2.8

2.9

139.89

152.50

ng/l

0.55

771

6460

Oesophagitis

242

1699

1.47

7.04

3.6

3.0

203.77

212.35

ng/l

0.10

226

1562

L02BX Other hormone antagonists and related agents

316

2335

1.41

7.03

3.1

219.46

236.16

ng/l

0.24

296

2168

Ehlers-Danlos syndrome

114

2.96

7.02

1.6

2.4

39.17

96.19

ng/l

2.26

100

Caught, crushed, jammed or pinched in or between objects

182

1204

1.56

7.02

3.0

3.2

134.39

162.28

ng/l

0.63

173

1089

False labour

592

2897

1.28

7.00

2.1

2.4

43.65

84.58

ng/l

11.02

520

2580

Other disorders of patella

522

4098

1.29

6.99

2.7

2.8

133.01

153.85

ng/l

0.48

473

3730

Superficial injury of shoulder and upper arm

472

3668

1.31

6.98

3.1

3.0

191.73

196.94

ng/l

0.10

428

3330

Radial styloid tenosynovitis [de Quervain]

178

1172

1.56

6.96

3.3

2.9

159.83

157.69

ng/l

0.02

161

1048

Intentional self-harm by unspecified means

167

2.57

6.93

2.6

124.72

120.02

ng/l

0.04

147

Otitis externa, unspecified

407

3103

1.34

6.92

3.6

3.0

173.72

171.91

ng/l

0.03

368

2814

Carcinoma in situ of skin

448

3480

1.33

6.92

3.2

247.27

232.12

ng/l

0.28

411

3203

Salpingitis and oophoritis

584

4660

1.27

6.91

2.8

2.7

152.58

150.63

ng/l

0.04

540

4254

Other disorders of conjunctiva

642

5191

1.26

6.91

3.9

3.0

230.13

203.60

ng/l

0.75

587

4775

Status epilepticus

154

989

1.62

6.89

4.8

2.8

199.56

233.87

ng/l

0.48

143

908

Dementia in Alzheimer disease

774

7822

0.81

6.89

3.6

3.4

226.23

301.10

ng/l

5.66

716

7220

Anterior Iridocyclitis

794

6555

1.23

6.87

3.6

3.0

184.71

185.45

ng/l

0.01

737

5957

Bursitis of shoulder

106

620

1.79

6.86

2.7

3.0

123.28

199.12

ng/l

2.03

564

Unspecified event, undetermined intent

508

1.87

6.85

3.2

3.1

139.01

171.73

ng/l

0.61

459

Hepatocellular carcinoma

131

817

1.70

6.84

3.1

3.4

225.33

273.13

ng/l

0.76

121

764

Post-traumatic wound infection, not elsewhere classified

117

704

1.74

6.84

3.5

3.1

319.61

199.71

ng/l

1.23

109

640

Granulomatous disorders of skin and subcutaneous tissue

102

590

1.80

6.84

3.3

2.9

130.73

171.63

ng/l

0.94

540

Single spontaneous delivery

1180

7308

0.84

6.83

2.9

160.01

190.91

ng/l

2.09

1084

6685

Poisoning by narcotics and psychodysleptics [hallucinogens]

231

2.31

6.82

2.3

2.7

122.50

138.02

ng/l

0.16

197

Alcoholic liver disease

428

3301

1.33

6.82

2.9

3.0

290.65

202.69

ng/l

1.04

400

3005

Dermatitis due to substances taken internally

209

1434

1.50

6.80

3.9

2.8

173.39

197.28

ng/l

0.40

189

1306

Other diseases of peritoneum

190

1283

1.54

6.79

2.9

3.0

174.71

200.45

ng/l

0.52

176

1181

Use of disulfiram, acamprosate or naltrexone

289

2099

1.41

6.78

3.0

2.8

146.36

143.66

ng/l

0.04

258

1876

Herpesviral [herpes simplex] infections

434

3349

1.32

6.78

3.9

2.9

168.70

181.90

ng/l

0.30

388

3051

Tumor necrosis factor alpha inhibitors

462

3587

1.31

6.77

2.4

2.9

103.93

136.96

ng/l

2.02

409

3210

Carcinoma in situ of skin of scalp and neck

175

1174

1.59

6.76

3.2

3.3

282.70

264.42

ng/l

0.17

162

1089

Strabismus

965

8096

1.20

6.75

3.5

3.0

170.81

176.86

ng/l

0.18

866

7343

Polycystic ovarian syndrome

103

594

1.76

6.74

2.6

2.7

74.01

76.22

ng/l

0.04

516

Sulfonylureas

1780

12461

1.15

6.72

3.9

3.0

320.78

252.35

ng/l

6.17

1641

11515

Adalimumab

286

2074

1.40

6.71

2.3

2.9

98.23

133.51

ng/l

1.47

252

1846

Hypertrophy of breast in women and men

620

4995

1.26

6.71

2.4

2.7

119.12

145.87

ng/l

1.29

554

4560

Heterophoria

259

1850

1.43

6.69

4.6

3.1

141.81

174.49

ng/l

0.86

234

1662

Other/unspecified synovitis and tenosynovitis

425

3276

1.32

6.69

3.1

2.9

266.26

193.56

ng/l

0.67

385

2978

FESS (DNB20)

435

3365

1.32

6.67

2.8

2.9

100.32

160.14

ng/l

5.37

399

3043

Acute generalized exanthematous pustulosis

177

1181

1.55

6.66

3.9

3.1

159.22

210.94

ng/l

1.14

160

1083

Inguinal hernia, unilateral

131

820

1.68

6.65

3.2

3.1

193.64

204.79

ng/l

0.15

118

760

Femoral hernia, unilateral

131

820

1.68

6.65

3.2

3.1

193.64

204.79

ng/l

0.15

118

760

Inguinal of femoral hernia, unilateral

131

820

1.68

6.65

3.2

3.1

193.64

204.79

ng/l

0.15

118

760

Other erythematous conditions

153

991

1.61

6.65

2.5

3.0

163.25

200.70

ng/l

0.66

144

903

Perineal laceration during delivery

155

1915

0.65

6.63

1.8

2.4

53.50

80.80

ng/l

2.35

132

1698

Prepatellar bursitis

185

1248

1.53

6.61

3.5

3.0

214.50

195.49

ng/l

0.25

169

1138

Achilles tendinitis

382

2908

1.34

6.60

3.0

2.8

156.89

191.53

ng/l

1.14

352

2649

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

266

1914

1.42

6.60

2.1

2.7

153.21

135.72

ng/l

0.25

236

1742

Mental disorders, not otherwise specified

226

1578

1.46

6.58

2.7

3.0

160.12

140.68

ng/l

0.29

196

1403

Disorders of synovium and tendon in diseases classified elsewhere

555

1.82

6.53

2.7

3.1

147.06

197.69

ng/l

0.62

503

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

979

8266

1.20

6.53

3.0

2.8

146.49

158.46

ng/l

0.47

890

7477

Squamous cell neoplasms and carcinomas of the skin

572

4604

1.27

6.53

3.6

3.5

318.71

282.13

ng/l

0.85

524

4253

Oxicams

1082

5205

1.20

6.51

3.2

3.4

197.10

307.47

ng/l

12.84

989

4823

Superficial injury of wrist and hand

690

5641

1.24

6.51

3.1

3.0

147.99

162.43

ng/l

0.52

597

5078

Contusion of other and unspecified parts of foot

158

1030

1.57

6.49

2.6

3.0

105.21

151.21

ng/l

1.87

139

918

Papillary adenocarcinoma of thyroid gland

192

1309

1.51

6.48

4.3

3.1

169.30

165.43

ng/l

0.05

175

1189

Inflammatory diseases of the central nervous system

313

2324

1.38

6.46

2.8

3.0

182.40

188.63

ng/l

0.09

281

2104

Speech disturbances, not elsewhere classified

424

3295

1.32

6.45

4.2

3.1

211.54

230.52

ng/l

0.42

400

3006

Other disorders starting during childhood or adolescence

104

604

1.74

6.42

7.6

4.1

131.33

154.79

ng/l

0.35

514

Open wound of shoulder and upper arm

439

1.91

6.42

3.1

3.2

181.07

202.05

ng/l

0.25

393

Benign neoplasm of meninges

456

3578

1.31

6.42

2.7

3.1

161.82

191.43

ng/l

1.31

419

3284

Giant cell arteritis

215

1511

1.49

6.40

3.5

3.1

228.47

224.51

ng/l

0.05

197

1391

Intracranial and intraspinal abscess and granuloma

302

2.14

6.36

2.6

3.1

247.01

230.40

ng/l

0.11

270

Malignant neoplasm of endocrine gland

273

1991

1.41

6.34

3.7

3.1

171.08

175.17

ng/l

0.06

249

1807

Other peripheral vertigo

402

3109

1.33

6.33

3.0

3.1

140.06

203.21

ng/l

6.34

379

2850

Other/unspecified soft tissue disorders related to use, overuse and pressure

109

656

1.72

6.33

3.8

2.9

145.47

169.90

ng/l

0.48

596

Sleep disorders, other/unspecified

106

631

1.73

6.33

2.4

3.2

137.75

163.59

ng/l

0.30

559

Restless leg syndrome

582

4703

1.26

6.29

2.8

3.0

161.84

187.34

ng/l

1.18

529

4293

Paralytic ileus

183

1249

1.52

6.28

4.1

3.0

208.47

232.79

ng/l

0.36

168

1148

Otalgia

302

2239

1.38

6.28

3.3

3.1

127.78

192.32

ng/l

3.52

273

2027

Colonic or urogenital fistula

1066

9112

1.18

6.27

2.7

3.0

184.28

190.38

ng/l

0.16

966

8296

Corneal ulcer

681

5590

1.24

6.26

3.1

3.0

168.85

177.72

ng/l

0.19

620

5064

Injury of other and unspecified intrathoracic organs

276

2026

1.40

6.23

3.0

3.1

244.11

217.08

ng/l

0.34

254

1852

Nonspecific lymphadenitis

190

1301

1.50

6.23

2.9

3.0

189.14

148.12

ng/l

0.35

177

1171

Hyperosmolality and hypernatraemia

396

1.97

6.22

3.8

3.0

168.91

243.63

ng/l

1.79

368

Delivery, wide proxy

1029

6418

0.84

6.22

2.9

3.0

176.87

198.88

ng/l

1.04

957

5870

Nephrotic syndrome

128

809

1.65

6.21

4.7

3.5

668.99

203.87

ng/l

2.89

119

743

Sequelae of intentional self-harm, assault and events of undetermined intent

3.13

6.19

3.0

2.5

63.45

91.76

ng/l

0.66

Acute appendicitis, no complications

1985

17585

1.13

6.19

3.0

2.8

154.43

171.11

ng/l

1.13

1772

15980

Malignant neoplasm of retroperitoneum and peritoneum

219

2.37

6.18

2.1

3.6

116.23

236.84

ng/l

2.58

203

Ulcerative proctitis

203

1411

1.47

6.16

3.1

2.8

214.20

168.08

ng/l

0.52

181

1278

Effects of foreign body entering through natural orifice

901

7605

1.20

6.15

3.4

3.0

157.18

182.21

ng/l

1.07

803

6895

Hemiplegia

202

1407

1.48

6.14

3.1

217.80

220.25

ng/l

0.03

176

1285

Atrophic disorders of skin

602

4893

1.25

6.13

2.9

145.98

166.72

ng/l

1.04

541

4452

Dysplastic lesion of unknown severity of the cervix uteri

141

2.62

6.12

2.4

2.7

85.80

119.01

ng/l

0.30

131

Other endocrine disorders

161

1023

1.55

6.12

5.1

3.9

213.14

183.91

ng/l

0.24

150

922

Malignant neoplasm of head and neck

380

2933

1.33

6.09

2.6

3.3

289.28

232.36

ng/l

0.87

350

2709

Leisure time condition

727

6027

1.22

6.09

3.7

3.1

176.78

195.94

ng/l

0.90

674

5464

Other and unspecified vasculitis limited to skin

110

675

1.71

6.08

4.4

3.2

246.90

225.04

ng/l

0.23

101

621

Other noninfective disorders of lymphatic vessels and lymph nodes

147

963

1.58

6.08

4.1

3.0

190.59

186.69

ng/l

0.04

132

876

Generalized epilepsy, mode (most common among epilepsy diagnosis)

564

1.76

6.07

2.7

3.1

112.30

156.47

ng/l

0.93

506

Effects of other external causes

519

1.79

6.07

2.6

3.8

102.17

150.96

ng/l

1.37

454

Cutaneous lupus erythematosus

101

606

1.75

6.04

2.9

3.0

226.56

199.88

ng/l

0.19

559

Amputation of thigh

169

1148

1.54

6.04

5.7

3.3

491.05

282.45

ng/l

3.55

159

1056

Sequelae of injuries of neck and trunk

116

720

1.68

6.04

3.3

2.8

132.94

173.98

ng/l

0.91

106

655

Other superficial mycoses, including avohilmo

329

2482

1.35

6.03

2.8

2.9

142.23

156.44

ng/l

0.41

286

2217

Disorder of external ear, unspecified

140

910

1.60

6.02

3.3

3.0

218.82

195.99

ng/l

0.22

130

834

Other and unspecified injuries of thorax

420

1.90

6.02

4.4

3.2

195.84

209.99

ng/l

0.09

384

Malignant neoplasm of thyroid gland, including Hilmo

278

2052

1.39

6.01

3.6

3.1

160.68

175.42

ng/l

0.28

253

1860

Primary biliary cholangitis (PBC)

554

1.78

6.01

2.9

3.1

249.99

179.79

ng/l

0.64

505

Viral warts, including avohilmo

734

6092

1.22

6.00

3.2

2.9

160.62

160.82

ng/l

0.01

669

5492

Ankylosing spondylitis

295

2195

1.37

5.99

2.8

2.9

147.02

196.13

ng/l

1.71

268

1996

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

107

649

1.70

5.99

3.4

2.7

341.41

95.81

ng/l

3.43

573

Temporal arteritis

188

1307

1.51

5.98

3.5

3.0

204.17

224.53

ng/l

0.29

171

1204

Infection due to other mycobacteria, including avohilmo

474

1.86

5.98

3.5

3.0

134.31

200.83

ng/l

1.98

433

Acute myeloid leukaemia and myelodysplastic syndromes

132

853

1.63

5.98

3.5

3.4

257.81

276.88

ng/l

0.22

120

792

Abnormality of white blood cells, not elsewhere classified

201

2.37

5.98

4.5

3.4

197.21

186.04

ng/l

0.07

182

Lymphoid leukaemia

263

1934

1.41

5.97

2.8

3.3

254.15

239.26

ng/l

0.21

236

1784

Benign neoplasm: Choroid

296

2215

1.38

5.97

4.2

3.0

173.20

197.57

ng/l

0.46

269

2029

Malignant neoplasm of rectosigmoid junction, including Hilmo

152

1013

1.58

5.97

2.9

3.4

226.66

249.56

ng/l

0.24

137

941

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1171

10120

1.17

5.96

2.8

3.0

194.80

185.09

ng/l

0.19

1056

9189

Hypopituitarism

240

1729

1.42

5.96

3.8

3.3

130.20

168.07

ng/l

0.91

207

1550

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

115

713

1.66

5.94

2.4

3.0

116.73

153.59

ng/l

1.13

101

638

Other and unspecified disorders of skin and subcutaneous tissue

122

1891

0.63

5.93

4.9

3.1

196.76

200.15

ng/l

0.04

112

1720

Secondary parkinsonism+Parkinsonism in other disease

139

909

1.60

5.92

3.8

3.2

167.28

250.88

ng/l

2.73

125

833

Fasciculation

227

2.24

5.91

2.6

2.7

80.10

162.17

ng/l

2.37

204

Unspecified abortion

135

870

1.59

5.89

2.8

2.9

69.58

99.66

ng/l

1.57

122

781

Generalized epilepsy

128

816

1.61

5.88

2.9

3.0

119.47

165.85

ng/l

1.13

118

732

Other congenital malformations of skin

130

833

1.61

5.87

3.1

3.2

127.12

179.81

ng/l

1.56

115

757

Crohn disease

417

3263

1.30

5.87

3.0

2.9

152.57

161.99

ng/l

0.20

369

2927

Other ulcerative colitis

190

1318

1.48

5.86

3.7

2.9

253.44

172.00

ng/l

1.00

177

1190

Autonomic disorders

100

603

1.73

5.86

2.6

2.9

149.48

210.00

ng/l

0.62

552

Disorders of orbit

160

1075

1.54

5.86

2.5

3.1

175.21

169.24

ng/l

0.07

139

984

Pyogenic granuloma

380

1.93

5.86

4.1

3.1

162.28

208.12

ng/l

0.47

343

Vitamin D deficiency

365

1.95

5.86

3.3

3.0

132.05

172.07

ng/l

0.72

337

Other menopausal disorders

695

4685

0.82

5.84

2.4

2.8

101.07

188.74

ng/l

14.27

630

4315

Nail dystrophy

134

2.70

5.84

2.8

83.18

159.84

ng/l

1.63

122

Exposure to other and unspecified animate mechanical forces

578

1.73

5.83

2.9

3.1

191.01

150.11

ng/l

0.32

519

Antenatal screening

260

1990

0.73

5.82

2.3

71.60

81.28

ng/l

0.36

224

1766

Malignant neoplasm of colon, including Hilmo

935

7940

1.19

5.81

3.1

3.3

211.79

245.21

ng/l

1.80

856

7325

Other and specified injuries of hip and thigh

112

699

1.68

5.81

3.5

3.4

227.73

229.50

ng/l

0.01

103

644

Chronic iridocyclitis

188

1307

1.48

5.81

3.4

3.0

154.80

200.91

ng/l

1.23

172

1187

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

254

2.13

5.80

1.8

2.7

79.93

107.81

ng/l

0.48

230

Hypothermia

516

1.80

5.79

3.9

3.3

230.70

251.22

ng/l

0.19

472

Monoplegia

376

1.95

5.78

5.7

3.2

229.43

204.79

ng/l

0.13

346

Wegener granulomatosis

384

1.94

5.76

3.7

3.5

102.45

215.79

ng/l

3.57

352

Mixed conductive and sensorineural hearing loss

556

4523

1.26

5.76

3.1

3.0

172.26

216.78

ng/l

2.44

515

4155

Secondary parkinsonism

135

883

1.60

5.76

3.9

3.2

169.87

254.95

ng/l

2.67

121

814

Normotensive glaucoma

448

3567

1.29

5.75

3.4

3.1

205.21

224.65

ng/l

0.68

416

3282

Corneal scars and opacities

126

810

1.63

5.75

4.4

3.1

342.17

203.02

ng/l

1.02

118

740

Ulcer of vagina/vulva

100

605

1.71

5.74

2.9

2.8

110.72

190.95

ng/l

2.83

552

Assault by sharp object

276

2.08

5.73

2.8

76.16

111.89

ng/l

1.07

232

Benign neoplasm: Cerebral meninges

411

3233

1.30

5.73

2.7

3.0

155.18

193.14

ng/l

2.02

376

2967

Acute and subacute iridocyclitis

733

6120

1.21

5.73

3.6

3.0

187.43

183.98

ng/l

0.06

678

5565

Monoamine oxidase A inhibitors

435

3438

1.29

5.72

2.6

2.9

146.70

182.85

ng/l

1.38

397

3150

Multiple myeloma and malignant plasma cell neoplasms

242

1772

1.42

5.72

4.1

3.1

276.07

233.54

ng/l

0.67

224

1634

Viral agents as the cause of diseases classified to other chapters, including avohilmo

576

1.74

5.72

4.2

3.1

225.77

179.36

ng/l

0.34

524

Melanocytic naevi of trunk

442

3500

1.29

5.71

3.7

3.0

165.20

180.38

ng/l

0.49

407

3180

Carcinoma in situ of skin of upper limb, including shoulder

154

1044

1.57

5.71

3.0

3.2

264.14

255.42

ng/l

0.08

139

961

Malignant neoplasm of mesothelium and soft tissue

195

1376

1.47

5.68

2.4

3.2

199.49

227.90

ng/l

0.50

174

1268

Dislocation, sprain and strain of joint and ligaments of hip

177

1226

1.50

5.68

2.6

3.2

196.34

226.61

ng/l

0.43

168

1123

Contact with lifting and transmission devices, not elsewhere classified

414

1.88

5.68

3.0

3.1

169.87

174.68

ng/l

0.04

376

Ehlers-Danlos syndrome, including avohilmo

140

2.53

5.66

1.6

2.5

41.35

92.20

ng/l

2.29

123

Bulimia nervosa (incl. atypical)

338

1.93

5.66

3.0

2.8

61.31

75.51

ng/l

0.40

289

Use of rivastigmine

933

7966

1.19

5.65

3.2

3.4

186.21

278.14

ng/l

15.01

858

7352

Unspecified/other endometriosis

230

1622

1.41

5.65

2.4

2.8

93.70

154.41

ng/l

2.43

209

1476

Disorders of lacrimal system and orbit in diseases classified elsewhere

525

1.76

5.64

2.8

2.7

149.11

165.17

ng/l

0.20

485

Benign neoplasm: Rectum, anus and anal canal

935

7996

1.19

5.63

2.8

3.1

235.86

212.44

ng/l

0.80

855

7358

Sequelae of injuries of head

194

1366

1.46

5.59

2.9

2.8

171.53

184.40

ng/l

0.19

178

1237

Crossbite

183

1166

1.47

5.58

5.1

3.7

156.35

145.49

ng/l

0.11

163

1038

Nonsuppurative otitis media, including avohilmo

956

7050

1.18

5.58

3.0

2.9

141.73

156.75

ng/l

0.71

843

6325

Postzoster neuralgia

547

1.78

5.58

3.8

3.2

302.20

245.81

ng/l

0.43

513

Calcific tendinitis of shoulder

197

1390

1.45

5.58

3.6

2.8

108.76

171.66

ng/l

3.66

182

1254

Viral infections of the central nervous system, including avohilmo

269

1999

1.38

5.58

3.1

3.2

179.75

182.99

ng/l

0.03

242

1816

Recurrent dislocation of patella

109

675

1.64

5.57

2.0

2.8

69.87

112.65

ng/l

2.24

103

597

Other specified/unspecified necrotizing vasculopathies

360

1.95

5.56

3.2

3.4

239.80

233.10

ng/l

0.04

326

Inflammatory disorders of breast

171

1174

1.49

5.53

2.3

3.0

127.59

136.48

ng/l

0.11

148

1059

Nontraumatic intracranial haemmorrhage

960

8235

1.18

5.53

3.5

3.2

252.88

243.02

ng/l

0.28

868

7547

Other and unspecified rosacea

332

2548

1.33

5.52

3.2

2.9

149.96

177.19

ng/l

0.82

300

2322

Struck by thrown, projected or falling objec

181

1260

1.47

5.52

3.1

3.0

123.70

170.13

ng/l

2.02

160

1137

Thrombocytopenia, unspecified

305

2318

1.35

5.52

3.5

3.0

287.67

209.38

ng/l

2.15

284

2127

Viral agents as the cause of diseases classified to other chapters

499

1.78

5.51

4.4

3.2

241.20

181.66

ng/l

0.41

456

Other and unspecified iridocyclitis

177

1229

1.48

5.51

3.1

149.96

179.08

ng/l

0.83

163

1115

Malignant neoplasm of thyroid gland

250

1843

1.39

5.50

3.8

3.1

167.00

171.65

ng/l

0.07

228

1674

Recurrent dislocation and subluxation of joint

189

1324

1.45

5.49

2.3

2.9

102.97

138.26

ng/l

1.44

164

1179

Malignant neoplasm of tongue

602

1.72

5.48

1.9

3.4

244.47

218.15

ng/l

0.17

551

Diseases of external ear

1505

13320

1.14

5.47

3.3

3.0

195.25

202.65

ng/l

0.24

1360

12195

Injuries to the wrist and hand

4343

26728

1.08

5.47

3.1

2.9

172.86

192.09

ng/l

1.69

3934

24408

Psoriatic and enteropathic arthropathies

387

3031

1.30

5.46

3.0

2.8

189.07

162.40

ng/l

0.48

336

2759

Benign neoplasm: Transverse colon

508

4123

1.26

5.46

3.2

3.1

230.83

208.20

ng/l

0.62

464

3805

Other specified/unspecified spondylopathies

121

782

1.62

5.46

3.5

3.0

309.59

249.06

ng/l

0.32

108

718

Allergic conjunctivitis

2029

17549

1.12

5.45

2.6

2.8

149.74

162.24

ng/l

0.77

1781

15935

Haemangioma and lymphangioma, any site

335

2580

1.33

5.44

2.8

3.1

146.47

186.91

ng/l

1.32

306

2352

Mixed disorders of conduct and emotions, excluding more controls

167

2.32

5.43

1.9

3.0

23.97

86.28

ng/l

1.97

141

Pain and other conditions associated with female genital organs and menstrual cycle

540

3658

1.24

5.42

2.3

2.6

102.72

146.50

ng/l

2.92

462

3315

Habit and impulse disorders

234

2.13

5.41

2.1

2.7

70.22

108.94

ng/l

0.97

201

Cerebral palsy

248

2.10

5.40

3.0

2.8

135.51

131.55

ng/l

0.03

222

Other encephalitis

108

679

1.65

5.39

2.4

3.3

179.37

205.31

ng/l

0.21

100

619

Giant cell arteritis with polymyalgia rheumatica

188

1336

1.47

5.36

3.5

3.0

204.17

228.79

ng/l

0.37

171

1231

Lesion of radial nerve

151

1024

1.53

5.36

3.2

3.0

196.90

217.13

ng/l

0.22

137

940

Acute alcohol intoxication

1004

8658

1.17

5.34

3.2

3.0

232.10

212.28

ng/l

0.36

921

7892

Infection due to other mycobacteria

446

1.83

5.33

3.7

3.0

142.15

197.55

ng/l

1.41

405

Erythema intertrigo

116

746

1.63

5.33

4.1

3.1

221.03

217.54

ng/l

0.04

107

697

Haemangioma, any site

318

2440

1.33

5.33

2.8

3.1

149.82

188.89

ng/l

1.16

289

2222

Bell's palsy

449

3595

1.27

5.33

3.2

3.0

176.33

200.63

ng/l

0.73

402

3275

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

263

1967

1.37

5.33

2.8

3.0

176.31

192.53

ng/l

0.31

241

1802

Pedal cyclist injured in noncollision transport accidents

391

3078

1.29

5.32

3.0

2.9

163.45

168.03

ng/l

0.10

366

2766

Sub-endpoint used in defining T1D endpoints

1122

9593

1.16

5.32

3.7

3.2

321.41

222.73

ng/l

5.97

1046

8642

Contact with sharp object, undetermined intent

511

1.75

5.31

2.2

3.0

159.75

172.05

ng/l

0.11

459

Scar conditions and fibrosis of skin

137

910

1.55

5.31

3.4

2.9

134.28

159.17

ng/l

0.49

124

820

Other and unspecified corneal deformities and disorders

123

800

1.59

5.30

3.5

2.9

185.28

195.89

ng/l

0.06

115

728

Colorectal adenocarcinoma

1020

8713

1.17

5.28

2.8

3.3

232.55

244.10

ng/l

0.36

933

8039

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

247

1837

1.39

5.28

2.9

3.4

216.78

256.44

ng/l

0.93

231

1708

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

217

2.18

5.27

2.6

2.5

84.35

141.63

ng/l

0.81

199

Arnold-Chiari syndrome

109

2.70

5.27

2.8

3.3

99.74

126.83

ng/l

0.25

Late syphilis

330

1.96

5.27

3.4

3.2

347.88

178.28

ng/l

1.55

297

Other congenital malformations of nervous system

127

2.56

5.27

2.7

3.1

91.42

124.36

ng/l

0.37

116

Viral infections of the central nervous system

248

1838

1.38

5.26

3.1

3.2

184.00

185.08

ng/l

0.01

222

1673

Small fibre neuropathy

135

901

1.56

5.26

4.0

3.1

195.70

203.29

ng/l

0.07

121

829

Anuria and oliguria

180

2.37

5.25

5.8

4.7

290.79

243.33

ng/l

0.16

165

Generalized skin eruption due to drugs and medicaments

150

1020

1.52

5.25

4.2

3.1

162.87

214.67

ng/l

0.94

136

932

Injury of nerves and spinal cord at neck level

592

1.70

5.24

3.1

181.67

206.54

ng/l

0.26

541

Acne

209

1492

1.41

5.23

3.3

2.8

107.99

105.14

ng/l

0.05

179

1272

Contact with other and unspecified heat and hot substances

135

2.56

5.22

2.9

2.7

282.00

143.62

ng/l

0.45

113

Open bite

120

774

1.58

5.22

5.2

3.4

139.07

122.01

ng/l

0.14

109

678

Primary biliary cholangitis, wide definition

577

1.70

5.20

3.1

2.6

194.37

185.87

ng/l

0.09

522

Unspecified nephritic syndrome

578

1.70

5.19

3.4

3.2

293.81

212.14

ng/l

0.79

527

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1942

16733

1.12

5.17

2.5

2.8

149.49

162.69

ng/l

0.80

1703

15197

Unspecified jaundice

224

1644

1.40

5.16

3.2

2.9

315.49

234.61

ng/l

1.30

207

1503

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

497

1.77

5.15

2.1

3.3

124.51

205.65

ng/l

2.82

454

Tongue abnormality

255

1911

1.37

5.14

3.0

3.1

170.28

200.11

ng/l

0.67

232

1751

Spondylopathies in diseases classified elsewhere

356

1.92

5.13

2.8

3.1

133.89

233.97

ng/l

2.57

331

Thyroiditis, unspecified

325

1.94

5.12

3.2

2.9

145.12

159.99

ng/l

0.15

300

Spontaneous rupture of synovium and tendon

334

2597

1.31

5.10

3.4

2.9

159.84

206.17

ng/l

1.52

308

2370

Ménière disease

402

3203

1.28

5.09

3.2

3.1

197.30

212.10

ng/l

0.27

379

2937

Idiopathic thrombocytopenic purpura

125

826

1.57

5.07

3.3

3.5

195.76

211.08

ng/l

0.21

113

757

Congenital iodine-deficiency syndrome/hypothyroidism

127

843

1.57

5.07

3.5

3.0

211.83

228.34

ng/l

0.18

116

774

Viral meningitis, including avohilmo

107

679

1.62

5.07

3.9

2.9

180.57

139.96

ng/l

0.22

603

Portal vein thrombosis

400

1.84

5.06

3.1

3.2

206.81

194.94

ng/l

0.08

358

Crowding of teeth, including avohilmo

179

1037

1.45

5.06

3.4

3.7

109.34

121.34

ng/l

0.20

166

895

Anoxic brain damage

402

1.85

5.04

5.2

3.0

232.67

240.13

ng/l

0.06

365

Secondary polycythaemia

100

629

1.66

5.04

3.5

3.1

299.16

196.43

ng/l

1.50

570

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

299

2301

1.33

5.02

2.3

3.3

192.87

221.19

ng/l

0.77

268

2118

L02BB Anti-androgens

481

3923

1.26

5.02

3.0

3.3

230.04

274.77

ng/l

1.55

453

3646

Graves disease, strict definition

306

2352

1.32

5.02

3.3

2.9

141.72

155.37

ng/l

0.42

269

2126

All dysplastic lesions of the vulva

143

972

1.51

5.00

2.4

3.1

196.14

158.80

ng/l

0.42

128

877

Early lumbar disc prolapse operation

245

1822

1.36

4.99

2.5

2.8

73.40

85.87

ng/l

0.35

213

1581

Malignant neoplasm of liver and intrahepatic bile ducts

161

1127

1.49

4.99

3.2

3.3

225.76

262.71

ng/l

0.64

150

1054

Focal epilepsy, strict definition

796

6783

1.19

4.98

3.1

169.08

212.54

ng/l

3.25

731

6183

Hypoparathyroidism

159

1109

1.49

4.97

4.7

3.0

166.46

201.88

ng/l

1.01

148

1020

Posteruptive colour changes of dental hard tissues

3.36

4.97

3.4

2.1

49.32

113.96

ng/l

1.82

Graves ophthalmopathy, strict

461

1.76

4.96

2.9

3.0

155.71

168.15

ng/l

0.13

428

Pyoderma gangrenosum

164

2.35

4.95

2.5

3.2

331.42

164.96

ng/l

0.67

150

Other disorders of cornea

389

3095

1.28

4.95

3.1

3.0

214.65

192.80

ng/l

0.27

355

2825

Chronic tubulo-interstitial nephritis

146

1000

1.51

4.94

2.8

231.21

200.34

ng/l

0.38

133

903

Emotional disorders and disorders of social functioning with onset specific to childhood

506

1.69

4.94

3.7

3.4

63.07

119.02

ng/l

1.86

435

Femoral hernia

196

1421

1.43

4.92

3.9

3.0

203.73

218.06

ng/l

0.22

178

1315

Hypersomnia

258

2.03

4.91

2.2

3.1

114.65

165.28

ng/l

0.78

231

Encephalitis

112

727

1.60

4.91

2.4

3.2

176.05

205.28

ng/l

0.26

104

661

Type 1 diabetes, wide definition, subgroup 2

470

0.35

4.90

4.6

3.2

848.51

320.63

ng/l

1.51

434

Retinal detachment with retinal break

575

4778

1.23

4.89

3.0

3.1

204.31

205.08

ng/l

0.01

539

4381

Lower leg

133

2.51

4.89

2.5

2.7

124.54

166.99

ng/l

0.53

116

Intercostal neuropathy

199

2.23

4.88

4.0

3.2

96.17

227.97

ng/l

3.92

185

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

162

1138

1.47

4.85

3.0

207.17

205.37

ng/l

0.02

151

1041

Hypertrophy of breast

492

4016

1.24

4.85

2.1

2.7

72.83

129.12

ng/l

12.82

436

3674

L04AC Interleukin inhibitors

187

1341

1.42

4.85

2.3

2.8

119.04

141.59

ng/l

0.44

171

1196

Dermatophytosis, including avohilmo

2699

24268

1.10

4.84

2.8

2.9

183.52

187.51

ng/l

0.19

2451

22167

Graves ophthalmopathy

541

1.69

4.84

2.8

2.9

150.74

161.56

ng/l

0.13

499

Left hemicolectomy

112

734

1.60

4.84

4.1

3.2

242.98

246.62

ng/l

0.03

103

678

Polypectomy (DHB20)

259

1963

1.35

4.83

2.6

3.0

121.00

191.26

ng/l

5.07

238

1791

Foreign body in respiratory tract

183

1312

1.43

4.83

4.5

3.0

129.76

195.74

ng/l

2.23

161

1194

Other/unspecified enthesopathies, not elsewhere classified

324

2529

1.31

4.81

3.1

3.0

226.25

208.77

ng/l

0.23

287

2300

Endometriosis

1118

5660

1.16

4.80

2.7

2.8

116.60

197.92

ng/l

15.87

1015

5180

Pediculosis, acariasis and other infestations, including avohilmo

512

4200

1.23

4.80

2.9

176.13

150.79

ng/l

0.50

459

3761

IgA nephropathy (IgA glomerulonephritis)

535

1.69

4.79

3.0

504.63

170.28

ng/l

2.92

482

Seropositive rheumatoid arthritis, strict definition

589

4912

1.22

4.79

2.8

2.9

212.74

177.53

ng/l

1.16

539

4494

Mandibular retrognathia

163

1139

1.45

4.78

2.7

3.0

74.11

127.93

ng/l

3.15

150

1011

Dependent personality disorder

391

1.81

4.77

2.4

3.1

183.08

161.00

ng/l

0.15

360

Normal-pressure hydrocephalus

137

1967

0.67

4.77

2.5

3.2

164.47

258.43

ng/l

3.03

119

1810

Conjunctivitis

2934

21738

1.09

4.77

3.0

2.9

154.19

178.13

ng/l

2.77

2610

19805

Benign neoplasm of urinary organs

212

1566

1.40

4.76

3.0

3.1

191.32

210.04

ng/l

0.20

193

1440

Acne vulgaris

155

1073

1.46

4.75

3.6

2.8

87.93

85.66

ng/l

0.03

135

908

Other and unspecified glaucoma

358

2845

1.29

4.74

2.9

3.2

239.19

240.94

ng/l

0.03

327

2608

Rash and other nonspecific skin eruption

365

2898

1.28

4.73

2.7

3.1

217.96

200.69

ng/l

0.28

332

2645

Insulin, fast-acting (human)

442

3582

1.25

4.69

3.2

3.0

354.02

183.65

ng/l

4.69

409

3187

Propionic acid derivatives

1263

5582

1.15

4.69

3.2

3.5

211.02

297.12

ng/l

8.58

1152

5141

Dystonia

194

1413

1.41

4.67

2.6

3.1

138.62

187.30

ng/l

0.89

175

1274

Chronic Coagulation defects

438

1.75

4.67

3.0

3.2

173.81

144.20

ng/l

0.26

403

Benign neoplasm: Liver

492

1.71

4.66

2.0

3.0

128.13

170.18

ng/l

0.64

447

Convergent concomitant strabismus

161

1133

1.45

4.66

3.2

3.1

190.79

155.16

ng/l

0.29

139

1011

Benign neoplasm: Skin of eyelid, including canthus

670

5671

1.20

4.66

2.8

3.0

223.79

200.29

ng/l

0.33

617

5197

Unspecified chronic bronchitis

152

1063

1.48

4.66

3.8

3.0

168.11

255.25

ng/l

2.16

135

970

Fluid overload

3.18

4.65

5.2

3.7

184.62

210.02

ng/l

0.14

Other diseases of gallbladder

195

1426

1.41

4.65

2.8

3.0

208.12

215.03

ng/l

0.10

178

1303

Anti-inflammatory and antirheumatic products, non-steroids

1262

5582

1.15

4.64

3.1

3.5

222.69

297.12

ng/l

6.26

1142

5141

Malignant neoplasm of colon

765

6552

1.19

4.63

3.2

3.3

218.45

238.97

ng/l

0.74

701

6037

Gestational diabetes (for exclusion)

497

4167

0.82

4.63

2.1

2.3

64.05

81.66

ng/l

1.40

434

3708

Acute lymphadenitis

175

1253

1.43

4.61

3.0

2.9

205.30

171.82

ng/l

0.37

156

1127

Urethral stricture

267

2050

1.34

4.61

3.1

3.0

246.50

236.90

ng/l

0.11

244

1886

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

318

2499

1.31

4.61

3.2

3.4

206.41

242.67

ng/l

1.07

296

2315

Dermatographic urticaria

195

1422

1.40

4.60

3.0

2.8

122.54

160.35

ng/l

0.92

173

1276

Necrobiosis lipoidica, not elsewhere classified

2.95

4.59

3.7

2.3

161.25

111.68

ng/l

0.26

Burns and corrosions of external body surface, specified by site

362

2879

1.28

4.59

2.7

2.9

198.30

178.74

ng/l

0.34

326

2594

Kela-code for behavioural disturbances in mental retardation

204

2.17

4.59

2.1

3.6

82.69

193.40

ng/l

2.60

187

Paraplegia, diplegia of upper limbs

582

1.65

4.58

2.9

3.1

194.04

208.58

ng/l

0.12

542

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

3.57

4.54

10.6

2.5

174.63

131.96

ng/l

0.24

LSIL lesion of the vulva

573

1.64

4.54

2.3

2.9

192.97

150.87

ng/l

0.36

519

Immunodeficiency associated with other major defects

3.76

4.54

5.3

2.1

204.40

175.72

ng/l

0.12

Malignant neoplasm of urinary organs, including Hilmo

541

4508

1.22

4.53

3.1

3.3

311.81

240.54

ng/l

1.64

507

4146

Peptic ulcer

239

2.05

4.53

3.5

3.0

265.28

232.54

ng/l

0.13

220

Other congenital malformations of intestine, including avohilmo

246

2.02

4.51

3.3

3.1

278.36

170.65

ng/l

0.80

222

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

280

1.93

4.51

2.5

3.5

116.67

177.76

ng/l

0.85

257

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

556

1.64

4.51

3.2

3.9

92.99

158.28

ng/l

2.46

490

Psoriasis

1090

9583

1.15

4.49

3.0

199.96

181.64

ng/l

0.62

980

8723

Foreign body in ear

429

1.75

4.48

3.4

3.3

134.75

163.21

ng/l

0.49

387

Myelodysplastic syndrome, including Hilmo

161

1153

1.46

4.47

3.6

3.4

258.04

264.76

ng/l

0.08

142

1075

Senility

333

1.86

4.45

2.3

3.4

320.48

271.38

ng/l

0.33

306

Central retinal artery occlusion

119

807

1.55

4.43

3.4

3.3

279.46

254.92

ng/l

0.26

112

751

Juvenile arthritis (FINNGEN)

104

677

1.56

4.42

3.0

3.1

190.00

154.45

ng/l

0.38

599

Postpartum haemorrhage

344

3568

0.79

4.40

2.0

2.4

80.25

89.79

ng/l

0.30

306

3212

Pedestrian injured in collision with pedal cycle

116

779

1.54

4.39

3.0

3.1

185.86

206.21

ng/l

0.23

102

713

Infections with a predominantly sexual mode of transmission

785

6726

1.17

4.39

2.6

2.7

167.19

130.51

ng/l

1.35

681

6005

Open wound of thorax

320

1.86

4.38

2.3

3.2

280.35

176.55

ng/l

0.45

283

Use of ropinirole

157

1123

1.45

4.37

3.2

3.1

153.19

213.11

ng/l

2.10

147

1036

Other otitis externa (chronic)

250

1914

1.33

4.36

2.6

3.0

131.45

196.09

ng/l

4.48

230

1740

Herpesviral [herpes simplex] infections, including avohilmo

829

7162

1.17

4.35

3.1

2.8

143.91

159.57

ng/l

0.67

739

6503

Anorexia (incl.atypical)

139

964

1.46

4.33

2.3

3.3

186.27

164.16

ng/l

0.14

116

862

Pseudomembranous colitis

167

2.23

4.33

4.4

2.5

228.35

182.84

ng/l

0.23

150

Vasomotor rhinitis (mode)

267

2065

1.32

4.33

2.9

3.0

193.68

185.49

ng/l

0.11

248

1883

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

253

1949

1.34

4.32

3.5

3.4

211.33

259.91

ng/l

1.33

235

1806

Hypermobility syndrome

115

769

1.52

4.32

2.1

2.5

107.76

98.67

ng/l

0.07

678

Other vitreous opacities

174

1266

1.42

4.32

3.5

3.0

142.30

197.05

ng/l

1.32

168

1165

Injury of muscle and tendon at hip and thigh level

361

2895

1.27

4.31

3.0

2.9

158.53

166.60

ng/l

0.15

328

2619

Intestinal malabsorption

170

1230

1.42

4.31

3.5

3.0

239.52

192.28

ng/l

0.53

150

1120

Erythema multiforme

535

1.65

4.31

2.8

3.1

156.88

190.78

ng/l

0.42

489

Postmenopausal atrophic vaginitis

789

4996

0.85

4.31

2.5

2.9

142.02

206.07

ng/l

5.84

720

4601

Other degenerative diseases of the basal ganglia

635

1.62

4.30

3.3

128.27

222.63

ng/l

4.07

582

Viral meningitis

100

652

1.57

4.28

3.7

2.8

188.96

142.56

ng/l

0.24

580

Psoriatic arthropathies

334

2656

1.28

4.28

3.0

2.9

189.30

169.83

ng/l

0.30

291

2421

Combined immunodeficiencies

237

2.01

4.27

3.5

2.8

163.62

203.19

ng/l

0.39

218

UC patients in KELA-register (code 208), prior to 1994

161

1158

1.43

4.26

2.9

231.38

193.07

ng/l

0.40

144

1058

Other renal tubulo-interstitial diseases

520

1.65

4.26

2.7

2.8

295.19

169.66

ng/l

1.18

473

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1401

9201

1.13

4.25

2.7

2.5

134.13

129.42

ng/l

0.20

1271

8334

Bullous disorders

259

2005

1.33

4.25

4.2

3.1

184.72

222.50

ng/l

0.99

239

1846

Other specified disorders of kidney and ureter

129

893

1.49

4.24

4.3

3.2

280.05

219.68

ng/l

0.74

119

823

Other injuries of upper limb, level unspecified

273

1.92

4.23

2.2

2.8

293.55

180.87

ng/l

0.31

245

Atopic conjunctivitis

132

914

1.48

4.22

3.3

3.0

145.03

162.91

ng/l

0.24

117

831

Benign neoplasm: Skin of scalp and neck

649

1.58

4.22

2.9

3.2

248.00

208.67

ng/l

0.30

593

Benign neoplasm: Liver/bile ducts

577

1.61

4.20

2.1

3.1

122.36

168.68

ng/l

0.85

526

Synovial cyst of popliteal space [Baker]

293

2304

1.30

4.19

2.9

3.0

195.60

213.94

ng/l

0.33

266

2098

Idiopathic urticaria

376

1.75

4.17

2.7

3.0

162.54

153.53

ng/l

0.06

337

Use of rotigotine

283

1.92

4.17

2.2

3.4

136.84

199.58

ng/l

0.85

258

Crohn's disease of large intestine

149

1058

1.44

4.17

3.0

2.9

168.72

166.84

ng/l

0.02

134

950

248

3192

0.76

4.15

3.0

3.1

411.87

237.05

ng/l

1.27

228

2934

Compression of brain

6.59

4.14

2.9

1.8

114.90

273.84

ng/l

—

Campylobacter enteritis

102

676

1.56

4.14

3.1

230.96

200.91

ng/l

0.24

615

Bacterial, viral and other infectious agents, including avohilmo

286

2242

1.30

4.13

3.6

3.1

226.81

163.68

ng/l

1.31

252

2006

Other and unspecified epidermal thickening

103

685

1.56

4.12

3.7

3.0

184.49

197.91

ng/l

0.14

625

Gonococcal infection

643

1.57

4.11

2.3

3.2

247.98

146.92

ng/l

0.51

579

Cerebral aneurysm, nonruptured

323

2577

1.28

4.10

2.9

3.0

173.45

183.88

ng/l

0.21

298

2354

Burns and corrosions

456

3768

1.23

4.09

2.8

3.0

190.60

177.83

ng/l

0.25

406

3393

Acute appendicitis

2637

22604

1.09

4.08

2.9

167.62

182.30

ng/l

0.68

2358

20586

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

113

2.52

4.08

4.0

3.7

445.38

186.04

ng/l

1.11

102

Myeloproliferative diseases

358

2897

1.26

4.07

3.6

3.1

209.20

218.44

ng/l

0.17

334

2656

Other and unspecified disorders of vitreous body

1846

16452

1.11

4.04

2.9

147.29

189.55

ng/l

6.21

1692

15174

Autism spe, excluding more controls

224

1.95

4.03

2.8

3.0

69.14

94.15

ng/l

0.44

191

Benign neoplasm: Caecum

494

4134

1.22

4.03

3.5

3.1

234.41

210.46

ng/l

0.58

457

3817

Allergic rhinitis

852

7321

1.16

4.02

2.6

3.0

102.13

147.63

ng/l

5.74

746

6599

Superficial injury of forearm

332

2660

1.27

4.00

2.6

3.0

238.11

179.50

ng/l

0.52

290

2407

Clear cell adenocarcinoma of kidney

216

1648

1.35

4.00

2.9

3.1

260.01

211.20

ng/l

0.55

203

1522

Chronic drug-induced interstitial lung disorders

4.36

3.99

2.6

2.3

269.21

132.21

ng/l

0.49

Exophthalmic conditions

243

1.96

3.98

1.8

2.9

202.62

186.43

ng/l

0.09

225

Personal history of malignant neoplasm

268

2095

1.30

3.98

2.0

2.4

123.55

140.74

ng/l

0.53

232

1897

Other and unspecified aplastic anaemias

302

1.86

3.98

3.3

300.59

192.01

ng/l

0.55

273

Calculus of kidney and ureter

1273

11398

1.13

3.98

3.1

3.2

189.75

223.98

ng/l

2.16

1163

10468

Other diseases of biliary tract

391

3201

1.25

3.97

3.1

3.0

253.82

221.87

ng/l

0.60

370

2934

Nontoxic multinodular goitre

835

7286

1.16

3.97

2.7

2.9

172.85

195.93

ng/l

1.19

771

6717

Other and unspecified acne

192

2.05

3.97

3.3

2.9

132.60

91.17

ng/l

0.39

167

Maxillary prognathism

2.94

3.97

2.8

2.6

36.34

94.93

ng/l

1.62

Other complications of labour and delivery, not elsewhere classified

1256

0.66

3.96

1.9

2.2

44.67

69.27

ng/l

1.75

1105

Anomalies of dental arch relationship, including avohilmo

536

4069

1.20

3.96

3.3

2.9

104.89

143.98

ng/l

2.28

483

3631

Other congenital malformations of integument, including avohilmo

2.95

3.96

3.8

2.4

385.74

175.63

ng/l

1.40

Other and unspecified mononeuropathies of upper limb

106

715

1.53

3.96

3.8

2.9

156.68

197.21

ng/l

0.52

100

656

Polyarteritis nodosa and related conditions

324

1.81

3.95

4.0

3.4

226.78

203.82

ng/l

0.14

293

Emotional disorders starting during childhood or adolescence

506

1.61

3.94

3.9

3.6

80.54

125.15

ng/l

0.94

431

Macular hole

274

2163

1.30

3.93

3.1

188.94

208.92

ng/l

0.41

257

1998

Psoriasis vulgaris

689

5928

1.18

3.93

3.0

218.33

182.61

ng/l

1.08

620

5408

Synovial hypertrophy, not elsewhere classified

146

2.22

3.93

2.2

3.0

93.87

107.01

ng/l

0.16

135

Chronic mastoiditis

114

785

1.51

3.92

4.0

3.2

235.77

232.07

ng/l

0.03

104

723

Herpesviral keratitis and keratoconjunctivitis

167

1227

1.40

3.92

4.0

3.0

171.83

197.87

ng/l

0.50

150

1122

Ingrowing nail

178

1319

1.38

3.90

3.0

2.9

240.43

180.76

ng/l

0.92

164

1194

Diabetes insipidus

181

2.10

3.90

2.5

3.0

80.52

150.44

ng/l

1.60

163

Collagenous colitis

358

2908

1.25

3.89

3.5

3.0

198.88

192.48

ng/l

0.08

320

2658

Stenosis and insufficiency of lacrimal passages

381

3116

1.25

3.89

3.7

3.0

218.27

212.02

ng/l

0.09

353

2856

Maxillary retrognathism

250

1.90

3.89

2.1

3.2

51.98

88.62

ng/l

2.08

223

Postpartum haemorrhage due to anatomy

1216

0.64

3.89

3.0

2.1

129.44

57.47

ng/l

0.81

1065

Malignant neoplasm of other connective and soft tissue, including Hilmo

180

1342

1.38

3.89

2.5

3.2

216.92

218.79

ng/l

0.02

163

1235

Pregnancy, childbirth and the puerperium

975

5784

0.87

3.88

3.2

3.1

205.52

219.44

ng/l

0.48

899

5279

Postviral fatigue syndrome

2.57

3.88

1.7

2.4

205.63

93.42

ng/l

0.34

Follow-up care involving plastic surgery

798

0.55

3.88

2.0

2.5

99.87

170.20

ng/l

2.03

721

Chronic diseases of tonsils and adenoids

2850

16657

1.08

3.88

2.8

2.9

132.22

174.37

ng/l

8.87

2544

15173

Achalasia of cardia

496

1.64

3.88

3.2

3.1

210.54

232.44

ng/l

0.17

459

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

165

1184

1.39

3.88

3.0

3.8

116.61

147.23

ng/l

0.94

149

1048

Other juvenile arthritis

562

1.58

3.87

3.1

3.3

195.68

149.69

ng/l

0.43

505

Carcinoma in situ of vulva

189

2.08

3.86

2.3

3.4

150.22

204.32

ng/l

0.40

176

Chronic laryngitis and laryngotracheitis

538

4549

1.20

3.83

3.2

3.0

151.94

193.63

ng/l

1.88

490

4173

Melanocytic naevi of ear and external auricular canal

116

2.40

3.81

3.5

3.1

171.46

254.56

ng/l

0.64

105

Volvulus

124

872

1.47

3.81

3.0

3.1

207.27

220.50

ng/l

0.15

114

810

Diabetic neuropathy

542

4580

1.20

3.79

4.0

3.6

268.84

245.57

ng/l

0.44

504

4196

Atypical mycobacterium lung infection

345

1.78

3.79

4.0

3.2

178.79

182.50

ng/l

0.03

314

Abscess of lung

405

1.71

3.79

4.3

3.2

266.42

198.05

ng/l

0.46

365

Complications of genitourinary prosthetic devices, implants and grafts

658

1.54

3.78

2.9

3.1

166.60

198.14

ng/l

0.47

604

Other acquired deformities of musculoskeletal system and connective tissue

163

1200

1.39

3.78

3.1

3.0

118.00

188.86

ng/l

3.48

148

1097

Benign neoplasm of major salivary glands

396

3266

1.23

3.76

2.7

3.0

223.06

205.11

ng/l

0.35

351

2991

Alcohol abuse counselling and surveillance

314

0.31

3.75

9.5

3.1

152.80

154.21

ng/l

—

281

Cysts of oral region, not elsewhere classified

208

1589

1.34

3.75

3.2

3.0

227.18

190.83

ng/l

0.35

193

1452

Dislocation of lens

542

1.61

3.74

2.2

2.9

217.99

263.66

ng/l

0.55

499

Benign neoplasm: Rectum

810

7091

1.16

3.74

2.8

3.1

236.27

207.80

ng/l

0.93

744

6526

Persons with potential health hazards related to communicable diseases

1012

8876

1.14

3.73

3.3

2.9

203.98

143.16

ng/l

2.35

915

7940

Other melanin hyperpigmentation

102

695

1.53

3.73

4.2

3.2

173.76

213.56

ng/l

0.76

644

Hordeolum and other deep inflammation of eyelid

197

1493

1.34

3.73

3.1

3.0

170.20

178.35

ng/l

0.11

178

1354

Chorioretinal inflammation

105

717

1.51

3.73

4.4

3.0

116.32

201.43

ng/l

3.30

663

Gonococcal infection, including avohilmo

101

682

1.52

3.73

2.3

3.3

240.05

141.08

ng/l

0.52

613

Divergent concomitant strabismus

236

1833

1.31

3.72

2.9

3.0

114.69

179.21

ng/l

3.74

212

1654

Malignant neoplasm of rectosigmoid junction

551

1.60

3.71

2.9

3.3

242.49

264.11

ng/l

0.15

513

Hyperfunction of pituitary gland

132

938

1.43

3.71

3.1

3.0

143.67

164.10

ng/l

0.31

118

841

Hydrocephalus

217

2794

0.76

3.71

2.8

3.0

146.40

236.03

ng/l

5.20

194

2551

Bacterial, viral and other infectious agents

264

2081

1.29

3.70

3.7

3.1

235.99

162.93

ng/l

1.46

231

1867

Wide developmental disorders, excluding more controls

319

1.74

3.69

3.0

3.7

65.37

120.13

ng/l

1.53

276

Injury of eye and orbit

464

3882

1.21

3.69

2.8

3.0

162.29

172.04

ng/l

0.27

418

3484

Abnormal findings on examination of urine, without diagnosis

170

1267

1.38

3.67

3.4

3.2

250.65

212.66

ng/l

0.67

163

1159

Contusion of ankle

118

824

1.46

3.66

3.7

3.1

175.24

153.74

ng/l

0.22

109

747

Other, unspecified and serous retinal detachments

136

981

1.43

3.64

3.6

3.1

184.79

219.32

ng/l

0.55

126

915

Suppurative otitis media, unspecified

533

1.58

3.63

4.6

3.2

155.88

201.03

ng/l

0.65

489

Beningn neoplasm: Meninges, unspecified

418

1.68

3.63

2.6

3.4

178.18

223.56

ng/l

0.38

387

Other benign neoplasm of uterus: Other parts/unspecified

117

1635

0.69

3.63

2.4

3.2

208.94

243.91

ng/l

0.60

111

1493

Fracture of neck

268

2131

1.29

3.61

3.3

3.1

303.53

224.66

ng/l

0.45

245

1959

Chondropathies

492

4148

1.20

3.61

3.1

2.9

162.91

169.63

ng/l

0.16

444

3751

Outcome of delivery

179

1465

0.74

3.61

2.0

2.3

55.97

76.75

ng/l

1.27

146

1306

Congenital malformations of eye, ear, face and neck

170

1266

1.36

3.60

3.2

3.6

149.90

175.66

ng/l

0.46

153

1132

Other Crohn's disease

193

1465

1.34

3.60

2.5

2.9

156.49

160.81

ng/l

0.05

164

1318

Anorexia

280

1.82

3.59

2.9

260.08

161.61

ng/l

0.63

255

Open wound of hip and thigh

101

688

1.50

3.59

2.7

3.1

142.93

171.11

ng/l

0.65

608

Postpartum hemorraghe, parous women as controls

344

3528

0.81

3.59

2.0

2.3

80.25

82.88

ng/l

0.07

306

3163

Persistent delusional disorders

289

2317

1.27

3.58

3.3

3.2

187.68

200.80

ng/l

0.20

269

2099

Congenital deformities of feet, including avohilmo

105

721

1.49

3.57

2.7

3.0

182.64

157.64

ng/l

0.20

641

Duodenal ulcer

491

4155

1.20

3.54

3.7

3.0

290.85

245.16

ng/l

0.96

438

3832

Pemphigus

147

2.18

3.53

3.4

2.6

142.11

207.20

ng/l

0.72

133

Urolithiasis

1382

12518

1.11

3.53

3.0

3.1

194.19

226.64

ng/l

1.99

1263

11501

Other meningitis

335

1.74

3.51

2.4

3.4

166.37

187.28

ng/l

0.16

300

Injury of muscle and tendon at wrist and hand level

476

4016

1.20

3.50

3.1

3.0

188.42

179.81

ng/l

0.07

430

3628

Other disorders of iris and ciliary body

117

828

1.46

3.50

3.7

3.2

259.57

234.33

ng/l

0.29

110

766

Other keratitis

375

3094

1.23

3.50

2.9

3.0

205.29

172.64

ng/l

0.55

333

2803

Benign neoplasm: salivary glands, exclude unknown (D119)

345

2830

1.24

3.49

2.6

3.0

199.61

203.18

ng/l

0.06

305

2595

Foreign body or object entering through skin

195

1492

1.33

3.48

2.6

2.9

142.05

167.58

ng/l

0.46

177

1347

Pedal cyclist injured in other and unspecified transport accidents

386

3198

1.22

3.46

3.2

3.0

163.07

181.73

ng/l

0.45

355

2885

Onycholysis

121

2.27

3.45

2.8

2.6

269.78

108.52

ng/l

0.90

105

Exposure to smoke, fire and flames

606

1.53

3.45

3.4

3.1

263.75

208.29

ng/l

0.35

550

Fenamates

592

3452

1.18

3.45

2.7

3.3

183.47

273.83

ng/l

5.93

525

3204

Other and unspecified follicular disorders

137

996

1.41

3.44

3.5

2.9

239.13

180.01

ng/l

0.55

125

900

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

1155

8530

1.13

3.44

3.0

3.3

218.65

242.68

ng/l

1.10

1077

7873

Injury of muscle and tendon at ankle and foot level

533

1.56

3.43

2.3

3.2

121.45

151.56

ng/l

0.35

482

Superficial injury of neck

344

1.70

3.43

2.2

3.1

181.65

165.29

ng/l

0.12

303

Mental and behavioural disorders due to cannabinoids

335

1.70

3.43

3.6

3.1

95.79

100.63

ng/l

0.05

279

Malignant neoplasm of urinary organs

450

3795

1.21

3.42

3.1

3.3

324.33

237.97

ng/l

1.73

422

3498

Injury of nerves at wrist and hand level

121

862

1.44

3.42

2.8

3.0

134.24

166.40

ng/l

0.67

108

782

Benign neoplasm of mouth and pharynx

415

3471

1.21

3.42

3.0

209.03

197.87

ng/l

0.19

369

3185

Primary hyperparathyroidism

465

3933

1.20

3.41

2.9

3.0

153.30

193.18

ng/l

2.17

429

3598

Benign neoplasm: Parotid gland

312

2540

1.25

3.41

2.6

3.0

201.18

199.66

ng/l

0.02

278

2325

Certolizumab pegol

262

1.80

3.39

2.0

2.7

41.88

115.30

ng/l

5.11

234

Other and unspecified pemphigus

2.83

3.38

3.6

3.2

145.18

157.12

ng/l

0.08

Alcohol withdrawal state with delirium

258

2058

1.28

3.38

3.1

3.0

265.19

190.34

ng/l

1.20

231

1874

Acquired pure red cell aplasia [erythroblastopenia]

2.47

3.38

2.9

3.5

271.09

216.55

ng/l

0.17

Periodontal disease, other/unspecified

658

1.50

3.37

3.3

3.0

105.52

166.42

ng/l

2.86

591

Inflammatory disorders of male genital organs, not elsewhere classified

364

1.70

3.36

2.8

3.2

218.75

227.48

ng/l

0.07

322

Oral lichen planus

103

718

1.48

3.35

2.4

3.1

103.84

188.72

ng/l

1.92

658

Disorders of purine and pyrimidine metabolism

137

2.20

3.35

4.0

3.6

421.00

200.73

ng/l

0.97

125

Oral leukoplakia, including avohilmo

106

744

1.47

3.32

2.8

3.1

184.93

203.52

ng/l

0.24

683

Retinal haemorrhage

119

855

1.44

3.32

3.5

3.1

191.62

232.32

ng/l

1.02

109

798

Simple and mucopurulent chronic bronchitis

166

1254

1.36

3.31

3.3

211.48

268.75

ng/l

0.92

156

1146

LeFortI or BSSO operation

642

1.49

3.30

2.0

2.8

61.49

122.39

ng/l

4.09

560

N06DA Anticholinesterases

2001

14256

1.09

3.29

3.0

3.3

202.07

273.80

ng/l

13.39

1840

13192

Use of anticholinesterases

2001

14256

1.09

3.29

3.0

3.3

202.07

273.80

ng/l

13.39

1840

13192

Benign neoplasm of other and unspecified sites

125

905

1.42

3.29

3.4

3.1

130.35

199.28

ng/l

2.77

113

830

L01XX Other antineoplastic agents

265

2134

1.27

3.27

3.4

3.1

199.13

219.57

ng/l

0.42

249

1960

Pseudopolyposis of colon

3.21

3.26

5.2

2.4

90.80

166.35

ng/l

0.49

Acute suppurative otitis media

622

5014

1.16

3.25

3.2

2.8

161.51

134.93

ng/l

0.80

550

4399

Ankylosing spondylitis, ICD10

277

2235

1.26

3.24

2.8

2.9

145.72

172.90

ng/l

0.68

252

2017

Carcinoma in situ of other and unspecified digestive organs

189

1462

1.33

3.24

2.7

3.1

218.69

206.56

ng/l

0.15

177

1356

Colon adenocarcinoma

602

5223

1.17

3.24

3.1

3.3

236.62

238.44

ng/l

0.04

552

4820

Urethritis and urethral syndrome

517

1.56

3.24

3.4

3.2

105.68

191.27

ng/l

3.38

463

Melanocytic naevi of scalp and neck

533

1.55

3.23

3.0

3.1

218.71

176.70

ng/l

0.35

490

Diffuse brain injury

114

812

1.43

3.23

2.6

190.31

231.61

ng/l

0.53

737

Other infective otitis externa

218

1713

1.30

3.23

3.4

3.1

171.80

188.16

ng/l

0.32

190

1559

Malignant neoplasm of renal pelvis, including Hilmo

386

1.67

3.21

4.0

3.7

391.00

246.66

ng/l

0.93

361

Hypercalcemia

187

1448

1.33

3.18

3.7

3.1

225.29

222.44

ng/l

0.03

171

1341

Paranoid personality disorder

368

1.66

3.18

2.5

2.9

179.94

167.16

ng/l

0.09

327

Infective bursitis

112

801

1.44

3.18

3.7

3.1

180.72

212.83

ng/l

0.38

107

732

Maltreatment syndromes

114

813

1.42

3.17

2.5

2.8

138.52

114.88

ng/l

0.23

707

Other and unspecified psoriasis

250

2003

1.27

3.17

3.0

262.41

188.24

ng/l

1.12

217

1828

Chronic conjunctivitis

100

700

1.47

3.16

2.5

3.1

169.30

192.36

ng/l

0.32

643

Benign neoplasm: Ascending colon

633

5522

1.16

3.16

3.5

3.0

252.51

202.28

ng/l

1.79

582

5096

Medial epicondylitis

115

825

1.42

3.15

2.6

3.0

108.35

165.39

ng/l

2.04

103

749

Other bullous disorders

106

753

1.45

3.14

4.7

3.3

177.34

208.99

ng/l

0.35

697

Monoarthritis, not elsewhere classified

139

1030

1.38

3.14

2.7

3.0

199.68

195.59

ng/l

0.03

126

936

Disorders of iron metabolism

323

1.70

3.13

3.2

3.0

165.67

162.02

ng/l

0.03

293

Injuries involving multiple body regions

125

911

1.40

3.13

4.1

3.1

183.12

204.78

ng/l

0.18

110

821

Dementia due to Parkinsons disease, excluding more controls

115

831

1.43

3.13

2.9

2.8

198.43

287.41

ng/l

1.43

106

762

Other and unspecified degenerative diseases of nervous system

136

1012

1.39

3.11

2.8

3.2

152.87

263.11

ng/l

6.26

127

938

Benign neoplasm: Descending colon

305

2507

1.24

3.11

3.3

3.1

227.64

207.56

ng/l

0.41

285

2304

Preterm labour and delivery

654

5707

1.15

3.10

2.6

2.5

116.83

120.58

ng/l

0.10

588

5179

Tuberculosis, IBD comorbidity

315

2597

1.24

3.10

4.0

3.2

224.34

270.04

ng/l

1.22

292

2377

Spirochaetal infections, other/unspecified

224

2807

0.79

3.09

2.3

3.0

152.60

184.36

ng/l

0.83

198

2573

Autoimmune thyroiditis

347

1.66

3.09

3.4

2.8

99.45

140.74

ng/l

0.78

316

Non-Hodgkin lymphoma, all

212

1676

1.30

3.09

3.4

3.3

284.42

257.83

ng/l

0.40

199

1548

Whooping cough, including avohilmo

240

1.80

3.09

1.9

3.0

152.77

124.33

ng/l

0.24

219

Contact with and exposure to communicable diseases

540

6231

0.86

3.08

3.5

2.8

108.56

130.01

ng/l

1.11

493

5517

Rosacea

426

3605

1.20

3.07

3.1

2.8

135.48

168.26

ng/l

1.49

385

3289

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

223

1772

1.29

3.07

2.3

3.0

165.47

177.02

ng/l

0.15

203

1629

Marginal zone B-cell lymphoma, including Hilmo

486

1.57

3.06

2.5

3.5

290.41

238.09

ng/l

0.29

453

Syphilis, including avohilmo

614

1.49

3.06

3.0

332.04

184.68

ng/l

1.46

551

Syphilis

614

1.49

3.06

3.0

332.04

184.68

ng/l

1.46

551

Monosomies and deletions from the autosomes, not elsewhere classified

3.53

3.05

6.6

3.3

205.33

143.68

ng/l

0.28

Tibial collateral bursitis [Pellegrini-Stieda]

235

1.82

3.05

1.8

3.2

137.34

196.17

ng/l

0.68

213

Malignant neoplasm of other connective and soft tissue

111

801

1.43

3.05

2.6

3.4

237.49

220.13

ng/l

0.16

102

740

Presbyopia

240

1921

1.27

3.04

2.7

2.9

134.73

143.62

ng/l

0.13

215

1734

Oesophageal obstruction

156

1187

1.35

3.04

3.2

3.0

192.19

227.05

ng/l

0.59

145

1098

Mucosal proctocolitis

379

3179

1.20

3.01

3.2

2.9

163.01

164.70

ng/l

0.03

341

2854

Alcohol induced polyneuropathy

275

1.77

3.01

4.0

3.2

268.62

180.55

ng/l

0.53

249

Benign leiomyoma with endometriosis

437

5122

0.84

3.00

2.6

2.8

126.19

175.24

ng/l

4.00

406

4700

Ophthalmic devices associated with adverse incidents

3.33

3.00

2.5

2.3

64.08

205.58

ng/l

2.66

Long labour

354

3595

0.83

3.00

1.9

2.4

86.05

97.31

ng/l

0.28

307

3247

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

451

3853

1.19

3.00

3.0

3.3

311.32

233.36

ng/l

1.56

423

3548

Assault by unspecified means

334

1.66

2.99

4.0

2.8

131.63

104.62

ng/l

0.37

291

Exposure to excessive natural heat

3.10

2.98

4.5

3.6

150.08

204.74

ng/l

0.47

Poor fetal growth

198

1548

1.29

2.97

2.2

2.3

103.22

75.05

ng/l

0.51

173

1371

Pleural plaque with presence of asbestos

357

2998

1.22

2.97

4.3

3.2

209.31

269.99

ng/l

2.61

336

2788

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

140

1048

1.36

2.96

2.3

2.9

118.01

179.71

ng/l

1.89

124

939

Contact with heat and hot substances

171

1318

1.32

2.96

2.8

3.2

239.76

191.77

ng/l

0.56

150

1197

Motor neuron disease (with DMD)

537

1.52

2.96

3.2

2.8

157.62

236.14

ng/l

1.38

487

Sacroiliitis, not elsewhere classified

106

757

1.42

2.95

3.1

2.8

158.76

150.67

ng/l

0.08

669

Other facial nerve disorders

685

1.45

2.95

3.0

134.86

207.39

ng/l

1.82

629

Other and unspecified injuries of wrist and hand

116

844

1.40

2.94

2.9

136.85

174.34

ng/l

0.78

101

769

Other lesions of median nerve

120

883

1.40

2.94

3.6

3.0

211.45

248.27

ng/l

0.41

108

817

Entropion and trichiasis of eyelid

418

3558

1.20

2.94

3.6

3.3

286.47

253.70

ng/l

0.59

388

3279

Postmenopausal bleeding

1084

5107

1.12

2.93

2.9

176.44

219.12

ng/l

2.97

969

4696

Scabies

137

1024

1.36

2.93

3.8

2.9

161.63

156.07

ng/l

0.06

125

929

Hyperprolactinaemia

560

1.49

2.93

3.0

2.9

114.49

125.15

ng/l

0.12

497

Other salmonella infections

126

932

1.38

2.92

2.6

2.8

358.68

197.47

ng/l

0.61

118

850

Other bursitis, not elsewhere classified

224

1.82

2.91

3.0

3.2

347.56

196.28

ng/l

0.86

201

Aneurysms, operations, SAH

652

5731

1.15

2.90

3.1

3.0

223.23

200.40

ng/l

0.68

587

5256

Primary open-angle glaucoma

1627

14437

1.09

2.90

3.4

3.2

215.52

245.30

ng/l

2.06

1506

13340

Acute alcohol intoxication ICD-9

132

987

1.37

2.89

4.1

3.0

226.32

214.97

ng/l

0.10

125

906

Injury of nerves at shoulder and upper arm level

248

1.77

2.85

3.4

3.1

184.81

190.63

ng/l

0.04

221

Use of biperiden

176

1371

1.31

2.85

3.4

3.0

120.79

187.22

ng/l

2.51

155

1250

Malignant neoplasm of kidney, except renal pelvis

401

3410

1.20

2.84

2.9

3.3

309.78

228.49

ng/l

1.45

378

3148

Scabies, including avohilmo

390

3296

1.19

2.84

2.8

2.9

190.72

141.21

ng/l

0.87

342

2935

Mixed disorders of conduct and emotions

216

1.79

2.83

1.9

3.5

23.97

103.99

ng/l

2.89

177

Intermittent heterotropia

152

1157

1.33

2.82

4.7

3.4

149.73

175.02

ng/l

0.35

137

1042

Use of levodopa decarboxylase inhibitor

674

5959

1.15

2.82

3.4

3.2

194.43

244.31

ng/l

2.97

621

5519

Nontoxic goitre/thyroid nodule

1217

11098

1.11

2.81

2.9

3.0

179.57

193.68

ng/l

0.71

1124

10193

Parapsoriasis

437

1.56

2.81

2.8

2.9

185.32

161.79

ng/l

0.19

401

Impacted cerumen

378

4450

0.84

2.80

3.4

3.1

191.54

219.20

ng/l

0.68

344

4088

Congenital malformations of the nervous system

348

1.62

2.80

2.7

3.7

79.53

145.84

ng/l

1.71

317

Other congenital malformations of skin, including avohilmo

237

1914

1.25

2.80

2.7

3.1

147.38

172.14

ng/l

0.54

207

1727

Deep bite

300

2174

1.22

2.80

3.5

3.2

121.15

154.93

ng/l

1.14

273

1939

Benign neoplasm: Mediastinum

2.54

2.79

2.8

2.6

183.59

172.85

ng/l

0.04

Cerebral atherosclerosis

447

1.56

2.78

3.9

3.4

213.91

279.49

ng/l

0.67

416

IBD patients in KELA-register

704

6230

1.14

2.77

3.0

2.9

172.50

162.15

ng/l

0.24

634

5615

Crohn's disease of small intestine

195

1542

1.28

2.77

2.9

2.8

161.46

159.58

ng/l

0.02

170

1391

Suppurative and unspecified otitis media

1013

8094

1.11

2.76

3.5

2.9

161.41

156.33

ng/l

0.15

905

7216

Inguinal hernia, bilateral

457

3940

1.18

2.73

3.1

255.52

225.49

ng/l

0.33

425

3635

Lens-induced iridocyclitis

3.28

2.73

4.4

1.9

718.42

199.11

ng/l

0.39

Hyperkinetic disorders (excl. ADHD)

238

1.73

2.73

2.9

3.8

152.06

131.00

ng/l

0.11

207

Disturbances of smell and taste

139

1056

1.34

2.72

2.3

2.9

114.70

191.48

ng/l

4.07

127

950

Exclusion endpoint for supernumerary teeth

154

1.94

2.72

3.0

3.1

67.21

107.41

ng/l

1.02

143

Vulvovaginal ulceration/inflammation in other diseases

158

1218

1.31

2.71

2.3

2.8

102.74

128.26

ng/l

0.66

136

1091

Benign neoplasm: Larynx

124

929

1.37

2.71

3.3

3.2

386.80

224.18

ng/l

0.43

112

848

Abscess of mediastinum

3.10

2.71

7.0

1.9

204.25

224.72

ng/l

0.08

Contact with machinery

410

3505

1.19

2.71

2.8

3.0

165.23

190.02

ng/l

0.72

377

3196

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

5.25

2.70

3.1

3.0

227.29

173.60

ng/l

—

malignant neoplasm of male genital organs

1312

7223

1.10

2.70

2.8

3.3

224.00

252.40

ng/l

1.22

1199

6644

Other obstetric trauma

722

0.62

2.70

2.1

2.4

71.73

68.04

ng/l

0.07

637

Malnutrition

624

1.46

2.69

6.3

3.9

238.03

239.15

ng/l

0.01

580

Abnormalities of forces of labour

129

1706

0.75

2.69

2.1

2.6

127.01

89.74

ng/l

0.48

112

1543

Inguinal or femoral hernia, bilateral

464

4011

1.17

2.69

3.1

254.59

227.24

ng/l

0.30

432

3701

Other condition

494

4283

1.17

2.68

3.4

3.0

190.46

181.32

ng/l

0.22

471

3873

Focal epilepsy, mode (most common among epilepsy diagnosis)

711

6315

1.14

2.68

3.1

3.2

168.67

212.04

ng/l

2.89

651

5750

Endometriosis ASRM stages 1,2

424

3629

1.18

2.68

2.4

2.6

82.04

122.55

ng/l

5.70

383

3293

Other deformities of toe(s)

120

895

1.37

2.67

2.7

3.1

188.10

191.55

ng/l

0.04

112

817

Parkinson's disease, strict definition

678

6022

1.14

2.65

3.2

204.27

242.30

ng/l

1.86

621

5572

Other and unspecified injuries of shoulder and upper arm

115

854

1.38

2.64

3.1

2.9

117.25

195.84

ng/l

2.06

107

781

Cystic kidney disease

107

786

1.39

2.64

2.7

3.1

485.91

175.94

ng/l

4.29

100

718

Mental and behavioural disorders due to use of other stimulants, including caffeine

353

1.58

2.63

2.6

2.9

140.37

101.03

ng/l

0.48

296

Other and unspecified haemorrhagic conditions

396

1.57

2.63

2.4

3.3

322.37

229.07

ng/l

0.69

370

Tooth agenesis EXCLUDE clefts and syndromes

481

1.49

2.63

4.4

3.1

140.44

128.32

ng/l

0.06

424

Essential (haemorrhagic) thrombocythaemia

156

1214

1.32

2.62

3.4

3.2

163.49

209.58

ng/l

1.70

149

1116

Covid-19 suspected case

622

5484

1.14

2.61

3.2

2.7

189.62

163.74

ng/l

0.83

554

4930

Carcinoma in situ of skin of eyelid, including canthus

2.60

2.61

2.6

2.4

271.88

271.98

ng/l

0.00

Ectopic pregnancy

437

3759

1.17

2.61

2.2

2.6

108.47

120.98

ng/l

0.44

394

3412

Muscle strain

103

752

1.40

2.61

4.1

3.2

147.35

181.09

ng/l

0.62

681

Pediculosis, acariasis and other infestations

182

1440

1.28

2.61

3.5

2.9

152.87

167.89

ng/l

0.26

167

1301

Contact with other hot fluids

634

1.43

2.60

2.2

3.5

222.13

175.03

ng/l

0.32

576

Leiomyosarcoma

203

1.83

2.60

2.0

4.1

154.31

239.72

ng/l

0.84

185

HSIL lesion of the vulva

414

1.55

2.57

2.6

3.1

181.96

195.63

ng/l

0.08

389

Frostbite

202

1.80

2.57

3.6

3.1

165.33

175.00

ng/l

0.04

175

Autism

269

1.66

2.56

2.8

3.0

67.38

105.15

ng/l

0.75

220

Appendicitis, broad definition

2802

23707

1.06

2.54

2.9

169.12

183.76

ng/l

0.71

2504

21600

Other disorders of male genital organs

133

1015

1.34

2.54

3.1

192.70

219.04

ng/l

0.38

125

906

Malignant neoplasm of breast, HER2-negative, including Hilmo

1492

8810

1.09

2.54

2.6

2.8

155.08

163.92

ng/l

0.42

1376

8028

Malignant neoplasm of breast, HER2-negative

1474

8760

1.09

2.53

2.6

2.8

159.70

164.35

ng/l

0.18

1354

7983

Juvenile osteochondrosis

528

1.47

2.53

2.8

3.1

120.29

172.23

ng/l

1.11

466

Myasthenia gravis

449

1.52

2.53

3.5

3.3

140.98

193.56

ng/l

1.08

411

Conductive hearing loss, unspecified

291

2431

1.21

2.53

3.2

2.9

147.53

203.38

ng/l

3.07

263

2213

Respiratory and cardiovascular disorders specific to the perinatal period

290

1.60

2.52

4.8

6.7

175.65

199.71

ng/l

0.11

263

Benign neoplasm: Anus and anal canal

115

864

1.37

2.50

2.8

3.2

260.50

226.24

ng/l

0.34

101

800

Macular pucker

739

6623

1.13

2.50

2.8

3.0

212.11

208.66

ng/l

0.08

679

6127

Leiomyosarcoma, including Hilmo

259

1.71

2.50

2.3

3.8

165.64

238.61

ng/l

0.88

239

Malignant neoplasm of breast, including Hilmo

1491

8810

1.09

2.49

2.6

2.8

155.18

163.92

ng/l

0.41

1375

8028

Malignant neoplasm of breast

1474

8765

1.09

2.49

2.6

2.8

159.86

164.28

ng/l

0.17

1354

7987

Inflammatory bowel disease, strict (require KELA)

704

6280

1.13

2.48

3.0

2.9

172.50

162.61

ng/l

0.23

634

5652

Autoimmune polyglandular failure

5.49

2.47

2.3

2.4

191.67

143.58

ng/l

—

Oral lichen planus, including avohilmo , including avohilmo

243

2001

1.23

2.47

2.1

2.9

96.24

167.20

ng/l

4.44

218

1826

Congenital malformations of genital organs

198

1580

1.26

2.47

3.1

3.2

154.75

128.83

ng/l

0.35

177

1396

Persons encountering health services in circumstances related to reproduction

1798

11201

1.08

2.46

3.3

2.8

120.88

138.01

ng/l

1.38

1628

10059

Other bacterial agents as the cause of diseases classified to other chapters

236

1.72

2.46

4.1

4.3

284.12

229.44

ng/l

0.39

217

Fall on and from ladder

303

2552

1.21

2.46

3.3

3.1

197.99

204.87

ng/l

0.11

280

2345

Postpartum hemorraghe, all women as controls

344

3947

0.85

2.45

2.0

2.4

80.25

89.26

ng/l

0.27

306

3527

Other endophthalmitis

133

2.00

2.44

3.1

2.9

206.88

226.22

ng/l

0.07

117

Undefined dementia

505

5304

0.87

2.43

3.3

3.5

324.96

318.26

ng/l

0.06

458

4838

Benign neoplasm: Lip

595

1.44

2.43

3.3

3.2

122.22

214.16

ng/l

3.97

547

Glycogen storage disease

5.64

2.42

2.2

4.7

323.17

101.08

ng/l

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

452

1.50

2.42

2.5

3.1

181.04

178.64

ng/l

0.01

407

Spermatocele

317

2684

1.20

2.42

3.4

3.1

172.83

265.14

ng/l

5.17

298

2466

Arthropathy in Crohn disease

176

1.83

2.42

3.0

3.7

92.90

100.90

ng/l

0.11

162

Episcleritis

151

1180

1.30

2.42

2.8

3.0

133.46

156.89

ng/l

0.36

137

1066

Pleural plaque without asbestos

184

1482

1.28

2.41

3.6

3.2

185.26

267.64

ng/l

2.90

173

1371

Fibrothorax

2.86

2.41

4.1

3.4

121.18

221.99

ng/l

0.65

Chronic suppurative otitis media

229

1879

1.24

2.41

4.3

3.2

189.90

215.08

ng/l

0.52

205

1712

Ankylosing spondylitis, strict definition

109

814

1.36

2.40

2.5

2.9

98.13

140.02

ng/l

1.23

720

Myeloproliferative diseases (CML excluded)

311

2633

1.20

2.39

3.4

3.1

214.03

220.84

ng/l

0.11

288

2410

Unspecified transport accident

2.30

2.39

2.9

3.4

84.88

158.41

ng/l

0.76

Melanocytic naevi of other and unspecified parts of face

187

1503

1.26

2.39

2.8

2.9

100.12

181.30

ng/l

7.56

169

1364

Glaucoma secondary to other eye disorders

167

1328

1.29

2.38

3.2

3.3

308.09

240.54

ng/l

0.81

154

1221

Blepharospasm

239

1.71

2.38

2.3

3.3

110.91

219.69

ng/l

2.79

221

Other disorders of optic disc

269

1.65

2.37

4.2

3.5

153.20

164.98

ng/l

0.07

245

Benign neoplasm: Connective and other soft tissue of head, face and neck

406

1.53

2.37

2.8

3.1

151.00

192.94

ng/l

0.36

370

Benign neoplasm: Skin of lower limb, including hip

716

1.39

2.36

4.4

3.1

172.53

201.60

ng/l

0.41

658

Anogenital herpesviral [herpes simplex] infection

135

1041

1.31

2.36

2.4

2.9

101.71

122.22

ng/l

0.62

119

918

Atopic dermatitis, strict definition with reimbursement

768

6628

1.12

2.35

2.8

139.48

135.31

ng/l

0.10

685

5924

Toxic effect of ethanol

105

783

1.36

2.35

2.7

2.8

167.79

163.74

ng/l

0.05

696

Sequelae of other and unspecified effects of external causes

106

2.08

2.34

4.9

3.2

130.94

196.35

ng/l

0.64

Diseases of appendix

2823

23872

1.06

2.34

2.9

168.79

184.29

ng/l

0.78

2522

21758

Neovascular glaucoma

166

1323

1.28

2.33

3.2

307.55

235.81

ng/l

0.87

153

1216

Toxic effects of substances chiefly nonmedicinal as to source

353

3020

1.18

2.33

3.1

3.0

172.05

178.24

ng/l

0.10

314

2711

Parkinson's disease, including avohilmo

748

6738

1.12

2.33

3.1

3.2

202.57

242.42

ng/l

2.24

688

6230

malignant neoplasm of male genital organs, including Hilmo

1324

7328

1.09

2.33

2.8

3.3

216.21

250.90

ng/l

1.89

1214

6736

Schizoid personality disorder

350

1.56

2.33

2.1

3.1

141.15

146.68

ng/l

0.04

311

Endometriosis of pelvic peritoneum

413

3245

1.17

2.33

2.4

2.7

78.90

147.74

ng/l

12.99

374

2972

Ulcerative enterocolitis

657

1.40

2.32

2.8

3.0

163.79

169.62

ng/l

0.04

591

Premenstrual syndrome

170

1.80

2.32

2.4

3.2

101.63

84.96

ng/l

0.29

146

Other bursitis of knee

351

1.56

2.32

4.7

3.3

222.52

206.27

ng/l

0.10

320

Malignant neoplasm of corpus uteri

274

3250

0.83

2.32

2.7

3.2

182.35

204.67

ng/l

0.53

250

2976

Circumscribed brain atrophy

721

1.39

2.32

2.8

3.2

120.98

259.90

ng/l

7.45

663

Benign neoplasm: Spinal cord

327

1.58

2.32

3.0

146.09

168.04

ng/l

0.22

296

Other abnormal findings of blood chemistry

165

1314

1.28

2.31

3.2

3.0

262.68

190.96

ng/l

1.13

157

1202

Malignant neoplasm of anus and anal canal, including Hilmo

369

1.55

2.31

2.5

3.4

135.24

227.86

ng/l

2.62

344

Upper arm

2.92

2.30

6.5

2.1

217.23

119.42

ng/l

0.51

Drug-induced myopathy

2.44

2.30

2.8

3.0

203.13

162.75

ng/l

0.24

Acute hepatitis B

2.32

2.29

2.4

2.7

167.63

86.80

ng/l

0.50

Papilloedema, unspecified

449

1.48

2.29

2.4

3.3

103.98

169.75

ng/l

1.96

410

Cystic kidney disease, including avohilmo

114

867

1.34

2.28

2.9

3.2

467.87

182.14

ng/l

4.10

106

794

Contact with other hot metals

344

1.56

2.28

3.6

3.2

218.48

167.83

ng/l

0.59

309

Erythema nodosum

729

1.38

2.28

2.9

3.0

208.84

185.16

ng/l

0.18

670

Tuberculosis, wide, including avohilmo

323

2757

1.19

2.27

3.9

3.2

221.71

274.02

ng/l

1.56

300

2527

Atopic dermatitis, strict definition

723

6345

1.12

2.27

2.7

2.9

137.19

134.08

ng/l

0.07

643

5682

Myelodysplastic syndrome

479

1.48

2.27

3.0

3.6

261.23

268.84

ng/l

0.05

444

Failure of sterile precautions during surgical operation

2.35

2.27

3.4

2.7

230.87

204.84

ng/l

0.12

Autoimmune hepatitis

211

1.73

2.26

3.3

2.4

115.43

172.29

ng/l

1.02

199

Pilonidal cyst

208

1699

1.24

2.26

2.5

2.7

157.13

126.21

ng/l

0.50

184

1491

Scleritis and episcleritis

178

1432

1.26

2.26

2.7

3.0

131.50

156.52

ng/l

0.46

162

1293

Other and unspecified mononeuropathies of lower limb

101

757

1.37

2.25

3.1

3.0

132.98

200.46

ng/l

2.00

701

Enteropathic arthropathies

459

1.47

2.25

3.3

2.9

155.17

163.22

ng/l

0.05

416

Foreign body in alimentary tract

191

1552

1.25

2.25

3.4

3.2

188.72

209.83

ng/l

0.32

172

1424

Appendectomy

2319

20795

1.06

2.25

2.9

2.8

164.55

172.41

ng/l

0.28

2078

18909

Labour and delivery complicated by fetal stress [distress]

284

2196

0.84

2.24

2.1

2.2

81.82

67.54

ng/l

0.28

250

1957

Intestinal helminthiases, other/unspecified, including avohilmo

2.41

2.23

2.9

2.3

530.40

137.70

ng/l

0.65

Antepartum haemorrhage, not elsewhere classified

145

1137

1.29

2.23

1.9

2.4

42.26

82.17

ng/l

4.98

130

1018

Schizotypal disorder

377

1.52

2.23

2.0

2.9

215.78

138.25

ng/l

0.48

332

Alcoholic gastritis

371

1.53

2.23

3.5

3.2

211.58

200.96

ng/l

0.06

341

297

1.57

2.23

5.7

6.8

190.67

207.37

ng/l

0.08

271

Mental and behavioural disorders due to tobacco

283

2389

1.20

2.23

3.0

292.10

169.15

ng/l

0.81

248

2172

Disorders of optic nerve, not elsewhere classified

614

1.41

2.23

3.6

3.3

249.72

216.85

ng/l

0.21

568

Varicella [chickenpox]

122

939

1.32

2.22

3.6

3.0

198.92

136.53

ng/l

1.01

108

838

Smoking dependency

283

2391

1.20

2.21

3.0

292.10

169.06

ng/l

0.81

248

2167

Deficiency of other B group vitamins

597

1.41

2.21

2.5

3.2

263.84

248.33

ng/l

0.08

549

Alzheimer’s disease (Early onset)

138

1743

0.78

2.18

2.6

3.4

213.40

316.81

ng/l

2.68

121

1581

Subacute thyroiditis

109

829

1.34

2.18

2.2

2.7

100.21

169.20

ng/l

1.69

101

747

Patellar tendinitis

259

1.62

2.17

1.8

2.8

81.97

170.32

ng/l

1.92

225

Tuberculosis, wide

318

2724

1.19

2.16

3.9

3.2

223.97

274.36

ng/l

1.44

295

2498

Congenital vesicoureteral reflux

2.44

2.16

2.5

2.7

110.62

116.16

ng/l

0.03

Blood alcohol or alcohol intoxication level

438

1.47

2.16

5.3

2.8

196.35

152.09

ng/l

0.51

393

Carcinoma in situ of skin of lower limb, including hip

113

872

1.34

2.15

2.8

3.3

255.24

239.95

ng/l

0.11

106

809

Colon adenocarcinoma, helper endpoint

602

5387

1.13

2.15

3.1

236.62

236.04

ng/l

0.01

552

4981

Fatigue fracture of vertebra

132

1.93

2.15

3.6

3.7

322.04

271.38

ng/l

0.17

125

Malignant neoplasm of prostate

1290

7057

1.09

2.15

2.8

3.3

227.68

256.09

ng/l

1.19

1176

6511

Third [oculomotor] nerve palsy

525

1.44

2.14

3.9

3.3

237.71

238.08

ng/l

0.00

485

Residual foreign body in soft tissue

154

1228

1.27

2.13

3.4

2.9

134.96

182.92

ng/l

1.14

140

1118

Other surgical follow-up care

102

771

1.35

2.13

2.8

2.6

260.92

182.07

ng/l

0.46

695

Pyoderma

474

1.45

2.13

2.7

3.5

185.28

191.91

ng/l

0.05

439

Other obstructive and reflux uropathy

130

1016

1.30

2.13

2.9

2.8

274.41

183.94

ng/l

1.09

110

911

Other abnormal auditory perceptions

230

1.66

2.12

3.0

3.4

67.09

204.72

ng/l

4.72

215

Non-small cell lung cancer, adenocarcinoma

278

2360

1.20

2.12

2.7

3.3

212.55

237.29

ng/l

0.39

254

2188

Oligomenorrhoea

616

1.38

2.11

2.7

2.9

114.31

156.84

ng/l

0.89

557

Autism spe

276

1.58

2.11

2.8

3.8

69.14

100.64

ng/l

0.66

231

Supervision of normal pregnancy

285

1923

0.84

2.11

2.2

2.3

56.27

81.05

ng/l

2.29

262

1707

Other orthopaedic follow-up care

180

1464

1.25

2.10

2.4

2.6

262.36

184.49

ng/l

0.87

165

1318

Other benign neoplasms of uterus

163

2007

0.80

2.10

2.4

3.3

179.58

222.97

ng/l

1.18

153

1836

Multifocal fibrosclerosis

163

1.82

2.10

2.9

3.1

177.51

285.97

ng/l

0.87

147

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

279

2369

1.19

2.10

2.8

3.0

148.38

179.59

ng/l

0.76

243

2162

Respiratory tuberculosis, confirmed

527

1.43

2.09

3.9

3.4

258.00

250.57

ng/l

0.05

482

Peritonsillar abscess

579

5167

1.13

2.08

2.5

2.9

139.65

164.90

ng/l

1.07

513

4682

Other and unspecified nail disorders

552

1.41

2.08

4.1

3.2

169.78

168.78

ng/l

0.01

500

Persons encountering health services in other circumstances

1324

14100

0.92

2.07

2.9

222.66

186.41

ng/l

1.53

1174

12934

Respiratory tuberculosis, confirmed, including avohilmo

545

1.42

2.07

3.8

3.3

251.32

246.47

ng/l

0.03

499

Respiratory tuberculosis

227

1898

1.22

2.06

4.1

3.2

226.89

272.65

ng/l

1.11

209

1754

Respiratory tuberculosis, confirmed and not-confirmed

227

1898

1.22

2.06

4.1

3.2

226.89

272.65

ng/l

1.11

209

1754

Alcohol-induced acute pancreatitis

122

952

1.31

2.06

3.0

2.9

267.90

181.53

ng/l

1.02

111

866

Amblyopia ex anopsia

118

915

1.31

2.06

3.3

3.4

164.87

192.94

ng/l

0.35

106

832

Other and unspecified localized connective tissue disorders

2.44

2.06

2.0

131.54

149.87

ng/l

0.09

Sclerosis of liver

5.52

2.06

9.6

1.6

207.00

118.45

ng/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

449

3958

1.15

2.06

2.4

3.2

226.16

234.83

ng/l

0.15

408

3655

Meningitis

152

1218

1.27

2.04

2.9

3.0

162.12

192.79

ng/l

0.49

131

1111

Allergic purpura

682

1.36

2.04

3.5

3.0

247.74

188.03

ng/l

0.78

623

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

297

1.57

2.04

3.7

4.0

255.72

209.34

ng/l

0.39

273

Adenocarcinoma and papilloma adenocarcinoma of rectum

431

3793

1.15

2.03

2.4

3.2

224.65

231.97

ng/l

0.12

392

3497

Assault by other and unspecified firearm discharge

3.62

2.03

9.0

2.0

115.14

113.63

ng/l

—

Bullous pemphigoid

105

809

1.34

2.03

4.1

3.4

225.00

253.87

ng/l

0.35

749

Pollen allergy

399

3436

1.15

2.00

2.6

3.1

93.89

129.57

ng/l

2.32

345

3052

Hypertrophy of tongue papillae

315

1.54

1.99

3.0

3.6

125.41

199.32

ng/l

1.41

287

Acute hepatitis B, including avohilmo

2.16

1.98

2.4

2.6

167.63

82.36

ng/l

0.54

Occlusion and stenosis of arteries, not leading to stroke

415

1.47

1.98

3.8

3.5

262.56

281.67

ng/l

0.09

380

Lichen sclerosus et atrophicus

411

3610

1.15

1.98

2.8

2.9

146.61

166.96

ng/l

0.86

370

3289

Right side

142

0.33

1.98

2.2

3.0

46.80

211.68

ng/l

—

127

Keratoconus

506

1.41

1.97

2.6

2.9

261.99

155.42

ng/l

0.39

455

Biliary cirrhosis, NAS

2.20

1.97

4.0

3.1

258.75

237.64

ng/l

0.09

Other and unspecified mononeuropathies, also in other diseases

108

836

1.32

1.97

3.0

3.1

167.04

223.46

ng/l

0.91

103

779

Burn and corrosion of head and neck

456

1.44

1.96

2.1

2.9

122.74

157.27

ng/l

0.31

409

Varicella [chickenpox], including avohilmo

136

1080

1.27

1.96

3.5

3.1

212.25

144.09

ng/l

1.05

122

963

Benign neoplasm: Floor of mouth

2.29

1.96

2.6

2.3

148.69

254.99

ng/l

0.77

Tuberculosis

268

2286

1.19

1.96

4.3

3.2

234.24

284.27

ng/l

1.42

246

2100

Bicipital tendinitis

158

1281

1.25

1.94

2.8

2.9

167.00

180.13

ng/l

0.16

142

1163

Benign neoplasm: Skin of other and unspecified parts of face

424

3740

1.15

1.94

3.3

3.1

208.02

218.58

ng/l

0.17

388

3425

Benign neoplasm of ovary

613

5523

1.12

1.93

2.8

2.9

163.08

174.39

ng/l

0.37

559

5063

Primary open-angle glaucoma, strict

1308

12161

1.08

1.93

3.4

3.1

211.47

242.49

ng/l

2.28

1208

11247

Separation of retinal layers (serosa)

139

1112

1.27

1.93

3.3

2.9

197.93

177.17

ng/l

0.20

123

1024

Malignant neoplasm of corpus uteri, including Hilmo

302

3494

0.85

1.93

2.7

3.2

179.50

203.32

ng/l

0.63

274

3204

Other and unspecified types of non-Hodgkin lymphoma, hilmo

169

1385

1.25

1.92

3.4

3.2

317.68

229.95

ng/l

1.26

158

1277

Polycystic ovarian syndrome, broad definition

162

1313

1.24

1.92

2.3

2.2

62.90

70.75

ng/l

0.30

146

1151

Other specific arthropathies, wide

475

1.42

1.92

2.6

2.9

166.41

190.69

ng/l

0.18

437

Melanocytic naevi of lower limb, including hip

136

1086

1.27

1.91

3.0

124.32

166.90

ng/l

1.75

129

994

Parkinson's disease

711

6466

1.11

1.91

3.2

204.37

240.83

ng/l

1.81

651

5980

Burns and corrosions confined to eye and internal organs

543

1.39

1.91

3.2

3.0

118.19

152.90

ng/l

0.64

486

275

1.54

1.91

6.0

7.2

203.14

220.33

ng/l

0.07

252

Other predominantly sexually transmitted diseases, not elsewhere classified

368

3211

1.15

1.90

2.6

2.7

117.32

123.07

ng/l

0.15

316

2844

Major anomalies of jaw size

511

1.40

1.87

2.8

3.1

111.81

131.28

ng/l

0.37

468

Noninflammatory disorders of female genital tract

1263

5879

1.08

1.86

2.9

2.8

153.00

201.28

ng/l

4.57

1150

5370

Malignant neoplasm of rectum, including Hilmo

529

4743

1.13

1.86

2.5

3.2

222.65

236.17

ng/l

0.30

484

4370

Other articular cartilage disorders

599

1.37

1.85

2.4

2.8

102.60

196.41

ng/l

3.32

545

Injury of urinary and pelvic organs

522

1.39

1.85

3.2

3.3

283.55

204.58

ng/l

0.55

475

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

170

1394

1.23

1.84

2.3

2.7

67.71

103.74

ng/l

2.99

150

1243

Prolapse and hernia of ovary and fallopian tube

191

1579

1.23

1.84

3.6

3.4

246.03

293.75

ng/l

0.39

177

1438

Use of selegiline

126

1567

0.79

1.81

3.6

3.1

182.96

241.27

ng/l

0.96

116

1448

Other abnormal products of conception

606

3576

1.12

1.81

2.1

2.4

58.71

86.77

ng/l

3.21

530

3209

Female infertility, cervical, vaginal, other or unspecified origin

520

3718

0.89

1.81

2.2

2.6

104.32

144.83

ng/l

3.02

474

3401

Biological medicines for asthma

396

1.44

1.80

3.4

2.8

82.76

115.92

ng/l

0.47

356

Other salmonella infections, including avohilmo

134

1077

1.26

1.80

2.5

2.8

347.34

193.06

ng/l

0.61

124

977

Polyp of middle ear

2.92

1.80

2.5

2.3

96.75

140.68

ng/l

—

Dislocations, sprains and strains involving multiple body regions

3.20

1.79

3.4

2.7

73.00

161.79

ng/l

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

471

4200

1.13

1.79

3.2

3.0

183.01

166.49

ng/l

0.31

426

3770

Other congenital malformations of face and neck

533

1.37

1.77

2.8

3.0

164.60

161.55

ng/l

0.02

475

Tuberculosis of other organs

693

1.34

1.77

3.8

3.4

222.84

270.43

ng/l

0.44

646

Other acute skin changes due to ultraviolet radiation

123

983

1.28

1.77

4.0

3.1

179.10

213.11

ng/l

0.63

116

908

Malignant neoplasm of anus and anal canal

157

1.76

2.5

3.5

152.30

209.85

ng/l

0.57

141

Female infertility

569

3790

0.90

1.76

2.2

2.6

105.10

145.82

ng/l

2.84

519

3465

Testicular hypofunction

105

822

1.30

1.76

2.9

173.56

152.12

ng/l

0.18

724

Glaucoma, exfoliation

542

4888

1.12

1.76

3.8

3.3

237.09

258.75

ng/l

0.45

506

4487

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

164

1.72

1.76

1.7

3.6

121.62

174.93

ng/l

0.77

148

Bilateral sagittal split ramus osteotomy operation

525

1.37

1.75

2.0

2.7

67.10

112.16

ng/l

2.20

459

Respiratory tuberculosis, bacteriologically and histologically confirmed

545

1.37

1.75

3.9

3.4

258.00

248.51

ng/l

0.06

500

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

170

1404

1.22

1.74

2.3

2.6

67.71

98.65

ng/l

2.43

150

1274

Benign neoplasm: Peripheral nerves and autonomic nervous system

409

1.43

1.74

3.3

137.94

178.44

ng/l

0.62

378

Fitting and adjustment of external prosthetic device

2.11

1.73

4.0

2.3

302.09

180.50

ng/l

0.59

Laparoscopic right hemicolectomy

253

2178

1.18

1.72

2.6

3.1

190.30

222.12

ng/l

0.80

234

2004

Arthropathic psoriasis

357

3141

1.15

1.71

2.9

188.35

170.33

ng/l

0.29

312

2862

Calcaneal spur

293

1.51

1.71

2.5

3.4

185.84

211.94

ng/l

0.13

268

Pemphigoid

126

1017

1.27

1.71

4.0

3.3

211.75

249.46

ng/l

0.61

113

940

Diseases of middle ear and mastoid

1950

15067

1.06

1.70

3.2

2.9

167.06

179.97

ng/l

0.66

1758

13632

Benign neoplasm: Other and unspecified parts of mouth

116

926

1.28

1.70

3.1

3.0

203.71

190.85

ng/l

0.16

102

848

Testicular dysfunction

119

951

1.27

1.70

2.8

181.57

152.29

ng/l

0.28

103

840

Maternal care for known or suspected malpresentation of fetus

215

1811

0.84

1.68

1.9

2.3

42.53

73.10

ng/l

3.76

180

1619

Toxic effect of alcohol

471

1.39

1.67

3.4

3.2

197.00

189.47

ng/l

0.06

425

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

2.12

1.66

3.3

3.0

88.93

126.54

ng/l

0.42

279

1.51

1.66

2.5

3.0

369.68

224.97

ng/l

0.56

249

Malignant neoplasm of nasal cavity and middle ear

129

1.80

1.66

2.6

4.1

102.77

218.09

ng/l

1.73

115

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

113

898

1.27

1.65

1.8

2.2

51.45

68.48

ng/l

0.91

803

Degenerative macular diseases

555

5031

1.12

1.65

3.4

3.1

234.96

227.76

ng/l

0.15

510

4629

Carcinoma in situ of penis

2.49

1.64

2.1

2.2

91.90

216.24

ng/l

—

Visual impairment including blindness (binocular or monocular)

286

2491

1.16

1.64

3.7

3.1

271.49

241.71

ng/l

0.43

260

2265

Other disorders of optic [2nd] nerve and visual pathways

212

1803

1.19

1.64

3.4

3.0

192.99

199.80

ng/l

0.08

193

1648

Ulcerative colitis (strict definition, require KELA)

487

4377

1.12

1.64

3.2

3.0

189.26

166.00

ng/l

0.47

440

3932

Other congenital malformations of circulatory system

594

1.34

1.64

2.2

3.0

168.55

170.84

ng/l

0.02

542

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

530

4788

1.11

1.62

3.1

2.9

183.52

167.04

ng/l

0.33

479

4308

Hypertrichosis

287

1.49

1.62

3.4

2.5

57.05

96.02

ng/l

1.43

256

Crohn disease (strict definition, require KELA, min 2 HDR)

155

1282

1.22

1.60

2.3

2.9

143.74

152.42

ng/l

0.11

136

1144

Varicose veins of other sites

210

1788

1.19

1.60

3.3

3.0

105.44

185.72

ng/l

6.89

190

1619

Disorders of optic nerve and visual pathways

285

2483

1.16

1.60

3.3

3.0

198.77

186.86

ng/l

0.17

260

2256

Other osteochondropathies

197

1668

1.19

1.60

3.1

2.9

189.75

167.10

ng/l

0.31

176

1519

Malignant neoplasm of prostate, including Hilmo

1294

7153

1.07

1.59

2.8

3.3

221.93

254.18

ng/l

1.60

1185

6596

Progressive external ophthalmoplegia

3.79

1.59

2.0

2.1

34.00

139.07

ng/l

—

Transient global amnesia

375

3335

1.14

1.59

3.3

3.1

139.90

212.78

ng/l

4.07

355

3062

Crohn disease (strict definition, require KELA)

158

1311

1.22

1.59

2.4

2.9

146.43

153.92

ng/l

0.09

138

1168

Injury of heart

2.32

1.58

4.9

2.2

167.91

173.60

ng/l

0.04

Lesion of sciatic nerve

185

1565

1.20

1.57

3.8

3.1

217.84

258.41

ng/l

0.71

167

1441

Carcinoma in situ of endometrium

128

0.37

1.57

2.8

2.7

46.40

220.24

ng/l

—

117

Lactose intolerance

615

1.32

1.56

2.3

3.0

157.76

171.51

ng/l

0.15

562

Polyhydramnios

579

1.32

1.56

2.0

2.5

75.62

83.09

ng/l

0.16

513

Malignant neoplasm of bronchus and lung, including Hilmo

1008

7828

1.08

1.55

3.1

3.3

219.40

246.53

ng/l

1.22

947

7233

Dermatitis herpetiformis

453

1.38

1.55

5.7

3.1

133.57

181.52

ng/l

0.64

420

Tic and related disorders

161

1.64

1.54

5.0

3.2

86.94

144.42

ng/l

0.91

142

Inflammatory disease of cervix uteri

146

1756

0.82

1.54

2.5

3.0

220.47

184.42

ng/l

0.41

131

1607

Other maternal disorders predominantly related to pregnancy

1469

8647

1.07

1.53

2.3

2.5

94.15

121.88

ng/l

3.15

1330

7853

Polycythaemia vera

142

1176

1.23

1.53

3.8

3.3

257.42

233.99

ng/l

0.22

132

1075

Abnormal findings on diagnostic imaging of central nervous system

146

1209

1.22

1.53

3.5

2.8

138.33

185.69

ng/l

1.13

134

1095

6-mercaptopurine

547

1.33

1.52

3.3

2.8

93.83

132.87

ng/l

1.03

478

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

318

1.45

1.52

3.0

3.2

111.62

197.82

ng/l

2.20

287

Disorder of the sleep-wake schedule

309

1.45

1.51

2.5

3.2

86.07

152.06

ng/l

1.68

277

Deficiency of other/unspecified vitamins

2.73

1.51

3.7

2.0

197.29

119.65

ng/l

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

220

1887

1.17

1.51

2.6

2.7

98.94

116.75

ng/l

0.69

197

1663

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

1.97

1.51

3.7

4.1

96.93

186.02

ng/l

1.15

Wide developmental disorders

408

1.38

1.50

3.0

4.1

65.37

131.96

ng/l

2.27

342

Female infertility, associated with anovulation

107

856

1.26

1.50

2.0

2.5

47.63

89.99

ng/l

2.42

762

Postpartum care and examination

211

1127

1.18

1.48

2.2

70.17

71.25

ng/l

0.01

186

995

Disorders of puberty

163

1.62

1.48

6.2

3.0

192.48

124.36

ng/l

0.31

143

Calcium deposit in bursa

2.25

1.47

3.1

2.4

117.45

151.53

ng/l

0.28

Hirsutism, drug-induced

3.29

1.46

2.2

1.4

60.20

93.25

ng/l

—

Other drug-induced secondary parkinsonism

263

1.50

1.46

4.3

3.2

168.94

189.26

ng/l

0.16

240

Behavioural syndromes associated with physiological disturbances and physical factors

3786

24695

1.04

1.46

2.7

3.0

160.05

189.65

ng/l

4.34

3437

22530

Perioral dermatitis

396

1.38

1.46

3.2

2.8

90.87

137.61

ng/l

1.09

363

Bitten or struck by other mammals

299

2633

1.14

1.45

2.6

2.9

174.87

154.67

ng/l

0.29

272

2363

Use of antiglaucoma preparations and miotics

364

3255

1.13

1.44

3.4

3.3

274.72

253.10

ng/l

0.37

329

2990

Contact with sharp glass

711

1.28

1.44

3.3

3.0

272.27

139.23

ng/l

0.97

628

Other demyelinating diseases of the central nervous system

614

1.30

1.44

2.2

3.0

110.85

142.15

ng/l

0.34

544

Cholesteatoma of middle ear

195

1671

1.18

1.44

4.2

3.1

233.45

221.60

ng/l

0.09

185

1537

Single delivery by caesarean section

248

1630

0.86

1.43

1.9

2.5

67.78

100.18

ng/l

1.83

219

1431

Multiple delivery

134

1614

0.82

1.42

2.1

2.6

86.06

128.99

ng/l

2.60

125

1463

Malignant neoplasm of bladder, including Hilmo

542

4887

1.10

1.41

3.3

3.5

262.01

283.38

ng/l

0.52

503

4523

Other and unspecified myoneural disorders

1.96

1.40

3.8

3.0

76.50

104.03

ng/l

0.50

Cerebral arteritis

2.25

1.39

3.1

2.3

75.90

102.61

ng/l

—

Idiopathic hypoparathyroidism

2.09

1.39

19.8

3.2

143.00

227.84

ng/l

0.66

Other superficial injuries of ankle and foot

1.80

1.38

4.1

5.7

145.24

204.84

ng/l

0.31

Maternal care for known or suspected fetal abnormality and damage

246

1813

1.15

1.38

2.2

2.3

62.05

74.92

ng/l

0.67

211

1622

Evidence of alcohol involvement determined by level of intoxication

159

1.61

1.38

3.7

2.4

170.59

152.57

ng/l

0.08

138

Contact with hot air and gases

136

1.68

1.38

2.5

3.5

366.80

159.10

ng/l

0.63

120

Chronic suppurative otitis media, including avohilmo

257

2254

1.15

1.37

4.2

3.2

189.89

209.09

ng/l

0.39

227

2048

Retinoschisis and retinal cysts

756

1.27

1.37

3.3

3.1

146.34

228.65

ng/l

2.22

703

Malignant neoplasm of nasal cavity and middle ear, including Hilmo

201

1.55

1.37

2.5

3.7

186.00

212.53

ng/l

0.11

182

Infections with a predominantly sexual mode of transmission, including avohilmo

967

8261

1.07

1.37

2.6

157.28

126.80

ng/l

1.29

843

7365

Spasmodic torticollis

745

1.27

1.37

2.6

3.2

97.08

176.34

ng/l

2.80

682

Contact with nonpowered hand tool

127

1052

1.22

1.36

3.1

3.0

117.97

180.39

ng/l

1.52

116

952

Malignant neoplasm of stomach, including Hilmo

251

2202

1.15

1.36

2.8

3.3

251.28

253.95

ng/l

0.02

235

2028

IBD (strict) with PSC

144

1.64

1.35

3.2

2.7

80.87

102.42

ng/l

0.32

130

Sequelae of infectious and parasitic diseases

242

2116

1.15

1.35

3.4

3.0

202.29

218.97

ng/l

0.29

216

1909

Adenocarcinoma of pancreas

1039

0.78

1.35

2.6

3.3

223.24

239.94

ng/l

0.12

968

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

419

3781

1.11

1.35

2.7

124.27

118.18

ng/l

0.15

361

3331

Maternal care related to the fetus and amniotic cavity and possible delivery problems

853

5375

0.93

1.33

2.3

2.5

76.64

109.08

ng/l

5.46

765

4866

Benign neoplasm: other/unspecified salivary gland

795

1.26

1.32

2.8

3.2

284.31

230.08

ng/l

0.39

734

Other congenital musculoskeletal deformities

2.45

1.32

4.6

3.4

35.75

89.03

ng/l

—

Childhood allergy (age < 16)

182

1281

1.18

1.31

3.7

3.4

76.39

103.30

ng/l

0.71

150

1080

Other effects of reduced temperature

2.16

1.31

4.1

2.6

195.00

123.44

ng/l

—

Intentional self-harm by hanging, strangulation and suffocation

135

0.43

1.31

7.3

3.5

98.50

144.96

ng/l

—

112

Pustular psoriasis

144

1213

1.20

1.31

4.0

3.3

157.43

178.64

ng/l

0.40

133

1109

Lesion of femoral nerve

154

1.61

1.30

2.0

2.8

92.77

166.73

ng/l

1.73

143

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

104

851

1.25

1.30

1.9

3.3

206.44

184.00

ng/l

0.21

774

Injury of nerves at ankle and foot level

1.76

1.30

2.2

3.1

223.92

207.27

ng/l

0.03

Use of glatiramer acetate

210

1.50

1.30

2.1

2.6

155.63

73.11

ng/l

0.38

188

Psoriatic arthropathies, ICD10

320

2857

1.13

1.30

3.0

195.84

167.95

ng/l

0.44

277

2601

Burn and corrosion of hip and lower limb, except ankle and foot

519

1.31

1.30

3.1

205.68

200.31

ng/l

0.03

464

Other abortion

138

1.63

1.29

2.2

2.8

99.53

140.63

ng/l

0.35

122

Placenta praevia

577

0.72

1.29

2.6

2.5

82.53

69.16

ng/l

0.18

513

Measles

170

1.56

1.29

3.0

2.5

250.90

77.75

ng/l

1.03

146

Measles, including avohilmo

170

1.56

1.29

3.0

2.5

250.89

77.75

ng/l

1.03

146

Mandibular retrognathia AND surgery (BSSO)

388

1.36

1.29

2.2

2.8

59.87

116.33

ng/l

2.64

344

Benign neoplasm: Tongue

762

1.26

1.28

2.8

3.1

255.08

199.36

ng/l

0.34

701

L02BA Anti-estrogens

466

5105

0.91

1.27

2.3

2.9

147.88

168.83

ng/l

0.87

427

4680

Traumatic amputation of ankle and foot

2.16

1.27

3.2

4.0

383.40

168.15

ng/l

—

Malignant neoplasm of thymus

1.89

1.27

2.9

3.7

226.36

164.60

ng/l

0.45

Intrahepatic Cholestasis of Pregnancy (ICP)

113

931

1.22

1.26

1.8

2.4

51.45

70.55

ng/l

1.29

817

All dysplastic lesions of the cervix uteri, vagina or vulva

635

5718

1.09

1.26

2.4

2.5

143.08

114.35

ng/l

1.00

566

5167

Carcinoma in situ of colon

109

900

1.23

1.26

2.6

3.2

182.15

210.85

ng/l

0.35

102

834

Pedal cyclist injured in collision with motor vehicle

690

1.26

2.5

3.0

138.47

161.08

ng/l

0.24

621

Contaminated medical or biological substances

2.87

1.25

2.6

2.2

91.60

186.26

ng/l

—

Other psoriatic arthropathies

310

2770

1.13

1.25

3.0

195.20

165.27

ng/l

0.47

267

2521

Diabetes mellitus in pregnancy

528

3067

1.10

1.24

2.0

2.3

77.64

80.09

ng/l

0.07

464

2728

Sequelae of transport accidents

1.81

1.23

3.1

128.80

127.84

ng/l

0.01

Congenital absence, atresia and stenosis of small intestine

2.50

1.23

2.8

2.7

430.83

141.42

ng/l

—

Melanoma of uvea

282

1.43

1.23

2.2

3.3

257.97

213.59

ng/l

0.20

254

Other papulosquamous disorders

256

1.44

1.22

2.6

3.0

87.84

211.95

ng/l

3.17

233

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

213

1.47

1.22

2.4

3.0

122.85

83.64

ng/l

0.23

188

Sequelae of burns, corrosions and frostbite

1.77

1.22

2.3

2.7

87.25

128.08

ng/l

0.60

Sequelae of infectious and parasitic diseases, including avohilmo

248

2193

1.14

1.20

3.4

3.0

201.21

217.56

ng/l

0.29

222

1979

Other congenital musculoskeletal deformities, including avohilmo

2.17

1.20

4.6

3.3

35.75

84.63

ng/l

—

Sequelae of tuberculosis, including avohilmo

643

1.27

1.20

5.0

3.4

281.33

313.46

ng/l

0.34

592

Aphakia

420

1.34

1.20

3.3

3.0

272.94

201.87

ng/l

0.79

386

Other specified disorders of external ear

143

1218

1.19

3.2

3.1

285.13

213.21

ng/l

0.54

132

1119

Puerperal sepsis

331

2978

1.12

1.19

2.3

2.7

110.61

133.02

ng/l

0.68

312

2737

Other or unspecified common variable immunodeficiency

1.94

1.18

6.4

2.1

75.75

116.43

ng/l

0.66

Chronic nephritic syndrome

127

1071

1.20

1.18

3.5

3.0

510.56

198.50

ng/l

2.89

117

982

Other disorders of the genitourinary system

489

4493

1.10

1.17

3.0

192.33

196.17

ng/l

0.08

454

4120

Distal bite

557

1.28

1.17

3.6

3.7

139.66

126.09

ng/l

0.10

493

Mesial bite

142

1.58

1.17

3.2

2.6

80.53

106.04

ng/l

0.28

134

Rickettsioses

2.14

1.16

3.5

3.9

140.88

184.49

ng/l

—

Sequelae of tuberculosis

628

1.27

1.16

5.1

3.4

284.18

316.37

ng/l

0.33

579

Vertical strabismus

107

889

1.22

1.16

2.5

3.0

145.80

183.54

ng/l

0.61

819

Acquired atrophy of ovary and fallopian tube

2.06

1.15

2.4

3.9

77.10

224.68

ng/l

—

Other protozoal intestinal diseases, including avohilmo

414

1.32

1.15

2.4

2.8

133.69

168.94

ng/l

0.50

380

Failed induction of labour

688

1.24

1.15

2.0

2.4

26.52

71.15

ng/l

7.03

599

Malignant neoplasm of rectum

419

3829

1.10

1.14

2.4

3.2

224.50

232.36

ng/l

0.14

385

3533

Open wound of wrist and hand

1588

14641

1.05

1.14

2.8

3.0

173.89

187.94

ng/l

0.69

1429

13317

Polyp of the female genital tract

1025

5466

1.07

1.14

2.6

2.9

165.92

207.42

ng/l

2.52

934

5014

Malignant neoplasm of breast, ER-positive, including Hilmo

1156

8136

1.06

1.13

2.5

2.8

158.58

169.99

ng/l

0.56

1061

7435

Medical treatment for female infertility

273

3027

0.89

1.13

2.0

2.2

67.51

75.51

ng/l

0.23

249

2688

Tuberculosis of other organs, strict, including avohilmo

812

1.23

1.13

3.6

3.4

225.06

267.36

ng/l

0.41

750

Panhypopituitarism

443

1.31

1.12

3.4

3.1

135.12

203.50

ng/l

0.93

403

Loose body in joint

585

1.27

1.12

2.5

3.0

222.71

188.32

ng/l

0.22

542

Pregnancy with abortive outcome

2237

11191

1.04

1.12

2.6

2.8

146.78

168.90

ng/l

2.14

2044

10239

Glaucoma-related operations

250

2230

1.14

1.11

2.9

3.3

197.73

228.47

ng/l

1.06

227

2061

Personality and behavioural disorders due to brain disease, damage and dysfunction

373

1.34

1.11

2.4

3.4

209.98

230.11

ng/l

0.10

338

Benign neoplasm of bone and articular cartilage

240

2131

1.14

1.11

2.7

3.0

192.44

173.44

ng/l

0.19

218

1935

HSIL lesion of the cervix uteri, vagina or vulva

403

3676

1.10

2.4

2.5

134.62

117.88

ng/l

0.38

358

3320

Malignant neoplasm of breast, HER-positive

1153

8132

1.06

1.10

2.5

2.8

158.70

170.05

ng/l

0.55

1058

7432

Intentional self-harm by other and unspecified firearm discharge

2.26

1.09

3.1

2.8

460.57

177.00

ng/l

—

Malignant neoplasm of thymus, including Hilmo

106

1.67

1.08

2.6

4.1

206.71

181.79

ng/l

0.17

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

115

972

1.20

1.08

4.4

3.2

232.14

266.04

ng/l

0.50

107

900

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

608

1.26

1.07

2.3

3.4

173.30

270.28

ng/l

2.52

565

Malignant neoplasm of stomach

216

1913

1.14

1.07

2.8

3.3

259.65

257.03

ng/l

0.02

202

1766

Torsion of testis

288

1.37

1.07

3.1

3.7

129.97

147.66

ng/l

0.12

239

Sudden idiopathic hearing loss

375

3423

1.10

1.07

3.5

2.9

206.63

209.36

ng/l

0.03

352

3132

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

433

3972

1.09

1.06

2.7

120.40

137.56

ng/l

0.49

391

3603

Endometriosis diagnosis and infertility diagnosis occurring together

196

1722

1.14

1.06

2.3

2.6

72.17

94.56

ng/l

1.37

183

1530

Infectious mononucleosis, including avohilmo

134

1144

1.18

1.06

3.3

2.8

105.47

112.13

ng/l

0.14

106

990

Infectious mononucleosis

134

1144

1.18

1.06

3.3

2.8

105.47

112.13

ng/l

0.14

106

990

Other leukaemias of specified cell type

1.99

1.06

1.8

2.8

276.20

278.94

ng/l

—

125

1062

1.18

1.05

2.0

2.2

141.01

61.24

ng/l

0.81

100

937

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

164

1426

1.16

1.04

2.4

2.8

142.66

153.62

ng/l

0.15

143

1274

Rickettsioses, including avohilmo

1.98

1.04

3.8

4.3

135.78

184.32

ng/l

—

Excessive earwax

2801

24551

1.04

3.0

3.1

166.74

208.51

ng/l

8.45

2588

22525

Other and unspecified water transport accidents

1.84

1.04

3.1

4.0

135.92

122.23

ng/l

0.09

Conjunctivitis (acute, non atopic), including avohilmo

4027

24984

0.97

1.04

2.9

3.0

163.79

194.70

ng/l

5.23

3628

22878

Dyslexia and other symbolic dysfunctions, not elsewhere classified

1.83

1.04

3.8

2.7

171.50

132.90

ng/l

0.24

Unattended death

273

0.64

1.04

2.8

3.3

344.78

240.64

ng/l

0.59

249

Disorders of puberty, all

196

1.45

1.03

5.9

3.2

186.35

128.46

ng/l

0.28

177

Non-small cell lung cancer, adenocarcinoma, helper endpoint

278

2508

1.12

1.03

2.7

3.1

212.55

234.93

ng/l

0.34

254

2314

Tuberculosis of other organs, strict

803

1.22

1.02

3.7

3.4

227.93

268.05

ng/l

0.38

741

Adenocarcinoma and papillary adenocarcinoma of stomach

114

968

1.20

1.02

2.6

3.3

232.08

290.54

ng/l

0.80

108

899

Sleep disorders

3598

24052

1.03

1.02

2.6

3.0

158.01

187.03

ng/l

4.21

3268

21935

Injury of nerves at forearm level

257

1.39

1.02

3.6

3.1

297.10

165.14

ng/l

0.48

230

Rare circulating lymphoid malignancy, including Hilmo

107

904

1.20

1.01

3.0

3.7

228.55

245.00

ng/l

0.15

843

Malignant neoplasm of respiratory system and intrathoracic organs

991

7784

1.06

1.01

2.9

3.3

206.52

247.29

ng/l

2.42

915

7189

Medicines for HER+ breast cancer

1240

12114

0.95

1.01

2.5

2.9

163.58

176.21

ng/l

0.52

1138

11127

Other specified acquired deformities of limbs

1.72

1.01

2.1

2.6

72.07

184.20

ng/l

1.67

Benign neoplasm: Ribs, sternum and clavicle

1.89

1.00

2.7

2.8

127.00

144.75

ng/l

—

Tic disorders

181

1.46

1.00

5.0

3.0

86.94

154.38

ng/l

1.16

159

Malignant neoplasm of vagina

1.89

1.00

2.3

4.3

391.82

193.39

ng/l

0.24

Contact with other sharp object(s)

158

1377

1.16

0.99

2.5

2.9

139.00

149.54

ng/l

0.11

142

1226

Follicular lymphoma, hilmo

160

1400

1.16

0.99

2.6

2.9

257.20

207.87

ng/l

0.66

145

1285

Dementia in other diseases classified elsewhere

194

1720

1.14

0.98

2.7

3.2

221.86

262.65

ng/l

0.70

180

1581

Retinal breaks without detachment

597

5577

1.08

0.98

2.7

3.0

137.45

184.60

ng/l

3.39

544

5116

Other rupture of muscle

141

1.53

0.98

3.2

125.38

156.40

ng/l

0.36

124

Demyelinating diseases of the central nervous system

197

1744

1.14

0.98

2.3

3.0

125.21

148.32

ng/l

0.45

170

1562

Acne varioliformis

1.84

0.98

1.6

2.8

303.89

207.01

ng/l

—

Guttate psoriasis

285

1.36

0.98

2.5

3.1

164.39

179.86

ng/l

0.07

254

Carcinoma in situ of other and unspecified genital organs

480

1.27

0.97

2.4

2.9

191.55

183.30

ng/l

0.05

448

Lactose intolerance, other/unspecified

551

1.25

0.97

2.3

3.0

151.75

177.67

ng/l

0.29

502

Traumatic amputation of wrist and hand

147

1280

1.16

0.97

3.4

3.0

228.39

204.37

ng/l

0.26

135

1171

Benign neoplasm: Conjunctiva

105

890

1.20

0.97

2.8

3.2

192.99

206.38

ng/l

0.10

818

Use of bromocriptine

2.36

0.96

2.7

180.17

150.00

ng/l

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

770

1.21

0.96

2.5

3.1

97.44

168.27

ng/l

3.85

706

Female infertility, uterine origin

1.81

0.96

1.4

3.0

26.89

148.05

ng/l

—

Malignant neoplasm of floor of mouth

151

1.51

0.95

2.7

3.7

573.82

216.38

ng/l

0.44

135

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

1.73

0.95

5.2

3.4

300.92

152.51

ng/l

0.79

Other disorders of prostate

102

1199

0.84

0.95

3.1

3.0

253.83

264.03

ng/l

0.08

1109

Labour and delivery complicated by umbilical cord complications

822

0.81

0.95

2.0

2.8

85.00

102.44

ng/l

0.34

735

Respiratory tuberculosis, not confirmed, including avohilmo

162

1425

1.15

0.94

4.0

3.3

210.40

271.66

ng/l

1.69

152

1313

Use of galantamine

350

3808

0.91

0.93

2.6

3.3

191.16

282.99

ng/l

7.15

318

3498

Degenerative myopia

168

1.47

0.93

3.0

3.3

244.33

199.33

ng/l

0.22

152

Oral lichen planus and hypothyroidism or thyroxine medication

483

1.26

0.93

1.8

2.9

105.13

164.63

ng/l

0.58

448

Disorders of eyelid in diseases classified elsewhere

811

1.20

0.92

4.1

3.0

202.74

209.83

ng/l

0.05

741

Respiratory tuberculosis, not confirmed

160

1409

1.15

0.91

4.1

3.3

211.79

271.25

ng/l

1.59

150

1299

Ulcerative rectosigmoiditis

228

2048

1.12

0.91

2.7

2.8

164.29

174.15

ng/l

0.15

204

1858

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

2.15

0.91

1.7

2.1

17.83

216.04

ng/l

—

Sequelae of other accidents

422

1.28

0.91

3.7

3.0

258.28

214.94

ng/l

0.28

382

Benign neoplasm: Connective and other soft tissue, unspecified

263

1.36

0.91

2.9

3.1

202.14

200.38

ng/l

0.01

241

Other contact dermatitis

230

2068

1.12

0.91

3.5

3.0

177.05

179.39

ng/l

0.03

213

1864

Complications following abortion and ectopic and molar pregnancy

826

0.81

0.90

2.5

3.0

118.25

162.30

ng/l

1.10

752

Superficial injuries involving multiple body regions

602

1.23

0.90

4.6

3.2

234.96

214.26

ng/l

0.10

546

Benign neoplasm: Pituitary gland, craniopharyngeal duct

155

1363

1.15

0.89

3.0

2.9

120.48

190.98

ng/l

2.97

141

1234

Severe bullous disorders, KELA reimbursement

1.92

0.89

2.5

2.3

192.25

108.54

ng/l

—

Pustulosis palmaris et plantaris

121

1046

1.17

0.89

3.1

153.19

165.15

ng/l

0.18

113

961

Complications of anaesthesia during labour and delivery

2.04

0.88

1.2

1.9

59.33

52.92

ng/l

—

Endometriosis of ovary

489

4288

1.08

0.88

2.7

2.8

116.92

180.12

ng/l

6.02

455

3926

Congenital malformations of ovaries, fallopian tubes and broad ligaments

105

897

1.18

0.88

2.6

2.9

115.28

115.31

ng/l

0.00

795

Anisometropia and aniseikonia

810

0.82

0.86

3.0

3.2

104.53

196.34

ng/l

4.37

750

Secondary malignant neoplasm of respiratory and digestive organs

617

1.22

0.86

3.1

3.4

159.49

239.94

ng/l

1.71

573

Drug-induced neutropenia

233

2107

1.12

0.85

3.0

153.48

181.14

ng/l

0.68

216

1917

Gluteal tendinitis

123

1068

1.16

0.85

2.7

2.9

92.68

190.02

ng/l

8.18

116

956

Chalazion

351

3235

1.09

0.85

2.5

3.0

169.21

180.04

ng/l

0.22

316

2940

Burns and corrosions of multiple and unspecified body regions

507

1.24

0.85

2.3

3.0

321.89

186.73

ng/l

0.84

459

Other proliferative retinopathy

1.59

0.84

3.1

2.3

456.33

235.89

ng/l

0.34

Caries in Clefts patients

121

1.51

0.84

2.7

3.2

67.69

125.47

ng/l

0.76

111

Malignant neoplasm of eye and adnexa, including Hilmo

491

1.25

0.84

2.7

4.0

321.78

238.04

ng/l

0.58

458

Congenital lens malformations

1.69

0.84

8.0

3.2

206.92

201.93

ng/l

0.02

Benign neoplasm: Skin of trunk

129

1128

1.16

0.83

3.4

3.1

178.91

191.92

ng/l

0.15

116

1040

Obstructed labour due to malposition and malpresentation of fetus

343

3446

0.92

0.83

2.2

2.3

76.73

83.25

ng/l

0.22

305

3092

Complications associated with artificial fertilization

180

1.40

0.83

1.6

2.6

39.37

82.29

ng/l

1.66

150

Foreign body on external eye

443

4127

1.08

0.82

3.1

2.9

155.14

168.22

ng/l

0.23

390

3713

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.82

0.0

5.7

—

166.85

—

L02BG Aromatase inhibitors

1045

10794

0.95

0.82

2.5

2.9

171.25

175.66

ng/l

0.12

954

9943

Aggressive periodontitis

556

1.22

0.81

2.8

3.1

153.40

205.29

ng/l

0.86

509

Hypospadias with an incomplete glans penis

1.88

0.81

6.2

3.3

510.17

164.75

ng/l

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

125

1094

1.16

0.81

4.0

3.0

178.98

208.40

ng/l

0.42

111

999

Cleft lip, lip and palate or palate

216

1.36

0.80

2.4

3.2

76.04

103.53

ng/l

0.46

194

Exposure to other specified electric current

411

1.25

0.80

3.1

3.7

87.59

131.44

ng/l

1.32

363

Non-small cell lung cancer

466

4308

1.08

0.80

2.8

3.4

192.41

265.29

ng/l

3.56

432

3984

Severe visual impairment, monocular

270

1.32

0.79

3.5

3.0

304.60

233.29

ng/l

0.41

246

Premature rupture of membranes

305

2363

0.92

0.79

2.3

2.5

73.64

90.31

ng/l

0.46

271

2113

Malignant neoplasm of palate

1.68

0.79

3.2

4.7

353.83

228.03

ng/l

0.20

Malignant neoplasm of heart, mediastinum and pleura

441

1.25

0.78

2.0

3.4

175.98

256.07

ng/l

1.37

411

Twin gestation

142

1253

1.14

0.78

2.0

2.4

52.36

86.89

ng/l

2.46

126

1125

Chondrosarcoma, including Hilmo

116

1.52

0.77

1.9

4.9

242.35

224.04

ng/l

0.05

106

Crushing injury of ankle and foot

1.70

0.77

5.4

3.7

155.45

213.03

ng/l

0.33

Qualitative platelet defects

1.66

0.77

3.4

2.6

104.08

182.11

ng/l

0.67

Non-small cell lung cancer, squamous, helper endpoint

172

1916

0.89

0.77

3.0

3.2

168.62

294.49

ng/l

7.91

162

1772

Left side

107

0.54

0.76

7.0

3.2

175.67

242.49

ng/l

—

Fistulae involving female genital tract

407

1.25

0.74

2.8

3.1

91.80

190.53

ng/l

2.65

372

Other infective (teno)synovitis

1.59

0.74

7.7

3.1

110.46

111.07

ng/l

0.01

Urticaria due to cold and heat

125

1.47

0.74

2.7

3.0

195.85

125.47

ng/l

0.19

116

Malignant neoplasm of vagina, including Hilmo

101

1.55

0.74

2.2

4.0

395.20

226.92

ng/l

0.29

Subarachnoid haemorrhage

385

3592

1.08

0.73

3.2

2.9

263.01

219.32

ng/l

1.03

340

3283

Pregnancy examination and test

237

1337

1.10

0.72

1.8

2.2

66.80

73.75

ng/l

0.12

198

1190

Hypogonadotropic hypogonadism

609

1.19

0.72

2.6

3.0

115.04

141.83

ng/l

0.28

528

Narcolepsy and cataplexy

101

1.51

0.72

3.6

2.7

119.53

170.67

ng/l

0.37

Varus deformity, not elsewhere classified

230

1.33

0.71

3.1

3.0

111.14

199.61

ng/l

1.45

212

Other intracranial haemorrhages

132

1173

1.14

0.71

4.4

3.2

311.61

247.41

ng/l

0.50

124

1082

Impacted maxillary molar

686

0.83

0.71

2.8

227.52

92.01

ng/l

1.00

582

HSIL lesion of the cervix uteri

330

3060

1.08

0.71

2.4

2.5

122.88

107.18

ng/l

0.32

293

2740

Dislocation, sprain and strain of joints and ligaments of elbow

154

1378

1.12

0.71

3.4

2.9

150.13

160.02

ng/l

0.12

142

1235

Other disorders of carbohydrate metabolism

1.60

0.70

2.3

3.8

187.83

132.31

ng/l

0.22

Migraine, single triptan purchase ok & required. ICD-code if available is included

2318

16137

0.97

0.70

2.5

2.8

96.12

149.84

ng/l

20.57

2050

14617

Triptan medication for migraine, single purchase ok

2318

16137

0.97

0.70

2.5

2.8

96.12

149.84

ng/l

20.57

2050

14617

Benign neoplasm: Eye, unspecified

102

1.52

0.70

3.8

5.8

450.87

313.81

ng/l

0.31

malignant neoplasm of female genital organs

548

5667

0.94

0.70

2.6

3.0

201.18

193.41

ng/l

0.16

502

5193

Glycosuria

1.92

0.70

2.4

152.40

210.02

ng/l

—

Type1 diabetes, definitions combined, early onset

832

0.85

0.70

2.9

3.4

265.50

110.05

ng/l

1.08

722

Ulcerative colitis (strict definition, all Crohn cases excluded)

398

3724

1.07

0.69

3.3

3.0

185.26

167.97

ng/l

0.29

364

3343

Foreign body entering into or through eye or natural orifice

234

2145

1.10

0.69

4.3

3.0

148.92

187.10

ng/l

1.36

212

1946

Enteritis due to Yersinia enterocolitica

1.53

0.68

6.0

2.4

105.07

173.71

ng/l

0.78

Impacted teeth

282

2620

0.92

0.68

3.1

2.8

163.30

110.86

ng/l

1.04

260

2248

Other cestode infections

1.59

0.68

2.2

2.3

82.83

242.50

ng/l

2.25

Benign neoplasm: Long bones of lower limb

669

1.18

0.68

2.7

2.8

164.96

156.21

ng/l

0.07

603

Complications predominantly related to the puerperium

554

5240

1.06

0.67

2.3

2.5

99.28

117.35

ng/l

0.71

511

4744

Other crystal arthropathies

625

1.19

0.67

3.6

2.9

334.27

243.92

ng/l

0.63

580

Tic and related disorders

197

1.34

0.67

5.0

3.8

86.94

142.56

ng/l

0.96

176

Secondary malignant neoplasm of other and unspecified sites

633

0.82

0.66

3.0

3.4

239.96

230.68

ng/l

0.06

590

Occupant of special vehicle mainly used on industrial premises injured in transport accident

1.52

0.66

4.5

3.8

73.93

237.19

ng/l

2.41

Other specified/unspecified hearing loss

347

3241

1.08

0.66

2.7

3.0

146.06

234.50

ng/l

6.75

324

2955

Seminoma of testis, including Hilmo

198

1.34

0.66

2.5

3.4

89.54

190.76

ng/l

2.11

178

Other specified/unspecified disorders of bone/cartilage

653

1.18

0.66

2.3

3.0

135.84

181.00

ng/l

0.59

591

Other disorders of breast

375

3512

1.07

0.65

2.5

2.8

174.18

146.78

ng/l

0.64

337

3198

Endometroid carcinoma of ovary

173

1.37

0.65

5.0

3.9

122.17

252.97

ng/l

1.21

161

Carcinoma in situ of other and unspecified sites

169

1536

1.11

0.64

3.6

3.2

261.30

239.11

ng/l

0.26

157

1423

Unspecified dementia

501

4746

0.94

0.63

3.3

3.4

322.06

325.39

ng/l

0.03

454

4344

Cachexia

139

1.40

0.63

3.1

3.0

579.60

181.15

ng/l

1.22

130

Malignant neoplasm of pancreas, including Hilmo

361

3386

1.07

0.62

3.3

3.4

191.83

238.92

ng/l

1.59

333

3125

Transient acantholytic dermatosis [Grover]

1.60

0.62

3.3

2.3

103.25

208.54

ng/l

—

Allergic contact dermatitis

361

3384

1.07

0.62

2.8

144.89

152.63

ng/l

0.15

330

3075

Other deformity of hallux (acquired)

201

1.32

0.61

3.2

3.1

164.92

208.73

ng/l

0.37

188

Obstructed labour due to maternal pelvic abnormality

346

3692

0.93

0.61

2.3

2.7

120.03

135.91

ng/l

0.38

311

3392

Endometriosis ASRM stages 3,4

649

6190

1.05

0.61

2.8

2.7

119.94

156.94

ng/l

3.55

598

5650

Carcinoma in situ, bladder

155

1409

1.11

0.60

3.7

3.1

264.08

241.69

ng/l

0.25

145

1305

Vestibular neuronitis

301

2811

1.08

0.59

3.1

3.0

223.14

192.74

ng/l

0.37

279

2574

Other conjunctival vascular disorders and cysts

623

1.17

0.59

3.2

3.1

229.72

206.03

ng/l

0.15

580

Abnormalities of ear ossicles

1.78

0.59

3.0

2.2

176.00

297.72

ng/l

—

Small cell lung cancer, helper endpoint

893

0.86

0.59

2.5

3.3

201.18

267.09

ng/l

0.80

824

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.59

0.0

6.2

—

218.48

—

Ovarian hyperstimulation (induction)

166

1.34

0.59

1.6

2.6

41.19

63.04

ng/l

0.58

140

Seminoma of testis

158

1.35

0.59

2.3

3.6

102.43

167.97

ng/l

0.92

140

Other disorders of skin and subcutaneous tissue related to radiation

1.74

0.58

3.5

3.4

101.83

176.08

ng/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1835

14638

0.97

0.58

2.8

157.31

169.94

ng/l

0.42

1677

13345

Malignant neoplasm of oropharynx, including Hilmo

606

1.17

0.58

2.9

3.3

237.81

221.03

ng/l

0.12

559

Other acantholytic disorders

1.60

0.58

4.2

2.4

176.50

255.76

ng/l

—

Burn and corrosion of wrist and hand

802

1.14

0.58

2.5

3.1

152.17

168.31

ng/l

0.20

715

Crystal arthropathies, rheuma endpoint

635

1.17

0.57

3.6

2.9

334.27

233.61

ng/l

0.73

588

Female infertility, tubal origin

783

1.14

0.57

2.4

2.6

115.70

113.76

ng/l

0.02

701

Postpartum haemorrhage due to retained placenta

164

1797

0.91

0.57

1.8

2.2

54.84

68.33

ng/l

0.62

148

1606

LSIL lesion of the cervix uteri

175

1911

0.91

0.56

2.5

2.6

153.99

104.73

ng/l

0.65

156

1711

Mumps

579

1.17

0.56

2.2

2.7

89.61

155.53

ng/l

2.30

520

Multiple gestation

143

1296

1.11

0.56

2.0

2.4

52.03

85.59

ng/l

2.43

127

1166

Congenital ovarian cysts

644

1.16

0.56

2.6

2.8

89.46

98.04

ng/l

0.10

570

Cervical polyps

290

2712

1.07

0.56

2.6

2.9

162.06

181.34

ng/l

0.35

259

2485

Atopic dermatitis

1758

14375

0.97

0.56

2.4

2.8

153.59

154.61

ng/l

0.04

1567

12957

Otosclerosis

214

2311

0.92

0.55

3.2

3.0

157.14

200.23

ng/l

1.13

190

2125

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

618

1.16

0.55

3.0

3.2

138.24

205.78

ng/l

1.19

571

Pervasive developmental disorders excl. Autism + Asperger

166

1.32

0.55

2.9

4.3

52.75

161.27

ng/l

2.73

144

Mumps, including avohilmo

590

1.16

0.55

2.1

2.8

89.61

155.12

ng/l

2.30

531

Subclinical iodine-deficiency hypothyroidism

1.60

0.55

1.7

2.0

55.17

155.45

ng/l

—

Spinal enthesopathy

105

937

1.13

0.55

3.6

3.2

213.87

342.97

ng/l

2.78

100

852

Procedures for purposes other than remedying health state

460

1.18

0.54

2.6

2.4

99.74

151.77

ng/l

1.35

420

Absence of one kidney, including avohilmo

1.46

0.54

1.6

2.8

296.56

228.65

ng/l

—

Other cestode infections, including avohilmo

1.49

0.54

2.2

2.3

82.83

229.96

ng/l

2.16

Malignant neoplasm of oropharynx

490

1.18

0.53

2.9

3.3

254.86

207.25

ng/l

0.33

451

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

517

1.17

0.53

2.7

3.1

117.59

156.85

ng/l

0.45

461

Carcinoma in situ of breast, intraductal

231

2481

0.93

0.53

2.6

2.8

144.75

157.91

ng/l

0.26

208

2285

Infections of genitourinary tract in pregnancy

196

1810

1.09

0.53

2.5

2.8

144.46

133.40

ng/l

0.14

181

1653

Psoas tendinitis

100

0.59

0.53

3.3

3.1

147.50

168.95

ng/l

—

Examination and encounter for administrative purposes

276

2585

1.07

0.52

2.9

2.8

158.75

203.70

ng/l

1.61

248

2387

Pneumoconiosis due to asbestos and other mineral fibres

792

1.14

0.52

3.9

3.2

217.57

288.71

ng/l

1.30

722

Systemic atrophies primarily affecting the central nervous system

148

1353

1.10

0.52

2.6

3.4

161.32

226.42

ng/l

1.25

142

1257

Brain meningioma, including Hilmo

172

1583

1.09

0.52

2.6

3.2

149.47

186.78

ng/l

1.00

158

1451

Colorectal neuroendocrine tumor and carcinoma

352

1.21

0.52

4.7

3.6

143.19

197.01

ng/l

0.81

330

Benign neoplasm of breast

331

3509

0.94

0.51

2.3

2.9

205.05

169.81

ng/l

0.78

294

3212

Malignant neoplasm of cervix uteri, including Hilmo

594

1.16

0.51

3.0

3.2

290.41

187.65

ng/l

0.76

538

Habitual aborter

188

1.28

0.51

2.0

2.6

38.06

70.59

ng/l

1.29

157

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

1.53

0.51

4.3

3.6

218.60

246.40

ng/l

—

Rapidly progressive nephritic syndrome

1.57

0.50

6.4

2.1

198.00

169.61

ng/l

—

Gastrojejunal ulcer

345

1.21

0.49

3.1

3.3

302.29

218.61

ng/l

0.52

321

Absence of one kidney

1.56

0.49

1.6

3.1

115.00

263.02

ng/l

—

Brain meningioma

165

1521

1.09

0.49

2.5

3.1

147.27

187.98

ng/l

1.09

152

1394

Psoriasis (vulgaris), strict definition

763

0.87

0.49

2.2

2.9

114.53

164.40

ng/l

1.11

689

Male infertility

806

0.88

0.49

4.3

3.0

143.65

141.42

ng/l

0.02

690

Benign neoplasm: Bone and articular cartilage, unspecified

146

1.32

0.48

2.7

4.1

181.05

136.02

ng/l

0.45

134

Iridocyclitis in diseases classified elsewhere

476

1.17

0.48

3.5

3.1

150.20

202.31

ng/l

0.90

435

Use of donepezil

1060

10416

0.97

0.48

3.0

3.4

213.54

278.74

ng/l

5.40

970

9625

Burn and corrosion confined to eye and adnexa

457

1.17

0.48

3.4

2.8

130.40

146.69

ng/l

0.18

408

Gastrointestinal stromal tumor and sarcoma

384

1.19

0.48

2.0

3.5

196.95

199.21

ng/l

0.02

356

Excessive attrition of teeth

2067

20004

1.02

0.48

2.8

138.02

164.15

ng/l

3.39

1853

18211

Calculus of lower urinary tract

203

1892

1.08

0.47

2.7

3.1

253.32

249.27

ng/l

0.03

187

1743

Melanocytic naevi, other sites/unspecified

239

2239

1.07

0.47

3.2

3.0

169.78

182.42

ng/l

0.22

228

2033

Malignant neoplasm of tonsil, including Hilmo

506

1.16

0.47

2.9

3.2

260.61

215.46

ng/l

0.31

466

Trichomoniasis, including avohilmo

192

1.27

0.46

4.6

3.3

302.00

159.12

ng/l

0.65

181

Sixth [abducent] nerve palsy

113

1029

1.11

0.45

3.0

3.2

245.60

231.90

ng/l

0.07

105

955

Prolonged pregnancy

193

1770

0.93

0.45

1.8

2.3

44.41

79.01

ng/l

3.13

166

1570

Other and unspecified injuries of ankle and foot

837

1.12

0.45

3.2

3.0

197.50

164.05

ng/l

0.38

751

MS-disease / Multiple Sclerosis

151

1392

1.09

0.45

2.3

3.0

134.98

136.35

ng/l

0.02

129

1247

Carcinoma in situ, eye

0.00

0.45

0.0

1.7

—

187.57

—

Benign neoplasm: Brain, supratentorial

330

1.19

0.45

2.8

3.2

243.76

178.37

ng/l

0.27

293

Malignant melanoma

629

6057

1.04

0.45

2.4

3.2

222.99

223.38

ng/l

0.01

566

5583

Benign neoplasm: Other specified/unspecified intrathoracic organs (+ respiratory system NOS of Icd-9)

1.50

0.44

5.3

2.8

153.13

144.62

ng/l

—

Non-seminoma of testis, including Hilmo

1.43

0.44

3.6

2.9

57.27

176.78

ng/l

1.29

Carcinoma in situ of other/unspecified female genital organs

0.00

0.43

0.0

2.5

—

141.47

—

Other disorders of amniotic fluid and membranes

172

1786

0.93

0.43

2.1

2.4

48.46

83.02

ng/l

3.98

147

1599

Eosinophilic cellulitis [Wells]

0.00

0.43

0.0

2.1

—

197.07

—

Pre-eclampsia superimposed on chronic hypertension

1.42

0.42

2.1

2.9

50.88

78.71

ng/l

—

Special screening examination for infectious and parasitic diseases

478

3336

1.05

0.42

2.0

2.4

139.10

121.23

ng/l

0.51

379

2965

Sequelae of other and unspecified infectious and parasitic diseases

127

1167

1.09

0.42

2.8

2.9

134.31

166.94

ng/l

0.57

110

1044

Benign neoplasm: Skin, unspecified

119

1091

1.10

0.42

3.1

3.0

188.60

199.40

ng/l

0.12

103

998

Diphyllobothriasis and sparganosis, including avohilmo

0.00

0.42

0.0

4.1

—

122.07

—

Malignant neoplasm of uterus, part unspecified

1.54

0.42

4.4

3.6

353.40

285.07

ng/l

—

Dementia due to Parkinson's disease

115

1055

1.10

0.42

2.9

3.3

198.43

256.66

ng/l

0.82

106

969

Crushing injury of lower leg

1.50

0.41

1.2

2.0

26.40

253.62

ng/l

—

Chromophobe cell carcinoma of kidney

178

1.27

0.41

3.1

3.6

288.55

207.24

ng/l

0.30

162

Other symptoms and signs involving the digestive system and abdomen

553

5324

1.04

0.41

3.4

2.7

179.09

190.61

ng/l

0.21

506

4874

Triptan medication for migraine, min. 3 purchases

1477

10778

1.02

0.40

2.3

2.6

84.72

125.74

ng/l

7.80

1302

9699

Radiodermatitis

1.41

0.40

1.6

3.2

380.33

200.09

ng/l

—

Benign neoplasm: Rectum/anal canal icd-9

270

1.20

0.40

3.1

3.3

270.98

281.88

ng/l

0.06

252

Malignant melanoma of skin

473

4545

1.04

0.40

2.4

3.2

219.70

225.41

ng/l

0.10

426

4181

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

227

2140

1.07

0.39

2.4

3.4

174.39

219.55

ng/l

1.16

205

1956

Non-small cell lung cancer, including Hilmo

663

6014

1.04

0.39

3.0

3.3

183.32

258.16

ng/l

5.79

623

5553

Intentional self-harm by jumping or lying before moving object

0.00

0.39

0.0

6.2

—

91.11

—

Small cell lung cancer, including Hilmo

863

0.90

0.39

2.5

3.3

201.18

286.52

ng/l

1.13

807

Small cell lung cancer

863

0.90

0.39

2.5

3.3

201.18

286.52

ng/l

1.13

807

Hereditary corneal dystrophies

120

1107

1.09

0.39

2.8

3.2

196.44

193.79

ng/l

0.03

110

1016

Type 1 diabetes, strict (exclude DM2)

169

1573

1.07

0.39

2.7

3.1

191.11

124.58

ng/l

1.08

156

1385

Hallux rigidus

475

4567

1.04

0.38

2.5

2.8

190.25

198.67

ng/l

0.16

425

4205

Syndrome of inappropriate secretion of antidiuretic hormone

152

1.28

0.38

2.6

247.39

224.40

ng/l

0.08

135

Pneumoconiosis due to dust containing silica

1.37

0.37

3.0

3.8

277.83

252.72

ng/l

0.07

Other and unspecified hydrocephalus

526

1.13

0.37

3.1

3.3

168.61

209.68

ng/l

0.43

480

Palindromic rheumatism

235

1.21

0.37

2.0

2.9

125.09

173.21

ng/l

0.39

219

Dysplasia of cervi uteri

538

3923

0.96

0.37

2.6

2.7

136.74

161.15

ng/l

0.75

486

3573

Malignant melanoma, including Hilmo

704

6827

1.03

0.37

2.5

3.2

225.43

225.57

ng/l

0.00

633

6296

Communicating hydrocephalus

628

0.88

0.36

2.6

3.3

183.78

240.03

ng/l

0.64

581

Malignant neoplasm of tonsil and base of tongue, including Hilmo

698

1.11

0.36

2.6

3.3

264.66

212.83

ng/l

0.39

645

Benign lipomatous neoplasm of other sites/unspecified

287

3012

0.95

0.36

3.1

3.2

261.77

213.88

ng/l

0.71

269

2763

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

128

1187

1.08

0.36

2.8

2.9

135.30

168.41

ng/l

0.58

111

1064

Benign neoplasm: Skin of ear and external auricular canal

138

1285

1.08

0.36

4.3

3.2

243.52

235.84

ng/l

0.07

128

1183

All dysplastic lesions of the cervix uteri

488

4625

1.04

0.36

2.4

128.85

107.69

ng/l

0.57

434

4153

Congenital retinoschisis

1.43

0.36

3.3

2.2

82.33

253.92

ng/l

—

Retained placenta and membranes, without haemorrhage

276

2626

1.05

0.36

2.7

2.6

90.16

122.94

ng/l

2.05

258

2400

Benign neoplasm: Pancreas

909

0.91

0.36

2.8

3.1

184.79

214.85

ng/l

0.29

841

Other/unspecified crystal arthropathies

200

1.22

0.35

2.5

3.2

154.16

221.01

ng/l

0.91

185

Other benign neoplasm of uterus: Cervix uteri

136

1.27

0.34

2.9

2.5

130.47

178.97

ng/l

0.44

123

Type 1 diabetes, definitions combined

169

1582

1.07

0.34

2.7

3.0

191.11

122.31

ng/l

1.14

156

1393

Abnormal findings in cerebrospinal fluid

1.32

0.33

3.3

2.7

232.83

96.54

ng/l

—

Malignant neoplasm of bronchus and lung

854

6955

1.03

0.33

3.0

3.3

204.84

253.07

ng/l

2.87

794

6429

Bacterial meningitis

837

1.09

0.33

3.2

3.0

154.73

186.93

ng/l

0.37

769

Other or unspecified paralytic strabismus

143

0.76

0.33

3.2

2.9

282.82

173.42

ng/l

0.22

130

Type 1 diabetes, strict definition

1038

0.92

0.32

2.6

3.1

220.06

90.74

ng/l

1.34

894

Supernumerary teeth EXCLUDE clefts and syndromes

1.29

0.32

1.2

2.7

36.00

92.93

ng/l

—

Congenital malformations of uterus and cervix

257

1.17

0.32

3.0

2.6

150.47

107.06

ng/l

0.48

223

Ulcerative colitis (strict) with PSC

110

1.29

0.32

4.1

3.0

111.14

121.07

ng/l

0.08

Oesophagitis, drug-induced

1.35

0.32

2.4

3.0

137.00

247.41

ng/l

—

Hereditary retinal dystrophy

324

1.15

0.31

2.8

4.1

117.87

200.29

ng/l

2.05

296

Tonsillectomy and adenotomy

1417

9663

1.02

0.31

2.6

2.9

103.21

131.81

ng/l

2.81

1233

8635

Endovascular or surgical operations to intracerebral aneurysms

167

1767

0.94

0.31

2.8

3.1

227.31

186.48

ng/l

0.54

151

1607

Other disorders of breast and lactation associated with childbirth

196

0.81

0.30

2.1

2.6

44.73

105.27

ng/l

2.10

168

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

574

1.11

0.29

3.3

3.5

121.92

261.43

ng/l

5.26

534

Other sexually transmitted chlamydial diseases

755

1.09

0.29

1.9

2.7

112.50

79.65

ng/l

0.43

634

Diastasis of muscle

139

1.23

0.29

2.5

3.2

44.83

159.51

ng/l

2.86

121

Malignant melanoma of skin, including Hilmo

572

5559

1.03

0.29

2.5

3.2

221.23

228.61

ng/l

0.15

516

5115

Haemorrhagic and haematological disorders of fetus and newborn

257

1.16

0.29

3.9

7.3

160.69

229.03

ng/l

0.44

237

Infections of breast associated with childbirth

468

1.11

0.29

2.6

2.7

93.30

86.48

ng/l

0.09

410

Insomnia

3435

23604

1.01

0.29

2.6

3.0

153.67

183.32

ng/l

4.68

3118

21502

Adenomyosis (Endometriosis of uterus)

394

4070

0.96

0.29

2.4

2.9

121.75

195.91

ng/l

8.50

350

3730

Malignant neoplasm, without specification of site, including Hilmo

185

1758

1.06

0.28

2.8

3.3

281.26

262.21

ng/l

0.15

172

1619

Viral conjunctivitis

384

1.13

0.28

2.4

2.9

156.08

159.72

ng/l

0.02

341

Malignant neoplasm of tonsil

442

1.12

0.28

3.0

3.3

272.37

208.55

ng/l

0.40

407

Laparoscopic left hemicolectomy

509

1.11

0.28

1.8

3.2

224.82

198.97

ng/l

0.17

465

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, including Hilmo

1.25

0.28

3.6

3.9

717.13

166.29

ng/l

—

Mononeuritis multiplex

1.33

0.27

3.8

2.5

108.30

136.86

ng/l

—

ILD medications: acetylcysteine

206

1.18

0.27

2.7

2.9

148.58

241.80

ng/l

0.82

190

malignant neoplasm of female genital organs, including Hilmo

627

6126

0.97

0.27

2.7

3.0

215.39

194.39

ng/l

0.44

575

5608

Malignant neoplasm of bone and articular cartilage, including Hilmo

520

1.10

0.26

3.6

3.3

161.82

213.18

ng/l

0.60

485

Adenocarcinoma and ductal carcinoma of pancreas

121

1284

0.94

0.26

2.6

3.5

225.45

234.98

ng/l

0.08

112

1188

Non-small cell lung cancer, squamous

172

1806

0.95

0.26

3.0

3.4

168.62

292.45

ng/l

7.31

162

1667

conjunctival degenerations and deposits

569

1.10

0.26

2.9

3.0

148.78

208.14

ng/l

1.06

525

Carcinoma in situ of cervix uteri

173

1646

1.05

0.26

2.4

2.6

128.23

124.13

ng/l

0.06

155

1465

Leiomyoma of uterus

2168

11992

1.01

0.26

2.7

2.8

165.12

170.68

ng/l

0.23

1978

10959

Peripheral retinal degeneration

860

0.93

0.25

3.3

3.1

124.36

201.45

ng/l

2.64

795

Optic neuritis

782

1.08

0.25

2.8

3.1

201.35

148.84

ng/l

0.62

704

Hydrocephalus in other diseases

137

0.79

0.25

3.1

2.6

116.91

175.11

ng/l

0.62

126

Deep endometriosis

248

2384

1.04

0.25

3.0

123.83

168.93

ng/l

2.58

226

2165

Bicornuate uterus

1.19

0.25

2.4

2.3

123.78

63.04

ng/l

—

Type 1 diabetes, strict definition, subgroup 1

961

0.93

0.25

2.4

3.1

191.12

91.76

ng/l

0.95

827

Cyst of Bartholin Gland

744

1.08

0.25

1.7

3.2

91.89

151.53

ng/l

2.24

671

Other congenital malformations of limb(s)

1.27

0.24

3.7

2.9

147.47

110.45

ng/l

0.11

Acute appendicitis, with complications

652

6371

1.03

0.24

2.8

3.0

207.51

193.81

ng/l

0.15

586

5819

Benign mammary dysplasia

471

4584

1.03

0.24

2.5

2.9

158.69

181.02

ng/l

0.96

422

4207

Optic atrophy, wide definition

443

0.90

0.24

3.2

3.5

326.70

221.41

ng/l

0.39

405

Malignant neoplasm, without specification of site

132

1254

1.06

0.23

2.9

3.4

306.07

284.68

ng/l

0.13

125

1159

Other disorders of choroid

429

1.10

0.23

3.5

3.3

202.39

224.39

ng/l

0.16

398

Embedded and impacted teeth

490

3873

1.03

0.22

3.1

2.8

141.17

121.70

ng/l

0.49

450

3362

Malignant neoplasm of trachea

0.00

0.22

0.0

3.2

—

134.82

—

Spontaneous abortion

1214

7997

1.02

0.22

2.5

2.6

103.28

132.52

ng/l

3.21

1122

7277

Toxic effect of metals

0.00

0.22

0.0

2.6

—

181.09

—

Microcephaly

0.00

0.22

0.0

4.5

—

283.00

—

Toxic effect of other inorganic substances

0.00

0.21

0.0

2.3

—

168.92

—

Acne, including avohilmo

365

2867

1.03

0.21

2.8

2.6

120.78

114.98

ng/l

0.12

308

2490

Renal cell carcinoma of kidney

110

1160

0.94

0.21

3.1

3.3

349.58

280.38

ng/l

0.59

103

1074

LSIL lesion of the cervix uteri, vagina or vulva

275

2660

1.04

0.21

2.3

2.6

164.26

120.20

ng/l

0.79

243

2396

Dental pulpitis, including avohilmo

3211

20358

1.01

0.21

2.7

2.9

126.97

168.61

ng/l

9.10

2838

18557

Renal agenesis and other reduction defects of kidney

1.26

0.21

1.8

3.1

561.60

191.37

ng/l

—

Diseases of thymus

1.27

0.20

3.2

1.9

247.50

129.57

ng/l

—

Malignant neoplasm of larynx, including Hilmo

645

1.08

0.20

2.7

3.2

309.07

276.00

ng/l

0.15

600

Malignant neoplasm of eye, brain and central nervous system

132

1259

1.05

0.20

2.0

3.4

165.77

209.56

ng/l

0.62

118

1158

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

733

1.07

0.20

3.9

3.4

177.31

253.62

ng/l

1.53

681

Congenital malformations of ear causing impairment of hearing

1.23

0.20

2.5

2.7

74.67

154.24

ng/l

—

Erosion and ectropion of cervix uteri

788

0.93

0.20

3.2

3.0

267.77

205.70

ng/l

0.58

722

Other and unspecified disease of Bartholin gland

726

0.93

0.20

3.1

147.73

188.92

ng/l

0.64

666

Malignant neoplasm of base of tongue

154

0.83

0.19

1.7

3.8

340.15

183.23

ng/l

0.31

141

Endometriosis of rectovaginal septum and vagina

228

2206

1.04

0.19

3.0

130.86

197.94

ng/l

4.33

208

2024

Benign neoplasm: Brain, unspecified

128

1.18

0.18

2.5

3.6

257.27

223.24

ng/l

0.07

117

Other puerperal infections

920

1.06

0.18

1.6

2.5

38.64

74.60

ng/l

4.04

798

Mesothelioma, including Hilmo

435

1.09

0.18

1.9

3.2

164.88

260.91

ng/l

1.66

404

Other inflammation of vagina/vulva

599

1.07

0.18

2.6

2.9

124.54

133.80

ng/l

0.08

542

Infections specific to the perinatal period

153

0.84

0.18

8.4

5.8

123.31

175.89

ng/l

0.42

142

Congenital hydrocephalus

1.17

0.18

2.1

2.2

32.57

112.19

ng/l

—

Vitreous prolapse

1.16

0.18

2.1

3.3

431.29

213.89

ng/l

—

Supervision of high-risk pregnancy

328

1918

1.03

0.18

2.2

70.68

82.56

ng/l

0.50

293

1708

Carcinoma in situ of prostate

131

0.83

0.18

2.5

3.6

181.55

230.37

ng/l

0.29

116

Primary angle-closure glaucoma

165

1591

1.04

0.17

3.1

228.59

235.15

ng/l

0.07

152

1465

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

330

1.10

0.17

2.2

3.6

111.37

201.89

ng/l

1.93

304

Use of interferon beta-1a

320

1.10

0.17

2.1

2.8

77.28

86.56

ng/l

0.16

280

Other and unspecified cicatricial alopecia

1.21

0.17

1.6

2.9

89.13

87.93

ng/l

—

Melanoma in situ of other and unspecified parts of face

443

0.92

0.17

2.2

3.3

295.62

240.16

ng/l

0.21

408

Exposure to other and unspecified man-made environmental factors

359

1.09

0.17

2.6

3.8

144.64

182.15

ng/l

0.49

320

Malignant neoplasm of bladder

285

2773

1.03

0.17

3.0

3.5

257.58

290.26

ng/l

0.64

261

2573

Benign neoplasm: Cranial nerves

813

0.94

0.17

2.9

3.0

238.84

193.26

ng/l

0.15

749

Renal agenesis and other reduction defects of kidney, including avohilmo

101

1.20

0.17

1.8

2.9

623.33

184.39

ng/l

0.86

Colour vision deficiencies

1.15

0.16

2.4

2.5

103.62

145.36

ng/l

—

Pterygium

975

0.95

0.16

4.0

3.0

250.99

231.10

ng/l

0.16

901

Unspecified urinary incontinence

314

3065

1.03

0.16

3.5

3.0

190.81

199.33

ng/l

0.18

279

2802

Diabetic retinopathy, strict definition

668

5833

1.02

0.16

4.3

3.5

384.99

223.58

ng/l

7.35

637

5313

Carcinoma in situ of breast

1.16

0.16

1.3

2.5

63.33

170.74

ng/l

—

Trichomoniasis

178

1.13

0.15

5.1

3.3

359.20

164.04

ng/l

0.80

167

Sexual dysfunction

390

1.08

0.15

2.2

3.0

132.04

145.35

ng/l

0.14

350

Paralytic strabismus

240

2336

1.03

0.15

3.5

3.0

260.83

213.85

ng/l

0.58

220

2136

Diabetic maculopathy

476

4413

1.02

0.14

3.9

3.4

362.72

218.53

ng/l

5.23

442

4001

Pediculosis and phthiriasis, including avohilmo

112

1.17

0.14

2.1

3.1

137.71

130.73

ng/l

0.04

101

Chondrosarcoma

1.21

0.14

1.7

4.6

342.60

231.83

ng/l

—

Motorcycle rider injured in noncollision transport accidents

532

0.94

0.14

3.2

3.0

149.01

147.32

ng/l

0.02

471

Gender identity disorders

118

0.84

0.14

1.6

3.1

28.20

53.62

ng/l

—

103

Other noninflammatory disorders of cervix uteri

145

1499

0.96

0.14

3.1

3.0

292.31

201.41

ng/l

1.06

129

1372

Maternal care for other known or suspected fetal problems

322

2065

0.98

0.14

1.9

2.4

63.55

71.84

ng/l

0.33

288

1837

Pneumoconiosis due to other inorganic dusts

0.83

0.14

4.6

3.0

198.75

254.91

ng/l

—

Use of dimethyl fumarate

1.20

0.14

1.6

2.5

85.92

63.59

ng/l

—

Optic atrophy

418

0.93

0.14

3.3

3.5

334.21

217.43

ng/l

0.43

380

Malignant neoplasm of base of tongue, including Hilmo

232

0.90

0.13

1.9

3.6

252.67

209.91

ng/l

0.12

215

Malignant neoplasm of larynx

510

1.06

0.13

2.5

3.3

369.75

262.84

ng/l

0.47

476

Crohn disease (strict definition, all UC cases excluded)

109

1050

1.04

0.13

2.4

2.8

124.60

157.84

ng/l

0.54

943

Benign neoplasm of male genital organs

652

0.95

0.13

2.7

3.1

288.57

232.84

ng/l

0.31

594

therapeutic use

103

992

1.04

0.13

3.6

2.9

245.57

200.76

ng/l

0.48

914

Other congenital malformations of female genitalia

1.18

0.12

4.8

2.3

112.90

98.92

ng/l

—

Malignant neoplasm of breast, ER-negative, including Hilmo

763

7049

1.01

0.12

2.8

3.0

188.08

184.29

ng/l

0.09

706

6462

Malignant neoplasm of pancreas

281

2753

1.02

0.12

2.7

3.4

186.06

235.70

ng/l

1.57

260

2545

Use of rasagiline

823

0.96

0.12

2.8

3.1

172.69

207.97

ng/l

0.52

763

Use of levodopa decarbox-comt-inhibitor

111

1147

0.96

0.11

2.8

3.1

232.83

229.12

ng/l

0.03

101

1058

Other noninflammatory disorders of vagina

217

2121

1.02

0.11

2.7

2.9

176.12

199.77

ng/l

0.35

197

1934

Malignant neoplasm of breast, HER-negative

697

6772

0.99

0.11

2.8

3.0

195.38

186.93

ng/l

0.20

642

6210

Uterine polyps

920

5317

1.01

0.11

2.5

2.9

158.70

206.09

ng/l

2.90

831

4883

Desensitization to allergens

771

0.96

0.11

2.6

3.0

97.44

103.89

ng/l

0.11

664

Malignant neoplasm of oesophagus

898

1.04

0.11

2.5

3.3

212.89

244.87

ng/l

0.41

833

Benign neoplasm: Testis

1.16

0.10

3.5

3.2

301.64

226.86

ng/l

0.18

Endometroid carcinoma of ovary, including Hilmo

251

1.08

0.10

4.8

3.8

110.05

231.56

ng/l

1.44

231

Premature separation of placenta [abruptio placentae]

319

1.07

0.10

2.1

2.8

73.05

96.81

ng/l

0.38

287

Medical abortion

2030

11056

0.99

0.10

2.6

2.8

165.99

166.94

ng/l

0.03

1842

10119

Macular cyst

114

1108

1.03

0.10

2.6

3.3

186.29

213.34

ng/l

0.36

100

1030

Miliary tuberculosis

1.07

0.09

2.8

3.6

191.80

233.42

ng/l

—

Toxic effect of contact with venomous animals

101

1041

0.97

0.09

3.1

3.0

190.11

181.89

ng/l

0.05

944

Pathological resorption of teeth

891

1.03

0.09

3.5

2.9

198.92

174.15

ng/l

0.28

805

Nontoxic single thyroid nodule

203

2071

0.98

0.09

3.3

2.8

215.50

174.30

ng/l

0.64

187

1890

Unspecified maternal hypertension

116

1.12

0.09

3.0

2.5

41.92

71.19

ng/l

1.45

105

Melanoma in situ, other sites/unspecified

1.15

0.09

2.7

3.4

121.91

194.76

ng/l

0.58

Allergic contact dermatitis due to drugs in contact with skin

527

1.05

0.09

3.9

3.0

193.22

189.22

ng/l

0.03

484

Dislocation, sprain and strain of joints and ligaments of head

793

1.04

0.09

2.8

3.2

128.05

159.53

ng/l

0.57

713

Ulcerative ileocolitis

807

0.96

0.09

2.5

3.0

212.52

162.58

ng/l

0.30

723

Disorder of carbohydrate metabolism, other/unspecified

1.10

0.09

2.3

3.2

52.50

101.36

ng/l

—

Viral conjunctivitis, including avohilmo

784

1.03

0.09

2.6

2.9

129.04

153.95

ng/l

0.29

698

Post-traumatic hydrocephalus, unspecified

0.78

0.08

2.2

4.5

75.40

283.90

ng/l

—

All dysplastic lesions of the vagina

548

1.04

0.08

2.9

2.8

102.76

163.63

ng/l

2.22

508

Other and unspecified syphilis, including avohilmo

0.77

0.08

1.4

2.6

213.80

179.40

ng/l

—

Osteochondrosis of ankle, juvenile

0.80

0.08

2.6

2.8

86.40

100.82

ng/l

—

Hydatidiform mole

215

1.07

0.07

1.7

2.4

50.30

124.22

ng/l

2.10

188

Other sexually transmitted chlamydial diseases, including avohilmo

119

1217

0.98

0.07

1.9

2.7

97.20

76.03

ng/l

0.38

1022

Contraceptive management

994

6992

0.99

0.07

2.8

2.6

100.16

118.47

ng/l

1.17

900

6242

Malignant neoplasm of uterus, part unspecified, including Hilmo

173

0.92

0.07

5.1

4.0

718.13

328.48

ng/l

0.96

160

Liveborn infants according to place of birth

0.87

0.06

23.3

5.8

324.89

227.44

ng/l

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

104

1063

0.98

0.06

3.0

2.8

126.32

129.72

ng/l

0.05

972

Microscopic polyangiitis

162

0.92

0.06

4.2

3.5

561.73

184.84

ng/l

0.62

148

Alzheimer’s disease (Early onset), excluding more controls

138

1278

1.02

0.06

2.6

2.9

213.40

336.25

ng/l

3.02

121

1161

Peroneal tendinitis

307

1.04

0.05

1.5

2.8

73.21

152.86

ng/l

2.33

283

Malignant neoplasm of brain

918

0.98

0.05

1.8

3.2

89.50

206.04

ng/l

6.77

838

Malignant neoplasm of brain, including Hilmo

140

1421

0.98

0.05

2.1

3.3

103.05

212.38

ng/l

8.81

126

1308

Degeneration of the brain due to alcohol

664

1.03

0.05

3.9

3.1

175.79

228.60

ng/l

0.62

606

208

2097

0.99

0.04

4.3

3.4

243.60

303.46

ng/l

1.15

195

1905

Malignant neoplasm of oesophagus, including Hilmo

126

1241

1.02

0.04

2.5

3.4

252.81

237.53

ng/l

0.15

114

1159

Placental disorders

1.10

0.04

1.5

2.4

19.90

99.79

ng/l

—

Other obstructed labour

142

1439

0.99

0.04

2.3

2.8

134.98

111.70

ng/l

0.37

127

1309

Malignant neoplasm of tonsil and base of tongue

596

1.03

0.04

2.7

3.3

292.47

212.88

ng/l

0.51

554

Benign neoplasm of thyroid gland

875

1.02

0.04

4.1

3.1

121.85

194.90

ng/l

3.30

804

Brain glioblastoma and astrocytoma

458

1.03

0.03

2.0

3.5

68.05

190.37

ng/l

5.64

424

Dermatitis due to ingested food

432

0.97

0.03

4.6

5.7

106.82

157.86

ng/l

0.75

381

Malignant neoplasm of ovary, including Hilmo

198

1997

0.99

0.03

2.6

3.0

189.50

176.31

ng/l

0.09

179

1825

Disorders of acoustic nerve

778

1.02

0.03

2.8

2.9

284.39

200.57

ng/l

0.29

710

Eustachian salpingitis and obstruction

151

1498

1.01

0.02

2.5

2.8

142.00

133.61

ng/l

0.10

135

1313

Maternal care for known or suspected abnormality of pelvic organs

425

2878

1.00

0.02

2.0

2.5

78.61

95.45

ng/l

0.63

370

2577

Degeneration of nervous system due to alcohol

671

1.01

0.01

3.9

3.1

175.79

221.31

ng/l

0.51

611

Human immunodeficiency virus [HIV] disease, including avohilmo

378

0.98

0.01

2.1

2.8

198.13

136.78

ng/l

0.31

334

Malignant neoplasm of ovary

147

1460

1.01

0.01

2.7

3.1

146.89

179.83

ng/l

0.51

133

1333

Other appendicitis

223

2241

0.99

0.01

2.5

2.9

182.86

177.27

ng/l

0.06

197

2040

Benign neoplasm of brain and other parts of central nervous system

191

1900

1.01

0.01

2.9

3.0

194.42

195.03

ng/l

0.00

170

1735

Maternal care for cervical incompetence

812

1.01

0.01

3.2

2.9

142.06

144.36

ng/l

0.03

747

Dentofacial anomalies [including malocclusion]

2250

17600

1.00

0.00

2.8

104.54

155.82

ng/l

13.14

2007

15955

Benign neoplasm of other and unspecified female genital organs

112

1126

0.99

0.00

2.9

3.0

266.70

181.68

ng/l

0.48

106

1028

Abrasion of teeth

1197

11975

1.00

0.00

2.6

2.8

118.08

164.19

ng/l

8.01

1092

10939

Motorcycle rider injured in other and unspecified transport accidents

109

1094

1.00

0.00

3.1

3.0

181.57

144.82

ng/l

0.36

958

Malignant neoplasm of other and ill-defined sites, including Hilmo

522

1.00

0.00

2.7

3.5

190.50

276.11

ng/l

1.03

485

Frontotemporal dementia

151

0.99

0.00

1.6

3.1

152.13

240.61

ng/l

0.72

136

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

621

1.00

0.00

4.1

3.3

361.02

251.98

ng/l

0.48

575

Melanoma in situ

160

1599

1.00

0.00

2.4

3.1

207.73

217.24

ng/l

0.11

142

1475

Rubella [German measles], including avohilmo

775

1.01

0.00

3.0

2.8

101.94

132.73

ng/l

0.58

690

Rubella [German measles]

775

0.99

0.00

3.0

2.8

102.74

132.73

ng/l

0.56

690

Frontotemporal dementia, wide, incl. Pick's disease

184

0.98

0.00

1.7

3.0

150.22

234.29

ng/l

0.85

165

Pediculosis and phthiriasis

1.02

0.00

1.7

3.5

158.53

150.93

ng/l

—

Use of riluzole

0.93

0.00

2.1

2.7

263.78

233.45

ng/l

—

Carcinoma in situ of respiratory system, other/unspecified

0.00

0.0

5.0

—

444.14

—

Other disorders of intestinal carbohydrate absorption

0.00

0.0

2.6

—

86.20

—

Haemophagocytic syndrome, infection-associated

0.00

0.0

1.6

—

85.00

—

Drug-induced folate deficiency anaemia

0.00

0.0

4.4

—

214.20

—

Other transitory neonatal endocrine disorders

0.00

0.0

1.2

—

113.00

—

Toxic liver disease with acute hepatitis, drug-induced

0.00

0.0

1.6

—

223.75

—

Other early complications of trauma

0.00

0.0

2.9

—

71.14

—

Pneumonia due to Haemophilus influenzae

0.97

-0.00

3.0

2.2

197.00

174.80

ng/l

—

Other congenital infectious and parasitic diseases

0.00

-0.00

0.0

9.4

—

349.40

—

Malignant neoplasm of other and unspecified major salivary glands

0.89

-0.00

2.8

4.1

56.25

164.05

ng/l

—

Mental and behavioural disorders due to hallucinogens

0.98

-0.00

2.8

2.4

139.67

128.28

ng/l

—

Brain medulloblastoma, helper endpoint

0.00

-0.00

0.0

6.9

—

76.86

—

Unspecified visual impairment

0.00

-0.00

0.0

1.6

—

304.20

—

Crushing injury of shoulder and upper arm

0.00

-0.00

0.0

2.4

—

64.43

—

Diastrofic dysplasy

0.00

-0.00

0.0

1.8

—

32.75

—

Monkeypox

0.00

-0.00

0.0

3.1

—

408.43

—

Disorders of other visual pathways

0.00

-0.00

0.0

2.6

—

147.40

—

Senile degeneration of the brain, not elsewhere classified

110

1.00

-0.00

2.6

3.2

120.98

334.68

ng/l

2.85

100

Hypervitaminosis D

0.00

-0.00

0.0

2.4

—

318.14

—

Chorioretinal scars

0.94

-0.00

3.9

3.5

346.63

157.79

ng/l

—

Protrusioacetabuli

0.00

-0.00

0.0

1.6

—

62.80

—

Follicular adenocarcinoma of thyroid gland

160

1.00

-0.00

2.5

3.9

285.09

274.76

ng/l

0.02

145

Asymptomatic human immunodeficiency virus [HIV] infection status

100

1.00

-0.00

2.0

2.9

404.70

124.54

ng/l

—

Brain medulloblastoma, including Hilmo

0.00

-0.00

0.0

6.9

—

76.86

—

Exposure to ignition of highly flammable material

0.94

-0.00

3.4

2.5

77.50

139.97

ng/l

—

Leptospirosis, including avohilmo

0.00

-0.00

0.0

2.3

—

70.33

—

Other and unspecified syphilis

1.00

-0.00

1.4

3.0

213.80

213.70

ng/l

—

Sequelae of inflammatory diseases of the central nervous system

0.97

-0.00

4.1

2.0

466.86

168.78

ng/l

—

Hereditary factor XI deficiency

0.00

-0.00

0.0

2.4

—

31.80

—

Psoriatic arthropathies, strict definition

0.00

-0.00

0.0

2.3

—

35.43

—

Fetal blood loss

0.00

-0.00

0.0

5.0

—

323.71

—

Monkeypox, including avohilmo

0.00

-0.00

0.0

3.1

—

408.43

—

Diphyllobothriasis and sparganosis

0.00

-0.00

0.0

2.1

—

99.00

—

Brain medulloblastoma

0.00

-0.00

0.0

6.9

—

76.86

—

Dietary selenium deficiency

0.00

-0.00

0.0

1.8

—

266.80

—

Malignant neoplasm of placenta

0.00

-0.00

0.0

1.9

—

79.00

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Natriuretic peptide B [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS